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Abstract
Abstract.
The herpes simplex virus genome contains an approximately 400 bp direct repeat at its 
ends known as the ‘a’ sequence, which contains all of the signals necessary for the cleavage 
and packaging of concatemeric replication products. During replication the genome is 
circularised, probably by direct ligation of the termini, generating a novel junction between 
two tandemly repeated ‘a’ sequences. We have cloned such a novel junction and in 
agreement with previous results (Nasseri & Mocarski, 1988), have shown that it can serve 
as a substrate for cleavage and packaging. The novel junction contains two highly conserved 
regions of the ‘a’ sequence which have been shown to be essential components of the 
packaging signal (pad and pac2). This thesis describes the introduction of specific 
mutations in this region and the development of a transient packaging assay to examine the 
effect of these mutations. In addition the mutants were tested for their ability to be serially 
propagated, extending the analysis beyond cleavage and packaging. Mutations were made 
using the motifs previously described by Deiss et al. (1986). The p ad  and pac2 regions as a 
whole were deleted using convenient restriction enzyme sites and individual motif mutations, 
were introduced using a site directed mutagenesis method based on that described by Kunkel 
etal. (1991). The mutant sequences were then tested for their ability to direct cleavage and 
packaging in the transient packaging assay. This identified that both the pad  and pac2 
sequences as a whole represent essential components of the packaging signal. Both the 
location and the sequence of the pac2 T rich element were also shown to be essential in a 
functional cleavage and packaging signal. In addition a substitution mutation of the pac2 
unconserved region reduced the efficiency of packaging directed by wt HSV-1 strain 17 but 
no effect on packaging efficiency was observed when HSV-2 strain HG52 was used. This 
result appears to indicate an unexpected divergence between HSV-1 and HSV-2. No 
function was attributable to either the conserved pac2 consensus sequence or any of the 
individual motifs of the pad  sequence. However, considering the importance of the pad  
region as a whole the lack of identifiably important motifs is likely to reflect a level of 
redundancy within the p ad  region as opposed to a lack of biological function.
Finally the mutants were used to examine the signals necessary for the serial 
propagation of defective genomes. This revealed that both GC rich regions of p ad  are 
involved in the serial propagation of defective genomes. No sequences within pac2 were 
identified as important. However, this may reflect either redundancy within the region or the 
importance of sequences which are also involved in DNA packaging.
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Introduction
Chapter 1 - Introduction.
Section 1 .1  - H erpesviruses - distinctive characteristics and structure. 
1.1.1 - Definition of the family Herpesviridae,
Herpesviruses are ubiquitous eukaryotic, enveloped viruses which have linear double 
stranded (ds) DNA genomes.
More than 100 herpesviruses have so far been isolated from a wide variety of 
eukaryotic organisms. Although the bulk of known herpesviruses have been identified in 
vertebrate organisms (fish, amphibians, reptiles, birds and mammals), at least one 
herpesvirus which infects an invertebrate organism has also been identified (Comps & 
Cochennec, 1993).
All of the herpesviruses identified to date share four common features:
1. All specify enzymes and other factors involved in nucleic acid synthesis and metabolism 
e.g. DNA polymerase and dUTPase. Herpesviruses also encode at least one protease and a 
variable number of protein kinases.
2. The synthesis of viral DNA, capsid assembly and at least one envelopment stage all occur 
in the nucleus of herpesvirus infected cells.
3. Virion production invariably leads to host cell death.
4. Most herpesviruses are known to establish a latent infection in their natural host.
Latency is a central feature of herpesviruses and is defined as the persistence of virus 
in the absence of clinically apparent infection. After initial infection of their natural host, 
herpesviruses frequently establish a latent infection with reactivated virus being detected 
either at a constant low level or intermittently in recurrent lesions.
Natural herpesvirus infections are usually limited to a single host, where they cause 
limited disease. However, while inter species infections are uncommon in nature, where 
they do occur, they can cause serious disease. This high degree of host specificity has been 
proposed as evidence that herpesviruses have co-evolved with their hosts which has been 
supported by examining the relationships between the genome sequences of multiple 
herpesviruses (McGeoch etal., 1995).
1.1.2 - Classification of herpesviruses.
Historically herpesviruses have been divided into three sub-families based on their 
biological properties, these being the alpha herpesvirinae, the beta herpesvirinae, and the 
gamma herpesvirinae (Roizman etal., 1992).
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Members of the alpha herpesvirinae sub-family are neurotropic and have a variable 
host range. They exhibit a relatively short reproductive life cycle, rapid spread in culture and 
the efficient destruction of infected cells. They also have the ability to establish latent 
infections in sensory ganglia. Members of this sub-family include herpes simplex virus type 
1 (HSV-1) and equine herpesvirus 1 (EHV-1).
Members of the beta herpesvirinae sub-family have a restricted host range, they have 
long reproductive cycles and the spread of virus infection from cell to cell is also slow. 
Infected cells frequently become enlarged (cytomegalia) and latent infections may be 
established in a variety of tissues including kidney, and secretary glands. Members of the 
this sub-family include human cytomegalovirus (HCMV), and human herpesvirus 7 
(HHV-7).
Members of the gamma herpesvirinae are lymphotropic, they also have a highly 
restricted host range but their reproductive cycle is variable. Latent infections are frequently 
established in lymphoid tissue. Members of this group include epstein-barr virus (EBV) and 
equine herpesvirus 2 (EHV-2).
With a few exceptions this classification corresponds to the groupings derived from the 
genetic relationships between the different viruses (Reviewed McGeoch et a l, 1993). 
Phylogenetic analysis of the available herpesvirus genomes has suggested a common 
evolutionary origin for the herpesvirus family approximately 200 million years ago. The 
exception to this is channel catfish virus, which appears to be even more distantly related to 
the herpesvirus lineage. How the recently identified oyster herpesvirus fits into the 
evolutionary picture is still unclear.
1.1.3 - Herpesvirus infections in humans.
Herpesviruses in general, cause a wide range of diseases in both humans and other 
animals. In the natural, immuno-competent, host the disease is not often fatal. In nature 
infections are usually restricted to a single species but, where inter species transmission does 
occur it can cause serious disease e.g. Pseudorabies virus infection of species other than pigs 
(Umene, 1998). In immunocompromised individuals herpesvirus infections can also be 
serious, even fatal e.g. HCMV infection of AIDS patients (Cotte et al, 1993). Some 
examples of human herpes vims infections are described below.
1.1.3.1 - Alphaherpesvirus infection.
The prototype alphaherpesvirus is HSV-1. Its natural host is man and primary 
infection usually occurs in the mucosa of the mouth or throat although HSV-1 is also capable 
of infecting the mucosa of the genital tract. Primary infection is usually asymptomatic but
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can lead to illness which is characterised by lesions in the mouth and throat, fever and a 
general malaise. Latency is usually established in the trigeminal ganglia, from where 
reactivation may occur. Reactivation is often associated with stress, fever, exposure to UV 
light, tissue damage and or immuno-suppression. Reactivated virus infection usually results 
in lesions of the skin in the area served by the trigeminal ganglia e.g. herpes labialis (cold 
sores)(Umene, 1998). One of the complications which can result from an HSV-1 infection 
is encephalitis, although this is usually restricted to neonatal and immuno-compromised 
individuals. Other complications can include keratitis and a disseminated infection involving 
organs such as the liver and adrenal glands (Whitley, 1996).
Varicella-zoster virus, the causative agent of chicken pox, and shingles, and HSV-2 
which is responsible primarily for recurrent genital infections are also alphaherpesviruses.
1.1.3.2 - Betaherpesvirus infection.
A betaherpesvirus which frequently infects man is human cytomegalovirus (HCMV). 
Primary infection typically occurs in morphonuclear leukocytes, monocytes or endothelial 
cells (Grefte et al., 1993; Saltzman et al, 1988 & Turtinen et al., 1987) and is usually 
asymptomatic even in immuno-compromised individuals. Where clinical disease does occur 
HCMV frequently causes a persistent fever and myalgia. Infrequent complications include 
pneumonia, hepatitis and encephalitis. The sites of viral latency remain unclear but sensitive 
detection methods have identified viral DNA in monocyte populations of peripheral blood 
(Taylor-Wiedeman et al., 1991)
Human herpesviruses HHV-6 and HHV-7 also belong to the betaherpesvirus 
subfamily.
AIDS patients appear to be particularly vulnerable to HCMV infection and infection of 
the liver, lungs, and CNS are quite common. HCMV also frequently infects the 
gastrointestinal tract of ADDS patients where disease can vary from superficial ulceration to 
more severe necrosis which often leads to a fatal perforation of the gut (Cotte et al., 1993).
1.1.3.3 - Gammaherpesvirus infection.
The gamma herpesvirus epstein-barr virus (EBV) infects man. Primary infection 
probably occurs in the mucosa of the nose and mouth, although it rapidly goes on to infect B 
cells which are transformed into an immortal lymphoblastoid state. Again primary infection 
is usually asymptomatic but EBV has been identified as the causative agent of a condition 
known as infectious mononucleosis in a proportion of adolescent primary infections. 
Symptoms range from a mild fever to months of debilitating illness including headaches, 
pharyngitus and general malaise. In immuno-compromised individuals the outcome of
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infection can be more severe, resulting in conditions such as oral hairy leukoplakia and 
Burkitt’s lymphoma.
Since its discovery EBV has been associated with several conditions characterised by 
malignant tumours, these include Burkitt’s lymphoma, nasopharyngeal carcinoma and 
Hodgkin’s disease (Magrath, 1990 & Kieff, 1995). Although EBV has been implicated in 
these conditions, secondary factors are also frequently involved e.g. co-infection with the 
malarial parasite plasmodium falciparim in cases of Burkitt’s lymphoma (Doumbe et al., 
1997).
Human herpesvirus 8 (Kaposi’s sarcoma) is a gamma herpesvirus which appears to be 
the causative agent of Kaposi’s sarcoma.
1.1.4 - Herpesvirus virions.
Herpesvirus virions vary quite considerably in size but all have a similar design. The 
virions range in size up to 200 nm in diameter but all are approximately spherical. The 
virions are composed of a linear ds DNA genome, which is packaged into an icosohedral 
capsid, an amorphous, often asymmetrical layer known as the tegument surrounds the capsid 
and this in turn is surrounded by a viral protein containing lipid envelope which is derived 
from the host.
1.1.4.1 - Herpesvirus genomes.
The genomes of all herpesviruses are linear ds DNA. The genomes range in size from 
120-240 Kbp but all are packaged into a capsid of between 100-110 nm in diameter. 
Although for many years the viral DNA was believed to be packaged around a protein core in 
a toroidal arrangement (Furlong eta l, 1972) more recent evidence suggests that herpesvirus 
DNA is packaged in a liquid crystalline arrangement, in the absence of a protein component 
(Booy et al, 1991).
Herpesvirus genomes often contain multiple internal and terminal repeat regions. 
These repeats give rise to considerable variation, both in terms of differences in the size of 
individual genomes (due to the copy number of terminal and/or internal repeats) and in the 
sequence arrangements of different viruses. Based on their sequence arrangements 
herpesvirus genomes can be classified into 7 classes, numbered 0-6, (Roizman et a l, 1992; 
Davison & McGeoch, 1995) (figure 1.1).
Group 0 genomes consist of a single unique sequence which lacks either internal or 
terminal repeat regions. The genome of the tree shrew herpesvirus is characteristic of this 
group of genomes (Koch et al, 1985).
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Figure 1.1 - Herpesvirus genome structures.
This figure shows a diagrammatic representation of the range of genome 
structures found in the herpesviridae. Genome structures 1-6 correspond to those 
defined by Davison & McGeoch (1995). Structure 0, corresponds to the F group 
defined by Roizman et al., 1992, without large terminal repeats.
Unique and repeat regions are shown as horizontal lines and rectangles 
respectively. The orientations of unique and repeat sequences are shown as arrows 
or arrow heads.
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Genomes which contain a single unique region which is flanked by direct repeats are 
designated as group 1 genomes. Channel cat fish virus is an example of a virus with this 
type of genome (Davison, 1992).
Group 2 and 3 genomes both have multiple copies of a terminal repeat sequence at their 
termini. However, while group 2 genomes have a single unique region, group 3 genomes 
have additional copies of the repeat sequence positioned internally. This gives rise to two 
unique regions which are flanked by inverted copies of the same repeat sequence. In 
addition the 2 unique regions of group 3 genomes are freely invertable which gives rise to 4 
equimolar genome isomers. Group 2 genomes include the genome of herpesvirus samiri 
(Albrecht et al., 1992), while characteristic group 3 genomes include the genome of 
cottontail rabbit herpesvirus (Cebrian et al, 1989).
EBV has a characteristic group 4 genome having a set of internal repeats which are 
unrelated to the terminal repeats (Baer et al, 1984).
Group 5 genomes have two unique regions which are flanked by inverted repeats. The 
repeats are not related and the repeat flanking the long unique region (UL) is significantly 
shorter than that flanking the short unique region (US). This leads to two genomic 
orientations of US but either completely or predominately one for UL. Varicella-zoster virus 
(VZV) has a characteristic group 5 genome structure (Davison & Scott, 1986).
Group 6 is similar to group 5 except that the inverted repeats flanking the UL region 
are larger and an additional repeat sequence known as the ‘a’ sequence is found at the termini 
and at the junction between the internal L and S segments. The presence of a larger UL 
flanking repeat also means that the UL region is freely invertable leading to the occurrence of 
4 equimolar genomic isomers. HSV-1 and HSV-2 are examples of herpesviruses with 
group 6 genomes (Roizman, 1979).
1.1.4.2 - Herpesvirus capsids.
Despite the fact that very little sequence homology is apparent between the major 
capsid proteins of some herpesviruses, cryo-electron microscopy has shown that 
morphologically the capsids are very similar (Booy et al, 1996). AH herpesviruses encode 
proteins which form an approximately icosohedral nucleocapsid of more than 100 nm in 
diameter. Of the herpesvirus capsids examined to date, all have a similar capsid stmcture. 
Capsids having a T=16 structure and comprise 162 capsomers (150 hexons and 12 pentons). 
Conserved features include the heterotrimeric complexes known as a triplexes which appear 
to stabilise the capsid structure, a closely knit inner floor layer, the axial channel which runs 
through each capsomer and the chimney like protrusions seen on both hexons and pentons 
(Booy et al, 1996).
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Three capsid types have been identified in infected cells and these have been labelled A 
(empty), B (intermediate) and C (full) capsids. B capsids appear to be the progenitors of A 
and C capsids which are believed to be the products of abortive and successful packaging 
events respectively. B capsids contain a proteinaceous core which is composed largely of 
the scaffold protein around which the capsid is formed. The proteinaceous core may be large 
or small dependent on whether the scaffold has undergone auto proteolysis following 
successful capsid assembly or not. The scaffold, once cleaved by the virally encoded 
protease, is believed to leave the capsid at the same time as the viral genome is packaged 
(Rixon, 1993).
1.1.4.3 - Herpesvirus tegument.
The tegument is an amorphous structure, surrounding the capsid, which is peculiar to 
herpesviruses. It has been frequently reported to be asymmetrically distributed but this may 
be an artefact of the conditions used to prepare the samples for electron microscopy (Rixon, 
1993). A variety of proteins have been identified as components of the tegument. The most 
notable group being the trans-activating proteins such as the HSV-1 protein UL48 (VP 16, 
ICP25, aTIF), a transcriptional activator which is required for the efficient expression of 
immediate early genes expression. For HSV-1 other components of the tegument include 
UL41 (VHS) which acts to shut off host cell protein synthesis (Smibert et al., 1992), US11 
which appears to be an anti attenuation factor for transcription (Roller et al, 1996) and UL36 
(ICP1-2) which amongst other things has been implicated in the release of viral DNA from 
the capsid (Batterson et al, 1983).
1.1.4.4 - The envelope.
The envelope of herpesviruses is derived from altered patches of cellular membranes 
(Morgan et al, 1959). Herpesvirus capsids have been observed budding into the perinuclear 
space and this was assumed to be how the virions obtained their envelopes. There are 
however, other studies which suggest that the virion envelope is not derived from either the 
nuclear or ER membranes thus supporting the hypotheses of de-envelopment and 
re-envelopment stages during virion maturation (Vangenderen et a l, 1994; Browne et al, 
1996).
Under the EM the lipid envelope contains numerous protein spikes which have been 
identified as viral glycoproteins (Wildy & Watson, 1963). The number of glycoproteins 
encoded by different herpesviruses varies but HSV-1 encodes at least eleven. Some have 
been implicated in the early stages of infection e.g. gB, gC, gD, gH and gL (UL27, UL44, 
US6, UL22 and UL1 respectively). The glycoproteins may also have roles in immune
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modulation (Friedman et a l, 1984; Johnson et al, 1988) and preventing the secondary 
infection of cells (Campadelli-Fiume, 1988).
Although glycoproteins make up the largest proportion of virally encoded membrane 
proteins in HSV-1, several other non-glycosylated proteins have also been assigned to the 
envelope. These include UL34, UL20 and UL43, the functions of which are unknown 
(Campadelli-Fiume, 1994).
1 .2  - Herpes sim plex virus type 1 . 
1.2.1 - Introduction.
Herpes simplex viruses were the first human herpesviruses identified and herpes 
simplex virus type 1 (HSV-1) is probably the most studied herpesvirus to date. HSV-1 is 
the prototype herpesvirus and as such a considerable amount is known about its structure, 
biology and life cycle.
1.2.2 - The HSV-1 genome.
The HSV-1 genome is approximately 152 Kbp in size, with a G+C content of 
approximately 68%. The genome conforms to the pattern of a class 6 genome as described 
in figure 1.1. It contains two unique regions denoted UL and US, which are 108 and 13 
Kbp, respectively, and are flanked by inverted repeats which have defined structures. The 
inverted repeats are composed of elements designated ‘a’ (250-500 bp), ‘b’ (8.8 Kbp) and 
‘c* (6.6 Kbp) sequences. The terminal L repeat (TRL) has a minimum structure of an ‘a’ 
and a ‘b’ sequence, there may, however, be more than one ‘a’ sequence present. The 
terminal S repeat (TRS) only ever contains a single ‘a’ sequence giving it the structure ‘ca’. 
The internal repeats are inverted with respect to the terminal repeats, which means that the 
structure of the HSV-1 genome can be written as amb-UL-b’a’nc’-US-ca, where m and n are 
variable. Figure 1.2 shows a diagrammatic representation of the HSV-1 genome (Ward & 
Roizman, 1994, McGeoch et al, 1988, Sarisky & Weber, 1994a). The invertable nature of 
the two unique regions gives rise to equimolar amounts of four functionally equivalent 
isomers (Martin and Weber, 1996).
1.2.2.1 - HSV genes and gene expression.
The HSV-1 genome contains approximately 80 open reading frames (ORFs) which 
have been divided into three classes based on when they are expressed during infection. 
These are the a  (immediate early or IE), |3 (early) and y (late) genes (Jones & Roizman,
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1979). Although there is some blurring of the boundaries, in general the genes are co- 
ordinately regulated in a cascade fashion.
The first genes to be expressed after infection are the a  genes, which reach a peak of 
expression approximately 2 hours post infection. Four of the five IE proteins are involved in 
regulation of gene expression (a4 / ICP4 or Vmwl75, aO / ICPO or Vmwl 10, a22 / ICP22 
or Vmw68 and a l l  / ICP27 or Vmw63). The fifth (a47 / ICP47 or Vmwl2) plays a role in 
inhibiting antigen presentation by infected cells. IE genes are expressed in the absence of 
prior viral protein synthesis and are characterised by the presence of the sequence 
TAATGARAT (where R is a purine) within their promoters (Gaffney et al., 1985).
P genes reach a peak of expression between 5 and 7 hours post infection and require 
the prior synthesis of a  proteins (Honess and Roizman 1974). This class of genes has been 
further divided into p] and p2 based on when they are first detected. The products of p1 
genes appear very quickly after infection but are differentiated from a  proteins by their lack 
of a TAATGARAT sequence and their requirement for a  proteins for efficient activation. An 
example of a pj gene is UL39 (ICP6) the large component of the viral ribonucleotide 
reductase. p2 genes are exemplified by the gene for the viral DNA polymerase. The 
remaining six proteins required for HSV-1 DNA synthesis are also P genes.
y genes generally reach a peak of expression after viral DNA replication has begun and 
again these genes have been sub-divided into two groups yi and y2. A characteristic gene 
is that encoding gD (US6) which is expressed relatively early in infection and is not 
dramatically affected by the inhibition of viral DNA replication. y2 genes, which are 
characterised by the gene encoding gC (UL44) are expressed late in infection and their 
expression is effectively inhibited in the absence of viral DNA replication (Kibler et al., 
1991).
1.2.2.2 - DNA replication.
The major features of herpes simplex virus DNA replication have comprehensively 
been reviewed by Challberg (1991) and Boehmer & Lehman (1997). Herpes simplex 
viruses have 3 origins of replication, which are described in sections 1.2.2.3 and 1.2.2.6, 
any one of these represents the essential cis-acting signal required for viral DNA synthesis. 
In addition HSV-1 contains seven genes that specify proteins with essential trans-acting 
functions in DNA synthesis. These are genes UL5 , UL8, UL9, UL29 (ICP8), UL30, 
UL42 and UL52. The functions of the encoded proteins have now been elucidated and their 
role in DNA replication characterised. UL5, UL8 and UL52 encode the three components of 
a trimeric helicase-primase complex. UL30 and UL42 represent the catalytic and accessory 
subunits of a heterodimeric DNA polymerase. UL29 encodes a single-stranded DNA
8
Introduction
binding protein, and UL9 a homodimeric protein that binds to specific sequences within the 
origin regions and can also function as a DNA helicase. It is thought that the initial event in 
viral DNA synthesis is the binding of UL9 to the origin regions and that the other proteins 
are recruited by virtue of a series of specific protein-protein interactions to form a replication 
complex. Unwinding of the origin region then allows synthesis of RNA primers, their 
extension by the DNA polymerase and the establishment of replication forks. All the HSV-1 
proteins except UL9 are presumed to also have essential roles at the replication forks where 
they allow co-ordinated synthesis of the leading and lagging strands. RNA primers are 
probably removed by the viral DNA polymerase, but two host proteins, a DNA ligase and a 
DNA topoisomerase are likely to be required for replication of the genomic DNA.
The major problem associated with the replication of linear genomes relates to the 
mechanism by which the ends are faithfully copied. In the case of HSV-1 there is 
overwhelming evidence that the virus overcomes this problem by existing in an “endless” 
form during most of the replicative cycle. Following infection input genomes are rapidly 
circularized, a process that does not require de novo viral protein synthesis. As described 
later circularization is most likely to occur by a direct end-to-end ligation. Double stranded 
circular molecules are usually replicated by either a theta form or rolling circle mechanism. 
In the case of HSV-1 it is proposed that, like bacteriophage lambda, an initial amplification 
of circular template molecules by theta form replication is followed by a phase of rolling 
circle DNA synthesis. The evidence for this is, however, far from conclusive. Nevertheless 
at late times of infection the replicated DNA clearly consists of concatemeric molecules 
composed of tandem repeats of the whole genome. Although this is consistent with a rolling 
circle mechanism other possibilities cannot be excluded, for example similar products may be 
formed as a result of recombination or the yeast 2 micron circle mode of replication. 
Whatever the mechanism, at least two process are involved in the conversion of the 
concatemeric molecules to mature linear genomes. Branched structure due to recombination 
must be removed prior to DNA packaging and it is thought that the ‘alkaline exonuclease’ 
encoded by UL12 plays a role in this process. Finally the concatemers are cleaved at specific 
sites, a process very tightly coupled to their packaging into the preformed viral capsids
1.2.2.3 - The UL region.
The UL region (108 Kbp) contains at least 56 genes (UL1 -UL56). A number of other 
genes have been proposed, some of which appear to encode genuine original products (e.g. 
UL26.5 and UL49.5) whilst the status of others is less clear (e.g. UL8.5, UL9.5, UL12.5, 
UL15.5, UL43.5). Another important function which is contained within the UL region of 
the HSV-1 genome is the origin of replication, OriL. The HSV-1 genome contains 3 origins
9
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of replication, one copy of OriL in the long unique region and one copy of Oris in each of the 
TRS and IRS regions of the genome. The functional significance of having three origins of 
two types is not yet understood. It does appear however, that only one copy of either OriL 
or Oris is required for efficient DNA replication which implies a certain level of redundancy 
(Igaroashi et al., 1993; Polvino-Bodnar et al, 1987). OriL is located in the untranscribed 
region between the UL29 and UL30 genes. The smallest OriL fragment which has been 
shown to act as an origin of replication in a transient replication assay contains a 144 bp 
perfect palindromic sequence with a 20 bp region containing exclusively A and T residues at 
its centre (Hardwicke and Schaffer, 1995; Lockshon & Galloway, 1988; Spaete & Frenkel, 
1982)
1.2.2.4 - The US region.
The US region (13 Kbp) contains at least 12 genes (US 1-US 12), with a thirteenth 
possibly represented by the more recently described US8.5 gene.
1.2.2.5 - The RL repeats.
The RL region comprises the ‘a’ and ‘b’ sequences and in HSV-1 strain 17 is 9.2 Kb 
in length. The ‘b’ sequence specifies the RL1 gene(Ackerman et al., 1986; Sarisky & 
Weber, 1994b), the antisense open reading frame ORFP (Lagunoff & Roizman, 1995) and 
the RL2 gene (Everett, 1984). The RL1 gene encodes the critical neurovirulence factor 
ICP34.5 which appears to prevent host cell apoptosis and the associated protein synthesis 
shut off (Chou & Roizman, 1992). The function of the antisense transcript ORFP is 
unknown, but it has been proposed as an antisense regulator of RL1 expression (Randall & 
Roizman, 1997). The ‘b’ sequence also encodes the latency associated transcripts or LATs. 
During latency the viral genome is transcriptionally silent with the exception of the LAT 
region. LATs are, largely, non-polyadenylated spliced introns which accumulate in the 
nucleus of latently infected cells (Rock, 1993), but although a considerable amount is known 
about their occurrence their function remains unclear. Several suggestions have been made 
regarding their potential for protein expression (Perry & McGeoch, 1988; Wechsler et al, 
1988; Wagner et al., 1988 a&b) but no LAT associated polypeptides have yet been 
identified. In addition the location of the LAT transcripts also overlap the RL1 gene, on the 
opposite strand,. This observation has lead to the hypothesis that they, like ORFP, are 
involved in the negative regulation of the RL1 gene (Russell et al, 1987; Harris et al, 1989; 
Clements & Stow, 1989). As described in section 1.2.2.7a both the ‘b’ and ‘c’ sequences
10
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also play a role in the respective inversions of the UL and US regions of the genome, giving 
rise to the four genomic isomers.
1.2.2.6 - The RS repeats.
The RS region (6.6 Kbp) comprises the ‘a’ and ‘c’ sequences. The ‘c’ sequence 
contains the coding region of the RS 1 gene. This essential a  gene positively regulates most 
(3 and y genes while negatively regulating itself and RL2 (Ward & Roizman, 1994). Each 
copy of the ‘c’ sequence also contains a copy of the Oris, origin of replication. HSV-ls Oris, 
has been located within an approximately 100 bp region between ICP4 and ICP22 or ICP48 
genes on either side of the S region (Stow & McMonagle, 1983). The prominent feature of 
oris is a nearly perfect 45 bp palindromic sequence centred around an 18 bp AT rich 
sequence. Although Oris and OriL are non-identical approximately 80% sequence identity is 
exhibited over the region corresponding to the Oris palindrome and approximately 40 bp to 
one side of it. Both origins also contain two strong binding sites for the HSV-1 origin 
binding protein UL9. The activities of the origins appear to be stimulated by the presence of 
flanking transcription factor binding sites which are associated with the divergent US 12 (or 
US1)/ IE175 and UL29 / UL30 genes (Hardwicke & Schaffer, 1995; Wong & Schaffer, 
1991). Like the ‘b’ sequence, the presence of two copies of the ‘c’ sequence in the HSV-1 
genome plays an important role in the inversion of the L and S segments.
1.2.2.7 - The ‘a’ sequence
The experimental work presented in this thesis is concerned with the role of the ‘a’ 
sequence in viral DNA packaging. The following section therefore reviews in greater depth 
our knowledge of the ‘a’ sequence structure and function.
The ‘a’ sequence of HSV-1 strain 17 is 380 bp in size and is itself composed of both 
quasi unique sequences and repeat elements. In addition, the ‘a’ sequence proper is flanked 
by a repeat element known as the DR1 repeat which is 20 bp long. Single ‘a’ sequences are 
flanked by separate DR1 repeats but where two ‘a’ sequences are tandemly repeated they 
share the intervening DR1 repeat. The DR1 repeat contains the site for viral DNA cleavage 
during the packaging of concatemeric DNA, however, the actual sequence of the DR1 repeat 
has been shown to be unimportant. This has lead to the hypothesis that cleavage occurs a 
fixed distance from a separate cleavage signals (Varmuza & Smiley, 1985).
The ‘a’ sequence itself contains two quasi unique regions, ub and uc, separated by a 
number of repeat elements, in the case of HSV-1 strain 17 these are known as DR2 repeats. 
It is the variability in the number and length of these internal repeats which gives rise to the
11
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variability in the size of ‘a’ sequences from different strains of HSV-1. The ub element is 80 
bp long while the uc element is slightly shorter at 72 bp. Separating these two elements are 
approximately 19 copies of the 12 bp DR2 repeat. The role of the DR2 repeats is not clear as 
they have been shown to be nonessential for the processes of encapsidation and genome 
isomerisation (Varmuza & Smiley, 1985)
A functional analysis of the ‘a’ sequence has identified two specific regions required 
for DNA cleavage and packaging which mapped to the ub and Uc elements. These sequences 
were shown to correspond to regions of conserved sequence found at the termini of a range 
of herpesviruses and this has lead to these elements being labelled the p ad  and pac2 
homologies (Deiss et al, 1986; Broil et al, 1999).
Based on DNA sequence comparisons, Deiss et al. (1986) identified four distinct 
regions within p a d , (l) a 40 to 50 bp GC rich region, which is followed by (2), a C or G rich 
region of variable length, (3) a T rich element which interestingly has a conserved location 
relative to the end of the genomes of a wide range of herpesviruses, (4) the final element is 
another G rich sequence.
Pac2 was defined as comprising (l) a short sequence with a consensus sequence 
CGCCGCG, (2) an unconserved region which is followed by (3) a T element which, like the 
p ad  T element is rich in thymidine and has a conserved start point, (4) the pac2 element 
finishes with a GC rich element (see figure 1.3). Subsequent investigators, using the larger 
number of sequences available, have been less convinced of the pac2 consensus sequence 
preferring to define pac2 as two GC rich regions separated by a T rich element (Broil et al., 
1999).
The functions of individual regions of p ad  and pac2 identified by Deiss et al., (1986) 
have not been subsequently investigated to test their functional significance.
As mentioned above ‘a’ sequences are found at the L and S termini as well as at the 
L-S junction. This arrangement means that even in a virion containing only single ‘a’ 
sequences, a tandemly repeated ‘a-a’ junction, will be formed when the genome circularises, 
shortly after infection. This scenario conflicts however, with the observation that, single ‘a’ 
sequences predominate in concatemeric DNA (Locker & Frenkel, 1979). This seems to 
suggest a complex replication mechanism in which the number of ‘a’ sequences may first be 
reduced and then amplified.
i) - Genome isomerisation and recombination.
The perceived importance of the HSV-1 terminal repeats, and in particular the ‘a’ 
sequence, in genome isomerisation has varied greatly over the years.
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Introduction
Initially in the mid 1970s it was thought that genome isomerisation was mediated by 
whole inverted repeats, in a process of homologous recombination (Sheldrick & Berthelot, 
1974). In 1980 however, an attempt was made to examine the actual mechanism of genome 
isomerisation. This was achieved by taking restriction endonuclease fragments of the 
genome and inserting them into the UL region of the genome. Using this system it was 
shown that the only fragment to drive additional genome isomerisation events (i.e. produce 
novel genomic isomers) was a fragment which spanned the L-S junction. The fragment in 
question contained a complete ‘a’ sequence as well as portions of the ‘b’ and ‘c’ sequences. 
This suggested that genomic isomerisation did not require a complete terminal or internal 
repeat (Mocarski etal., 1980). At this time the mechanism of isomerisation was believed to 
be one of site specific recombination. This was supported when it was shown that viral 
proteins were required in trans to initiate isomerisations within amplicons (an amplicon is a 
plasmid which contains both an origin of replication and a functional packaging signal) 
(Mocarski & Roizman 1982a & 1982b).
Some years later in 1988, following experiments in which duplicate L-S junctions or 
Tn5 transposon elements were placed into amplicons, it was shown that using only the 
minimum set of seven viral replication genes, isomerisation could be detected in amplicon 
sequences. These results indicated that recombination in HSV-1 was being mediated by the 
replication machinery and did not appear to be sequence specific. This made the probability 
of isomerisation occurring by a process of generalised recombination more likely (Weber et 
al, 1988). This finding was supported by work published in 1992, which found that while 
recombination between two directly repeated ‘a’ sequences was detectable in the absence of 
replication, it was greatly increased by the process of replication. One explanation for this 
observation was that during replication highly recombinogenic single stranded nicks were 
introduced into the genome. This would also account for the close link between replication 
and recombination (Dutch et al, 1992). In addition to the link between recombination and 
replication it was also observed that sections of the ‘b’ and ‘c’ sequences could lead to low 
levels of inversion (Longnecker & Roizman, 1986 & Vlazny & Frenkel, 1981).
All of these lines of inquiry seem to point towards a mechanism of homologous 
recombination for the isomerisation events observed in HSV-1. This model however fails to 
take into account firstly, the disproportionate recombinogenic activity of the ‘a’ sequence 
with respect to its size, and secondly the observation that sequences at each end of the ‘a’ 
sequence are particularly important in the process of recombination. Deletion of these 
sequences results in reduced DNA rearrangements and reduced generation of novel termini 
(Chou & Roizman, 1985; Smiley et al, 1990). It was noticed that the recombinationally 
sensitive regions of the ‘a’ sequence corresponded to the independently isolated signals for
13
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the cleavage and packaging of viral DNA. This, combined with the observation that inter ‘a’ 
sequence recombination could also occur between fragments which did not share any other 
homology, lead to the hypothesis that recombination was mediated by the free ends 
generated during cleavage and packaging. In early 1994 one publication gave support to the 
importance of this event and at the same time linked the ‘a’ sequence to observations 
supporting a mechanism of homologous recombination. The report proposed that it was 
double stranded breaks that were required for recombination and not specific DNA 
sequences. It was again confirmed that the cleavage and packaging signals were particularly 
important for the induction of high frequency recombination, however, by separating 
packaging signals from the cleavage event using a temperature sensitive mutant for 
packaging and introducing ds breaks into the viral genome with a non HSV-1 endonuclease, 
it was possible to show that it was the double stranded breaks which were responsible for 
the recombination. Therefore the ‘a’ sequence would appear to be a so called ‘hot spot’ 
simply because it coincides with a double stranded break generated by cleavage. In addition, 
it was noticed that the recombinogenicity of the ‘a’ sequence was only observed in the 
absence of its normal sequence environment, that is to say adjacent to the ‘b’ or ‘c’ 
sequences with their highly repetitious regions (Sarisky & Weber, 1994a). This suggestion 
is supported by work from two laboratories. Firstly the identification of a host cell 
endonuclease which cleaves viral DNA within DR2 repeats producing ds breaks (Wholrab et 
al, 1991) and secondly, the discovery that HSV-1 ss DNA binding protein possess a Rec-A 
like ability which promotes homologous pairing and strand transfer (Bortner et al, 1993).
In HSV-1 the dispensability of the ‘a’ sequence in the mechanism of L and S segment 
inversion was finally confirmed in 1996. A recombinant virus was engineered without ‘a’ 
sequences at the LS junction or the L and S termini. In order to produce a viable virus a 
single ‘a’ sequence was inserted into the thymidine kinase gene in the UL region of the 
genome. The resulting recombinant virus was able to invert its L and S segments at wt 
levels, producing all four genomic isomers. Interestingly only two of the genomes were 
packaged into virions allowing an investigation of the kinetics of recombination to be made. 
Infections using the virions containing only two genomic isomers resulted in regeneration of 
the other two isomers with a high degree of efficiency. All four genomic isomers were 
readily detected at a stage of infection, co-incident with the onset of DNA replication, 
supporting the idea that genome isomerisation is mediated by an ‘a’ sequence independent 
homologous recombination mechanism, which is enhanced by the process of DNA 
replication (Martin & Weber, 1996).
A number of alternative solutions to the genome isomerisation puzzle have also been 
proposed, although at present their validity is less well established. Firstly a mechanism for
14
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novel rolling circle replication has been proposed (Zhang et a l, 1994) which could account 
for genomic isomers. This model proposes the existence of circular dimers of two viral 
genomes, which could theoretically provide all of the genomic isomers in equimolar amounts 
simply by using different cleavage frames. Secondly a host recombinase has been isolated 
from un-infected cells which promotes inter ‘a’ sequence recombination in vitro. This 
recombinase, however, appears to have features which are not consistent with characteristics 
observed for HSV-1 recombination. Its role is, for this reason probably less significant 
(Bruckner et a l ., 1992; Sarisky & Weber et al, 1994a).
ii) - Genome circularisation.
In 1982 the role of the terminal repeats was proposed to include the circularisation of 
the genome (Mocarski & Roizman, 1982b). The prevailing view at the time was that ligation 
of the two termini was preceded by 5’-3’ exonuclease digestion of each terminal ‘a’ 
sequence, forming two cohesive ends (Wadsworth et al., 1976). However, it has been 
shown that the L terminus terminates with 18.5 bp of a DR1 repeat, while the S terminus 
terminates with 1.5 bp of a DR1 repeat (in each case 0.5 bp indicates a single nucleotide 3’ 
overhang). This means that the two might be directly ligated via their single base overhang 
in the process generating a complete 20 bp DR1 repeat. The free energy associated with the 
complementary binding of a single base pair is, however, very small making a protein 
interaction quite likely in this process. Although no candidate interactions have been 
identified to date, the fact that the each terminus contains at least one ‘a’ sequence suggests 
that signals within the ‘a’ sequence could prove to play an important role in this process. A 
mechanism of direct ligation of the termini would also appear to be important for 
circularization of the many herpes viruses which lack a terminally redundant element
A mechanism of genome circularisation which involves homologous recombination 
does however remain possible. In support of this, it has been shown that the ‘a’ sequence of 
HSV-1 can direct circularisation both by imprecise end joining and non-conservative 
homologous recombination (Yao et al, 1997).
A subsequent study of GPCMV has directly implicated the pac2 homology in the 
circularisation mechanism and appears to support a mechanism of direct ligation (McVoy et 
al, 1997). GPCMV generates three different termini which have been designated R, O and 
M. Viable genomes have an R terminus (containing a pad  homology) and either an M 
(containing a pac2 homology) or an O terminus. Both types of genome undergo 
circularisation soon after infection indicating that they contain all of the sequences necessary 
for circularisation. The O and M termini differ in the presence (M) and absence (O) of the 
terminal repeat and consequently there is very little sequence homology between them. 
Sequence comparisons have, however, identified two regions of the O terminus which
15
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appear to be related to the pac2 T rich element and 6 bp of the GC rich element which occur 
on the M termini. No region of homology corresponding to the pac2 consensus sequence 
was identified. Assuming that circularisation requires the specific recognition of both termini 
these observations appear to implicate pac2 or at least a degenerate pac2 sequence in genome 
circularisation. The other important aspect of this study is the finding that genome termini 
which lack extensive sequence similarity are efficiently joined during circularisation. This 
suggests that, in GPCMV at least, the principle mechanism of circularisation involves 
ligation of the termini rather than homologous recombination or cohesive end formation.
Finally, it also appears likely that cellular proteins are involved in the process of 
circularisation. The RCC1 gene of BHK cells, which is a regulator of chromosome 
condensation, has been implicated as viral DNA remains linear in cells lacking RCC1 
(Umene & Nishimoto, 1996).
iii) - The role of the ‘a’ sequence in the regulation of gene RL1.
The RL1 gene, which encodes the ICP34.5 protein, is unusual in that it lacks the usual 
regulatory sequences found upstream of HSV-1 genes. Surprisingly this includes the almost 
ubiquitous TATA box. The other striking feature about this gene, is the presence of an ‘a’ 
sequence directly upstream with its highly repetitious GC rich regions. In order to examine 
the regulatory mechanisms of this gene, promoter deletions were constructed. From these 
studies it was found that the promoter consisted of a core promoter, which had full wild type 
activity and two upstream silencer elements. These silencer elements mapped to the DR2 (‘a’ 
sequence) repeats and the DR6 (‘b’ sequence) repeats. These regions were found to posses 
an unwound SI nuclease sensitive (anisomorphic) DNA structure, the structure of which 
was essential for repressor function. Further study, using differently super coiled DNA and 
an in vivo protein : DNA binding assay, suggest that host cell, protein binding is involved in 
the silencing mechanism (Sarisky & Weber, 1994b). Despite this it has since been reported 
that the deletion of the DR2 repeats in a recombinant virus did not significantly effect the 
expression of ICP34.5 (Martin & Weber, 1998)
iv)- The role of the ‘a’ sequence in DNA cleavage and packaging.
The role of the ‘a’ sequence in the cleavage and packaging of the virus genome was 
first identified by Stow et al, (1983). Using an amplicon packaging system it was shown 
that a plasmid containing an origin of replication and sequences from the termini of the virus 
genome could be packaged into viral particles. Further investigations have shown that all of 
the signals required for cleavage and packaging are contained within a 179 bp sequence from
16
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the junction between two tandemly repeated ‘a’ sequences (Nasseri & Mocarski, 1988). 
This sequence contains most of the uc, ub sequences separated by a single DR1 repeat. The 
role of the ‘a’ sequence in cleavage and packaging is discussed in more detail in 1.3.2.1.
17
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1 .3  Virus Genome Packagin g. 
Section 1.3.1 - ds DNA packaging in bacteriophage.
The study of bacterial viruses, or bacteriophages, has been underway since their 
discovery, as filterable agents, between 1915 and 1917. This has lead to a considerable 
wealth of information about their structure and biochemistry as well as their life cycle.
The DNA of ds-DNA bacteriophages is packaged in a highly condensed form, within a 
protein shell made of virion encoded proteins. The current view is that in most cases the 
DNA is packaged in a quasi-liquid crystalline arrangement which gives a packaging density 
which approaches the maximum possible (Cerritelli et al, 1997; Booy et al, 1991).
Based on the arrangement of the virion genome, ds-bacteriophages can be divided into 
three groups (Fujisawa & Morita, 1997): 1) Linear genomes with non-unique sequences 
repeated at their terminus e.g. T4. 2) Linear genomes with unique sequences repeated at 
each terminus e.g. X, T3 and T7. 3) Other genome structures such as linear genomes with 
covalently attached protein or circular genomes. Of course considerable variation is apparent 
within these groups but in general they serve as a good basis for discussing the different 
strategies that bacteriophages employ to package their genetic material.
Despite this variation in the genome structures of ds bacteriophage, in general their 
replication mechanisms lead to an accumulation of concatemeric DNA, i.e. multiple copies of 
the phage genome joined head to tail. This high molecular weight DNA forms the substrate 
for the DNA packaging machinery, which produces packaged unit length genomes. Several 
mechanisms for DNA packaging are discussed below. However the focus is on the linear 
dsDNA phages such as T4 and X as they are more likely to share similarities with 
herpesviruses. The mechanisms utilised by viruses such as the small circular phages PI and 
P2 are not discussed.
The central elements of the DNA packaging process are thought to be similar for most 
ds DNA phages. DNA is packaged into a preformed protein shell known as the prohead. 
While the prohead may exhibit rotational symmetry the vertex through which the DNA enters 
the prohead is specifically known as the portal vertex. At this portal vertex the DNA enters 
through a non-head protein complex known as the connector. The connector is essential for 
DNA packaging but it is not thought to be responsible for catalysing the packaging reaction, 
this function is fulfilled by another non-head protein, the packaging enzyme or terminase. 
The energy necessary for DNA translocation is almost certainly provided by ATP hydrolysis 
and while it has not been exclusively shown that this is carried out by the terminase, several 
terminases have been shown to exhibit ATPase activity. In addition to providing the energy
18
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required for DNA packaging, ATP has also been implicated as an allosteric effector of 
packaging complex formation. (Shibata et al., 1987).
For a considerable number of bacteriophage the initial step in the packaging of 
concatemeric DNA involves the recognition of a specific sequence e.g. pac or cos site. This 
initial recognition event is followed by either a site-specific cleavage (e.g. X, T3 and T7) or 
cleavage at a non-specific site(e.g. Tl). This is known as the initial cleavage event. DNA is 
then packaged uni-directionally from the newly generated end. Once the procapsid is full a 
second cleavage is made. Again this cleavage may be site specific as in X, T3 and T7 or non 
specific as in Tl.
A variation on this type of mechanism is that employed by T4. T4 DNA packaging 
appears to be almost completely non site specific. The location of the initiation cleavage 
event is close to random, although there is some evidence of preferred initiation sites 
(Franklin et al., 1998), and the termination cleavage is performed only when the capsid is 
full i.e. when 104% of a unit length has been packaged (Black, 1995; Lin & Black, 1998) 
This, so called headful packaging, appears to have a role in the strategy of a number of 
bacteriophage, even those with defined initiation and termination signals, and although the 
mechanisms which control it are not fully understood, it is becoming apparent that the portal 
proteins play a central role (Cue & Feiss, 1997).
Central to the mechanism of DNA packaging is the packaging enzyme or terminase. 
Where they have been identified, terminase enzymes exhibit DNA dependant ATPase activity 
and it is the energy released by this hydrolysis which is thought to drive the 
thermodynamically unfavourable packaging process. In general terminases are commonly 
composed of two subunits, a large and a small subunit. The large subunit is responsible for 
procapsid binding, DNA translocation and DNA cleavage as well as containing either the 
putative or demonstrated ATP binding site (Rao & Black, 1988; Babbar & Gold, 1998). It 
is ATP hydrolysis at these sites which is thought to drive DNA translocation. The small 
subunits have DNA binding activities which appear to be involved in the recognition of the 
DNA to be packaged (Catalano et al, 1995).
1.3.1.1 - DNA packaging in bacteriophage X.
The bacteriophage X has been studied in some detail and for this reason the mechanism 
which it employs to package its DNA will be explored in a more detail.
The lambda virion is composed of an isometric (T=7) head, which contains the phage 
genome, a long tail, which is surrounded by a contractile sheath and a single fibre which is 
attached to a structure known as the base plate at the base of the tail. The genome, which is 
linear in the phage particle, is approximately 48.5 Kbp long and terminates in a
19
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complementary 12 bp 5’ overhang. Shortly after infection the termini are ligated together to 
form a covalently closed circle.
The lambda genome is replicated, initially via the theta mode of replication but at later 
stages rolling circle replication and recombination give rise to concatemeric DNA which 
forms the substrate for DNA packaging (Furth & Wickner, 1983).
a) - The packaging signal of lambda.
X has a tri-partite cleavage and packaging signal know as the cos site which is found at 
the junction between viral genomes in the replicated concatemer. Cos can be divided into 
three components, co^N, cosB and cosQ (figure 1.4).
CosN is 22 bp long and is the site of viral cleavage. Ten of these bases display 
imperfect rotational symmetry. CosN is both necessary and sufficient for terminase binding 
as indicated by the fact that the large subunit of the terminase has nicking activity at cosN 
(Rubinchik et al., 1994a). Terminase has been shown to introduce two ss nicks into cosN at 
positions Nj and N2 (figure 1.4b). In addition, kinetic studies of this interaction appear to 
suggest that it is a terminase dimer which binds to cosN (Tomka & Catalano 1993a).
CosB is composed of 3 core elements, R l, R2 and R3. Collectively these sites are 
involved in the initiation of DNA packaging. Along with ATP the cosB site stimulates the 
efficiency and fidelity of cosN cleavage by the terminase (Cue & Feiss, 1993a; Rubinchik et 
al, 1994a). More specifically, R l, R2 and R3 have been shown to interact directly with the 
small subunit of the terminase enzyme (Bear et al, 1984; Shinder & Gold, 1988). Another 
feature of the cosB site is the presence of a consensus binding site (II) for integration host 
factor (IHF)(Bear et al, 1984). IHF is the site specific, DNA bending protein of E. coli and 
it has been shown that IHF does bind to II introducing a sharp bend between R3 and R2 
(Kosturko et al, 1989). This has been proposed to facilitate co-operative interactions 
between terminases bound at R3 and R2/R1, a conclusion which is supported by the 
observation that deletion of R2 and Rl produces a phage which is IHF insensitive (Cue & 
Feiss, 1992). Finally, several mutant viruses have also implicated cosB in the termination 
cleavage, it appears that cosB and a second site 12, which is found between cosN and cosB 
(Xin & Feiss, 1988; Mendelson et a l, 1991) act in concert to direct nicking at N] during 
termination (Cue & Feiss, 1998).
The other major element of the cos packaging signal is the 14 bp cosQ. CosQ is not 
required for the initiation of packaging but cosQ- mutants have been shown to be defective in 
the termination cleavage event (Cue & Feiss, 1993b). CosQ is responsible for directing 
nicking at N2 during termination, however, as mentioned above, cosQ alone is not the only 
part of cos which has been implicated in the termination of packaging. Thus it appears that 
cosQ constitutes one part of a larger termination signal (Cue & Feiss, 1998).
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Figure 1.4 - Lambda’s packaging signal.
A. shows the component features o f the Xcleavage and packaging signal. The
cleavage event at the initiation o f packaging occurs at cosN in conjunction with 
Rl -3 and II which are are collectively known as m sB. Termination cleavage 
involves a number o f different sequences including those found at cosQ and 12.
B. shows the detail o f  the cleavage site <%>xN. Cleavage introduces two nicks 
which are 12 bp apart (N, and N2). The cleavage site as a whole exhibits 
imperfect rotational symmetry about the point marked by the red dot.
C. Shows the termini generated by the cleavage event. The terminase remains 
specifically attached to the cosB containing terminus, forming complex I.
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b) - X terminase.
The lambda terminase is composed of two virally encoded subunits, gpNul and gpA. 
The combined holoenzyme is responsible for a number of functions. These include the 
recognition of the concatemeric lambda DNA, the initiation of DNA packaging, including the 
introduction of nicks at cosN. The translocation of the viral DNA into the procapsid, with 
the concomitant hydrolysis of ATP and the terminal cleavage at cosN, in conjunction with 
cosQ, cosB and 12.
gpNul, the small subunit of the terminase, is the product of the N ul gene and is 181 
amino acids in size. gpA, the large subunit, is the product of gene A and is 641 amino acids 
in size. gpA has been shown to have, site specific endonuclease, DNA helicase and DNA 
dependant ATPase activities which closely resemble those seen for the terminase complex as 
a whole (Davidson & Gold, 1992; Rubinchik et al, 1994a & b). In addition to these, 
several other motifs have been identified. These include a domain for gpA binding to the 
prohead, a specificity domain for gpA : gpNul binding (Yeo & Feiss, 1995a) and a putative 
leucine zipper domain which is potentially involved in terminase dimerisation (Davidson & 
Gold, 1992).
The same techniques used above to dissect the functional elements of gpA have also 
been applied to gpNul. This identified domains for both cosB binding and gpNul : gpA 
interaction. The cosB binding domain forms a putative helix-tum-helix domain (Frackman et 
al, 1985) which is a characteristic of many sequence-specific DNA binding proteins. In 
addition to these domains, and in a marked departure from the other bacteriophage which 
have been studied in detail, the small subunit of the lambda terminase (gpNu 1) also exhibits 
DNA dependant ATPase activity (Becker & Gold, 1988; Tomka & Catalano 1993b; 
Rubinchik et al., 1994b)
c) - The packaging mechanism employed by lambda.
Using what is known about cos and the DNA packaging proteins of lambda a model 
for DNA packaging can be constructed (Catalano et al, 1995) (Figure 1.5).
i) - Initiation.
The initial step in the mechanism is the binding of terminase, probably as a terminase 
dimer, at a cos site on the replicated concatemeric DNA. This is followed by the introduction 
of two ss nicks in cosN (N! & N2). The binding of a terminase dimer, which has been 
alluded to above, is based on the imperfect rotational symmetry seen at the cosN site and on
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Figure 1.5 - A model for lambda DNA packaging.
This figure describes the model for XDNA packaging proposed by Catalano 
et al. (1995). A. The initial step in packaging probably involves at least one 
ATP associated terminase enzyme binding to cosN and cosB. B. Two nicks 
are introduced at N } and N2 in a mechanism which is stimulated by ATP but 
does not require ATP hydrolysis. C. The cohesive strands are subsequently 
separated and the protein complex undergoes a structural reorganisation which 
results in the formation of complex I. ATP is hydrolysed during this process 
but it is unclear whether ATP drives the strand separation or the structural 
reorganisation. E. Complex I binds to the portal vertex of a prohead 
generating complex II, DNA packaging then commences with the concomitant 
hydrolysis of ATP. F. DNA packaging continues until a suitable termination 
signal is reached. G. On reaching the termination signal cleavage occurs and 
the terminase dissociates, from the now full head but remains attached to the 
free terminus thus regenerating complex I.
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the kinetic analysis of the endonuclease activity of gpA, which predicts that two terminases 
are required to perform a single cleavage event (Tomka & Catalano, 1993a). In addition, the 
rotational symmetry of cosN is a common feature amongst DNA binding sites for dimeric 
proteins (Aggarwal etal., 1988)
As well as the interactions between gpA and cosN, the interactions between gpNul 
and cosB are also important in the formation of the initial complex. The binding of IHF at II 
appears to facilitate gpNul : cosB interactions and these in turn enhance the efficiency and 
fidelity with which the terminase is able introduce the initial nicks at cosN.
In addition to the protein components of this complex, another co-factor has been 
identified. Where low concentrations of terminase or cosB mutants were used, the presence 
of ATP has been shown to have a marked effect on the efficiency with which terminase is 
able to introduce nicks at cosN. Importantly, ATP hydrolysis is not required as non 
hydrolysable nucleotide triphosphate analogues have an analogous effect (Higgins et al, 
1988). It has been shown that the presence of ATP does not increase the affinity of the 
terminase for DNA. Instead the increased efficiency of nicking at cosN is a consequence of 
an apparent increase in the endonuclease activity of gpA (Cue & Feiss, 1993a).
In summary two heterodimeric terminases, IHF and ATP are all involved in the 
formation of the initial complex which forms with the cos DNA. This complex leads to the 
introduction of two single stranded nicks (12 bp apart) at casN.
Once the duplex has been cut by the terminase the annealed strands are separated, in a 
process which is performed by the gpA subunit of the terminase, and appears to require ATP 
hydrolysis (Higgins etal., 1988). Whether ATP hydrolysis provides the energy for strand 
separation, in a DNA helicase type mechanism, or whether ATP hydrolysis drives the 
reorganisation of the protein subunits which make up the complex remains unclear. What is 
apparent, however, is that at the same time as strand separation significant subunit 
reorganisation occurs, which leads to the formation of a relatively stable complex in which 
the newly formed terminus is bound to the terminase (Cue & Feiss, 1992 & 1993b). This 
complex, first identified by Becker et al, (1977), is called complex I.
It is as part of this complex that the gpA subunit(s) interact, via the connector, with the 
prohead. The interaction of the prohead with complex I, promoted by a viral protein gpFl 
(Yeo & Feiss, 1995b; Davidson & Gold, 1987), forms complex II. This large complex 
contains all of the necessary components for the packaging of the viral genome. gpFl 
appears to promote complex II formation by destabilising complex I, in a reaction analogous 
to the way in which chaperonins destabilise the gpO, gpP; DNAB protein complex which 
forms at the X origin of DNA replication (Liberek et al, 1988).
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iil - Translocation.
Complex II is responsible for translocating the viral genome into the prohead cavity, 
using the energy released by ATP hydrolysis. Very little is known about how this is 
achieved but a number of models have been proposed, some of which are discussed in 
section 1.3.1.4.
The translocation process is none-the-less quite impressive. It has been estimated that 
the full length lambda genome, of 48.5 Kbp, is packaged in less than 5 minutes using 
approximately 29,000 molecules of ATP. This rate of packaging, which equates to 
approximately 160 bp sec-1, combined with the relatively poor ATPase activity of purified 
terminases has lead to the suggestion that ATP hydrolysis probably occurs at more than one 
site e.g. multiple terminases, multiple sites of a single terminase, or even sites within the 
prohead (Morita et al, 1993; Shibata et a l, 1987). Several other properties of different 
DNA translocation complexes are also worthy of note at this point. For T3, the interactions 
between the DNA and the terminase during translocation have been shown to be weak, both 
in the presence and absence of ATP. The packaged DNA does not require superhelicity as 
both nicked and cross-linked DNA can be packaged. However, intercalating agents do 
inhibit packaging which suggests that the terminase recognises the exterior structure of the 
DNA helix (Fujisawa et al, 1987; Shibata et al, 1987).
iii) - Termination.
The termination of DNA packaging in lambda requires that cosN must be recognised 
and cut, the cohesive ends must be separated and the terminase must disassociate from the 
prohead. A feature of several viral DNA packaging mechanisms is processivity i.e. a second 
packaging event is initiated, directly, from the terminus generated by a termination event. 
For this to be possible the terminase must remain attached to the free unpackaged end.
A simple mechanism could be envisaged if cosN cleavage at termination were 
essentially similar to the cosN cleavage which results in the formation of complex I. 
However, the existence of cosQ suggests that termination is fundamentally different. cosQ, 
as described above, is essential for efficient DNA packaging in lambda. CosQ mutants, 
result in virions containing greater than unit length genomes as would be expected if the 
termination of packaging were impaired (Catalano et al, 1995). A clearer definition of cosQ 
function was provided by Cue and Feiss (1998). Their work indicated that cosQ alone was 
not a stop signal and that cosB and 12 also make significant contributions to the termination 
signal. cosQ appears to be involved in nicking at both Nj and N2, (figure 1.4). However, 
while cosQ is strictly necessary for nicking at Nj, at N2 nicking is actually increased in the
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absence of cosQ. CosB and 12 are important for both the efficiency and fidelity of nicking at 
N2.(Cue & Feiss, 1998).
Following cleavage the cohesive ends must be separated, a process which is presumed 
to occur via the same mechanism which generates complex I. For processivity to occur the 
terminase must also remain attached to the unpackaged genome terminus. This new complex 
probably resembles complex I and as such, is able to recmit an empty prohead to form 
complex II and reinitiate a second DNA packaging event (Catalano et al, 1995).
1.3.1.4 - Models for DNA packaging in ds bacteriophages.
Various different models for the mechanism of DNA translocation and the structure of 
packaged DNA in ds bacteriophages have been proposed, however, to date none has been 
conclusively established.
a) - Rotating connector models for DNA translocation.
The forerunner of these models is the rotating nut model described by Hendrix (1978). 
This model is founded on the observation that bacteriophage heads exhibit 5 fold rotational 
symmetry while the tails have 6 fold rotational symmetry. Unless the connector exhibits 30 
fold rotational symmetry this implies a symmetry mismatch at either the connector : head or 
connector : tail interface. As no protein is present in the connector at 30 copies the 
possibility of 30 fold rotational symmetry was thought to be unlikely.
Hendrix proposed that connectors had 6 fold rotational symmetry based on the 
observation that the tail : connector interaction was exclusively non-covalent but that the 
interaction was none the less relatively strong - the connector remaining attached to the tail 
during the chemical disruption, of bacteriophage (Serwer, .1976). Based , on these, 
observations he also proposed that the connector was fairly weakly bound to the head, 
possibly being held in place by steric constraints, much in the same way that a button is held 
in a button hole.
The proposed symmetry mismatch between the connector and the head has 
implications for rotation at this interface. An examination of the kinetics of this type of 
interaction showed that, between a 6 subunit surface (the connector) and a 5 subunit surface 
(the head) the bonds are relatively weak. In addition there are no strong energy barriers to 
rotation.
Hendrix proposed that DNA packaging was achieved in one of two ways. For 
mechanism 1, ATP hydrolysis is directly linked to the passage of DNA through the 
connector. The movement of the DNA relative to the connector occurring in an analogous 
way to polymerase moving along a DNA molecule. Rotation of the connector could occur 
subsequently in order to accommodate any twisting strain introduced into the molecule.
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Mechanism 2, proposes that ATP hydrolysis drives the rotation of the connector. This 
model requires that some part of the connector, which lacks 6 fold rotational symmetry, 
interacts directly with the DNA helix in an association analogous to the way that the threads 
of a nut and bold fit together. Thus, as the nut is turned the ‘bolt’ passes through the central 
hole.
Although subsequent investigators have since shown that connectors have 12 or 13 
fold symmetry (Dube et al, 1993) the occurrence of a symmetry mismatch holds true. The 
major weakness of both these models is their predicted energy requirement for packaging 
(approximately 1 ATP bp-1), which is almost twice that measured for 029 packaging (0.5 
ATP b p 1) (Guo et al, 1987)
The basic principle of a rotational motor has been subsequently adapted to form the 
basis of the rotating winch model (Tumquist et al, 1992) and the model described by Dube 
e ta l  (1993). These models give rise to energy efficiencies which are more in line with the 
experimental data.
The rotating winch model is essentially similar to the model described by Hendrix 
(1978). Supercoiled DNA was found to wrap around the outside of 029 connectors and this 
was interpreted as evidence for a winch like mechanism in which connector rotation, driven 
by ATP hydrolysis, effectively pushes the DNA into the head (Tumquist et al, 1992). This 
type of mechanism requires DNA which does not contain any nicks, which is at odds with 
the observed nicks in the packaged DNA of T4, T7 and X (Khan et al, 1995).
b) Osmotic pump models of DNA translocation.
In 1988 it was proposed that the reported ATP binding activity of the T4 major capsid 
protein (Rao & Black, 1985b) could be associated with an osmotic pump for DNA 
packaging (Serwer, 1988). This model proposes that capsid expansion on initiation of DNA 
packaging decreases the osmotic pressure inside the head, the portal vertex opens and DNA 
is driven through the pore by the osmotic gradient. In some models of this type all of the 
DNA is packaged in this initial event. However, in this model it was proposed that small 
molecules leaked into the head along with the DNA establishing the potential for a second 
osmotic gradient and a second packaging event. If the head were to contract after the initial 
expansion, a step potentially driven by ATP hydrolysis by the major capsid protein, the 
small molecules could be expelled through closeable pores. Subsequent re-expansion would 
re-establish the osmotic gradient and more DNA could be driven into the head.
This model requires that the bacteriophage capsid be capable of as much as 25% 
expansion, that the major capsid protein be able to contract and expand in an ATP dependent 
manner and that the head itself be variably porous and non porous to small molecules. These
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constraints combined with the observations of Rao and Black (1985a) which suggest that T4 
prohead expansion is not linked to DNA packaging appear to make this model for DNA 
translocation unlikely.
c) - The ratchet model of DNA translocation (Fujisawa & Morita, 1997).
This model was proposed with T3 in mind but its essential features may well apply to 
other viruses. The model envisages a single copy of the viral protein gpl9 bound to each of 
the six domains of the connector. gpl9 is the large subunit of the T3 terminase. In order to 
package DNA into the head it is proposed that an ATP associated conformation of gpl9 
binds to the sugar backbone of the DNA. DNA binding activates the DNA dependent 
ATPase activity and the hydrolysis of ATP to ADP and Pj results in a conformational change 
which pushes DNA into the head. When a new ATP molecule binds, gpl9 dissociates from 
the DNA and returns to its original extended conformation. The movement of the DNA 
molecule allows the next gpl9 to bind and the cycle is complete. When this cycle proceeds 
six times, six molecules of ATP will have been hydrolysed and 1 turn of the DNA helix will 
have been packaged. Thus this model produces a theoretical packaging efficiency of 0.59 
ATP b p 1 which is very close to the observed value of 0.55 ATP bp’1 (Shibata et al, 1987; 
Morita eta l, 1995)
d) - Models based on the structure of the packaged DNA.
Many different models for the structure of packaged DNA have been proposed; these 
include spiral folds (Black et al, 1985), liquid crystals (Lepault et al, 1987) twisted toroids 
(Hud, 1995) and coaxial spools (Cerritelli e ta l, 1997). Although none of these models has 
been found to be universally applicable, several interesting features have been identified.
It appears that, for T4 at least, the DNA is packaged in such a way as to allow the first 
end of the DNA to be packaged to be the first end to leave the head i.e. injection is not the 
reverse of packaging (Black and Silverman, 1978). As part of their work these investigators 
also speculated on a mechanism for DNA packaging which is driven via the introduction of 
torsional strain into DNA molecules.
Some bacteriophages have been shown to contain a proteinacious structure which 
resides on the inner surface of the connector. The core has been implicated in head assembly 
(Roeder & Sadowski, 1977) and it may also be involved in DNA injection (Garcia & 
Molineux, 1996). Although its precise role has not yet been established it has been proposed 
that the core may influence the arrangement of DNA during packaging.
Chemical cross linking studies have shown that in a large population of virions, all 
parts of the genome come into close proximity to the head proteins (Widom & Baldwin,
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1983; Serwer et al., 1992) indicating that there is significant variation in how the DNA is 
packaged into an individual virion. Despite this it is also clear that on a larger scale the 
packaged DNA has a highly ordered structure. Several studies have proposed that packaged 
DNA is in a liquid crystalline or quasi liquid crystalline state (Lepault et a l, 1987; Cerritelli 
etal., 1997).
Current thinking appears to favour the coaxial spool models for packaged DNA 
(Richards et al., 1973; Eamshaw & Harrison, 1977; Eamshaw et a l, 1978) as this type of 
packaging can accommodate both the locally crystalline arrangement of packaged DNA 
(Harrison, 1983) and the cross linking data without the need for the energetically 
unfavourable kinks required for the spiral fold model. Cryoelectron microscopy of packaged 
T7 DNA also tends to support the co axial spool models (Cerritelli et al., 1997)
Section 1.3.2 - DNA packaging in herpesviruses.
Compared to the understanding that we have of the bacteriophage systems, our 
understanding of herpesvirus packaging is relatively rudimentary. A variety of 
herpesviruses have been studied including HSV-1, HCMV, GPCMV and HHV-6. 
Although considerable parallels between these viruses have become apparent differences 
have also been identified and this has made drawing inferences from one system and 
applying them to another a difficult proposition.
As with the ds bacteriophage, herpesvirus replication is believed to culminate in a 
replicative mechanism analogous to rolling circle replication which produces high molecular 
weight concatemeric DNA which forms the substrate for the cleavage and packaging 
machinery. The concatemeric DNA is processed into unit length genomes and packaged into 
preformed capsids. B capsids are believed to be the progenitors of DNA containing C 
capsids, the scaffold proteins leaving the capsid at the same time that the DNA is packaged. 
The processes of cleavage and packaging have been shown to be closely linked with the 
majority of terminal fragments being found to be DNase resistant i.e. packaged (Deiss & 
Frenkel, 1986). This conclusion is also supported by studies of HSV DNA packaging 
mutants which fail to cleave concatemeric DNA in the absence of DNA packaging. In 
HSV-1 unit length genomes generated by cleavage at distinct signals are packaged although 
the fact that not every correctly orientated packaging signal is cleaved implies an element of 
consideration for headful packaging. Herpesviruses also appear to have an additional control 
mechanism for aberrant packaging events. Capsids which contain less than unit length 
amounts of DNA have been observed trapped between the inner and outer nuclear 
membranes suggesting that they are blocked in their subsequent maturation (Vlazny et al., 
1982).
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1.3.2.1 - Cleavage and packaging signals.
The ‘a’ sequence was proposed as the sequence responsible for directing the cleavage 
and packaging of the herpes simplex virus genome by Mocarski & Roizman (1982b), based 
on the observation that both unit length DNA molecules and defective genomes contained 
directly repeated ‘a’ sequences at their termini. The ‘a’ sequence was directly implicated in 
the cleavage and packaging process by Stow et al., (1983) who showed for HSV-1 that a 
minimal 550 bp of the L or S termini contained all of the sequences necessary for the 
cleavage and packaging of the viral genome. The only sequence which is common to both 
the L and S termini are the 400 bp ‘a’ sequences.
A comparison of the termini of many different herpesviruses has shown that certain 
sequences are particularly well conserved (Figure 3.44). These sequences are part of the 
quasi unique regions of the ‘a’ sequence but they are also found at the termini of 
herpesviruses which lack ‘a’ sequences. The implication is that these sequences are involved 
in the cleavage and packaging process and subsequent experimental evidence has lead to 
these regions being labelled the p ad  and pac2 sequences (see section 1.2.2.7). The 
occurrence of these sequences at the termini of herpesviruses other than the herpes simplex 
viruses is consistent with observations which have shown that their termini are also involved 
in cleavage and packaging. Sequences found at the termini of HCMV (Spaete & Mocarski, 
1985), EBV (Zimmermann & Hammerschmidt, 1995), MCMV (McVoy et a l, 1998), 
HHV-6 (Deng and Dewhurst, 1998), and GPCMV (McVoy et al, 1997) have all been 
directly implicated in the cleavage and packaging process.
Interestingly, while in general, there is considerable similarity between the pac 
homologies from different herpesviruses, there are some notable examples of variation from 
the common theme. For example, the T rich element of pac2 is particularly well conserved 
in almost all of the herpesviruses for which sequences are available but it is absent from the 
pac2 homologue of the HCMV genome (Broil et al, 1999). In GPCMV there appear to be 
two cleavage sites, one associated with an easily identifiable pac2 homologue, the other with 
a region which shares only partial homology with other pac2 sequences (McVoy et 
a l, 1997).
During the 1980s several investigators sought to functionally examine cleavage and 
packaging signals in infected cells. One of the observations that came from this work was 
that the sequence at the site of cleavage, in the DR1 repeat, was non essential (Varmuza & 
Smiley, 1985; Deiss & Frenkel, 1986). The non-essential nature of the DR1 repeat sequence 
was shown in a set of experiments in which an ‘a’ sequence fragment, which drove cleavage 
and packaging but did not contain a DR1 repeat, was inserted into the thymidine kinase gene 
of HSV-1. Sequencing of the novel termini which were generated by cleavage at this site
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revealed that the accuracy and location of cleavage with respect to the putative cleavage 
signals in p ad  and pac2 was unaffected by the absence of the repeat sequence.
The first study which attempted to introduce specific mutations into the packaging 
signal was carried out by Deiss and Frenkel (1986) and was rapidly followed by a second 
study (Deiss etal., 1986). These studies, using HSV-1 amplicons, specifically confirmed 
the importance of the p ad  and pac2 sequences in the cleavage and packaging process by 
observing that constructs lacking these sequences were not propagated in transfection 
derived virus stocks.
In 1988 the central role of p ad  and pac2 was conclusively shown when it was found 
that all of the signals necessary for the cleavage and packaging of HSV-1 were contained 
within a 179 bp fragment of viral DNA which spanned the junction between two tandemly 
repeated ‘a’ sequences (Nasseri & Mocarski, 1988). The structure of the fragment is such 
that it contains both the p ad  and pac2 elements that are present in the ub and uc regions of 
adjacent ‘a’ sequences, as well as a single DR1 repeat which separates them 
([DR4]06-uc-DRl-ub-[DR2]1). This arrangement is of interest for several reasons, firstly, 
assuming that genome circularisation occurs by ligation, it would be predicted to occur at the 
novel junction formed by the termini, even in a genome containing the minimum number of 
‘a’ sequences. Taking this to be true would suggest that in vivo the cleavage signal is 
presented as the junction between two ‘a’ sequences. Cleavage at a single ‘a’ sequence 
could only occur after an ‘a’ sequence duplication event. Secondly, the novel junction 
formed between two tandemly repeated ‘a’ sequences is the only arrangement in which the 
p ad  and pac2 sequences are brought close together. In a single ‘a’ sequence these 
sequences are as much as 400 bp apart. Finally a striking aspect of this study, was the 
finding that cleavage and packaging did not require the replication of the amplicon, implying 
that concatemeric DNA is not the sole substrate for DNA packaging. This observation does, 
however, remain unconfirmed.
One of the studies using whole ‘a’ sequences to drive amplicon DNA cleavage and 
packaging which was conducted during the 1980s showed that the HCMV ‘a’ sequence 
could act as afunctional cleavage and packaging signal for the HSV-1 packaging machinery 
(Spaete & Mocarski, 1985). This is particularly interesting as the HCMV ‘a’ sequence lacks 
the pac2 T rich element which is particularly well conserved in other herpesviruses, implying 
that this element is not required for cleavage and packaging. In a similar way, a more recent 
study of the terminal sequences of GPCMV has provided an unexpected source of additional 
information. As described earlier GPCMV has three potential termini designated R, M and 
O. The absence of repeat sequences at the O terminus or any other regions of homology 
between the R and O termini would appear to suggest that genome circularization occurs by
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direct ligation of the termini, as opposed to homologous recombination or strand annealing 
(McVoy eta l, 1997).
Despite the information which has been gathered about the sequences which are 
required for cleavage and packaging, there remains uncertainty in defining the actual 
arrangement of signals which forms the preferred cleavage and packaging signal in vivo. 
From the work carried out by Stow et a l (1983) it is apparent that amplicons containing 
single ‘a’ sequences can be packaged into viral particles, despite the fact that the essential 
p ad  and pac2 elements are approximately 400 bp apart. Conversely a fragment of viral 
DNA, as small as 179 bp, which spans the junction between two tandemly repeated ‘a’ 
sequences and has p ad  and pac2 in close proximity can also function as a cleavage and 
packaging signal (Nasseri & Mocarski, 1988). Although single ‘a’ sequences were reported 
to predominate in the concatemeric DNA of HSV-1 (Locker & Frenkel, 1979) it is difficult to 
explain how the termini of HSV-1, result from cleavage at single ‘a’ sequences. In order to 
account for this observation several mechanisms have been proposed including ‘a’ sequence 
duplication events (Deiss & Frenkel, 1986), staggered cleavage events and models for DNA 
packaging which involve discarding a large proportion of the replicated DNA which lacks a 
terminal ‘a’ sequence (Varmuza & Smiley, 1985 & Deiss et a l,  1986), but none of these 
models seems entirely satisfactory and to date it remains unclear which arrangement forms 
the preferred cleavage and packaging signal in vivo. Overall, the complementary portions of 
a DR1 repeat at the extreme ends of the genome and the presence of at least one ‘a’ sequence 
at both the L and S termini suggests that cleavage is more likely to occur in the DR1 repeat 
between two ‘a’ sequences. The novel junction contained within the 179 bp sequence 
constitutes the minimal cleavage and packaging signal so far identified and it is of interest to 
note, that it is only in this arrangement that the p ad  and pac2 sequences are brought into 
close proximity (figure 1.6).
In addition to the direct examination of cleavage and packaging several studies have 
been conducted looking for protein interactions with herpesvirus packaging signals. The 
reasoning behind this being the site specific cleavage of viral DNA will undoubtedly involve 
specific protein interactions. The first study was conducted using probes constructed from 
the ‘a’ sequence of HCMV. A protein from uninfected host cells which bound a probe 
containing most of the pac2 element, in a sequence specific manner was identified. The 
protein has an apparent molecular mass of 89 KDa and was found in a variety of human cell 
types. The protein was named pac2 binding protein (Pac2BP) (Kemble & Mocarski, 1989). 
The relevance of a host cell protein that binds to the cleavage and packaging signals lies in 
the observation that, in bacteriophages, host cell factors can play important roles in the 
packaging of viral genomes (Craig, 1985).
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Meanwhile, using HSV-1 sequences, another group isolated several sequence specific 
and non-specific protein complexes which formed with probes containing the pac2 element 
as well as parts of the DR1 and DR4 repeats. They identified two interesting complexes 
containing proteins from the nucleus of infected cells. The first complex contained two 
proteins, which were present in approximately equimolar amounts and their binding was 
shown to be sequence specific. One protein was identified as the virion protein ICP1 by its 
apparent molecular weight and by its reactivity with ICP1 specific monoclonal antibody. 
The second protein has an apparent molecular weight similar to that predicted for the virion 
protein ICP7.
The ICP1 protein, (UL36) has been implicated in the release of viral DNA from 
capsids. It is conceivable that this protein could be involved in escorting viral DNA in and 
out of the capsid (Batterson etal., 1983). The identity of the second protein which remains 
tightly bound to ICP1 throughout the purification process remains to be confirmed (Chou & 
Roizman, 1989).
The second protein complex contained a single polypeptide which bound in a 
non-sequence specific manner. A variety of observations, including apparent molecular 
weight, catalytic activity and monoclonal antibody reactivity, identify this protein as the gene 
product of UL12. UL12 encodes the alkaline nuclease of HSV-1 and has both endonuclease 
and exonuclease activity. While the protein in this study was bound in a sequence 
non-specific manner it could theoretically cleave DNA in a sequence specific manner if it 
were part of a sequence specific complex (Chou & Roizman, 1989).
The HCMV homologue of HSV-1 UL28 (HCMV UL56) has also been reported to 
bind specifically to and cleave the HCMV ‘a’ sequence (Bogner et al., 1998).
Interestingly, all of these reports represent single reports of sequence specific DNA 
binding activities but clearly reproducible data on this subject has not yet been provided.
1.3.2.2 - Models for the production of unit length genomes from
concatemeric DNA.
Several models for the cleavage and packaging process have been proposed in order to 
account for the varied observations regarding this part of the virus life cycle (Figure 1.7).
Varmuza and Smiley (1985) proposed two possible models for the cleavage of 
concatemeric DNA. The first, the ‘staggered nick mechanism’ proposed that the L and S 
termini arose as a product of two separate single stranded cleavages. They proposed that the 
cleavages are on opposite strands and at opposite ends of a single ‘a’ sequence. In this way 
each terminus would have a single-stranded 5’ overhang the length of the ‘a’ sequence, these 
termini would need to be separated and then filled in by repair synthesis. For a tandem ‘a’
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Figure 1.7 - Mechanisms for packaging herpesvirus genomes.
Cleavage
Defective genome packaging.
1. A concatemer of viral genomes is generated by 
rolling circle replication.
2. Packaging is initiated at an initial packaging 
signal and a unit length genome is packaged. The 
terminal cleavage is made before the terminal 
packaging signal giving rise to a packaged genome 
with only one terminal repeat
3. The unpackaged concatemeric molecule is able 
to act as a substrate for subsequent cleavage and 
packaging events.
In herpesvirus other than GPCMV this would lead 
to defective virions
B.
Cleavage
termini is either 
degraded or excised
The theft model.
1. A concatemer of viral genomes is generated by 
rolling circle replication.
2. Packaging is initiated at an initial packaging 
signal and a unit length genome is packaged. The 
terminal cleavage is made after the terminal 
packaging signal.
3. A genome with two terminal repeats is packaged 
but the the unpackaged concatemer has an un- 
packageable terminus which must be either excised 
or degraded.
‘a’ sequence duplication model.
1. A concatemer of viral genomes is generated by 
rolling circle replication.
2. Packaging is initiated at an initial packaging 
signal and a unit length genome is packaged. At 
the terminal signal, staggered nicks are introduced 
at either end of the repeat sequence. Repair 
synthesis then duplicates the terminal repeat
3.. A genome with two terminal repeats is packaged 
and a packageable terminus is regenerated.
ta— c d o
D.
Cleavage
d ---------  D O -
‘a-a’ junction model.
1. A concatemer of viral genomes generated from 
a template containing a tandemly repeated 
packaging signal.
2. Packaging is initiated at an initial signal and a 
unit length genome is packaged. At the terminal 
packaging signal, a cleavage is made between the 
tandem repeats.
3.. A genome with two terminal repeats is 
packaged and a packageable terminus is 
regenerated.
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sequence arrangement the situation would appear more simple, as a co-operative action 
between adjacent ‘a’ sequences could result in the nicks being positioned to generate a 
cohesive end of just a single base pair i.e. as found in virion DNA (Varmuza & Smiley, 
1985). The subsequent work of Nasseri & Mocarski supports this co-operative mechanism 
by showing that the essential components of the packaging signal were found at the junction 
between two tandemly repeated ‘a’ sequences (Nasseri & Mocarski, 1988). The second 
potential mechanism proposed by Varmuza and Smiley, was the so called ‘theft or sacrifice 
model’. This model requires that a double stranded cut be made at the L terminal ‘a’ 
sequence. This is followed by packaging until the next appropriately orientated L-S junction 
is found, where the S terminus is formed. This model’s name is derived from the outcome 
of cleavage at a single ‘a’ sequence. If cleavage were to occur at a single ‘a’ sequence then 
that ‘a’ sequence would be ‘stolen’ from one genome at the cost of the adjacent one 
(Varmuza & Smiley, 1985). This model suffers from several problems, namely, that it 
predicts the existence of termini, which lack a terminal ‘a’ sequence. As these termini have 
not been detected they would need to have been rapidly degraded with the corresponding 
wastage of synthesised DNA. Neither of these two models is however, capable of 
explaining the observed distribution of ‘a’ sequences at the L (an) and S (an=1) termini.
In 1986 Deiss and Frenkel proposed an extension of the theft model, which they called 
the ‘Modified Theft Model’. In this model a packaging complex is thought to traverse the 
HSV-1 DNA in either direction, starting from a random start point. They propose that 
cleavage occurs proximal to the first uc element encountered. Packaging then continues until 
the next directly repeated junction is found. A second cleavage then occurs proximal to the 
ub element (Deiss & Frenkel, 1986). This form of directional cleavage model can account 
for several observations, such as cleavage at directly repeated ‘a’ sequences and, providing 
that the scanning is US to UL, the observed distribution of ‘a’ sequences at the L (an) and S 
(an=1) termini.
Although there is still insufficient information on which to base a model for the 
translocation of herpesvirus genomes into the capsid, as with the bacteriophage systems 
which have been studied, the process appears to require ATP ( Dasgupta & Wilson, 1999).
1.3.2.3 - Proteins implicated in the cleavage and packaging of HSV-1 DNA.
Several proteins or genes have been implicated in the cleavage and packaging process. 
All were identified by isolating temperature sensitive (ts) or deletion mutants, whose 
phenotype suggested that they had functions in this process. The proteins implicated so far 
are the gene products of UL6, UL12, UL15, UL17, UL25, UL28, UL32 and UL33. One 
other gene, UL36, may also be involved in packaging, although to date it has only been
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implicated in the release of viral DNA from the nucleocapsid. In addition the structural 
proteins of the capsid and its scaffold are also obviously necessary for DNA to be packaged.
a) - UL6 .
UL6 is a y’ gene, indicating that it is expressed shortly after DNA replication 
commences. The gene encodes a protein with an apparent molecular weight of 
approximately 75 KDa and a study of its location revealed that it is tightly associated with the 
capsid proteins, most likely the hexons. The evidence suggesting that this protein is 
involved in cleavage and packaging comes from the study of a ts mutant tsF18. At the 
nonpermisive temperature (NPT) this mutant produces almost wild type levels of replicated 
DNA which is found as a high molecular weight concatemer. This mutant however, fails to 
cleave or package the DNA. B capsids also accumulate to near wt levels in the nucleus. The 
effect of this mutation can be reversed by a return to the permissive temperature (PT). There 
is however a requirement for de novo protein synthesis (Patel & McLean, 1995). This 
requirement for de novo protein synthesis may indicate that the mutant protein forms a stably 
inactive conformation at NPT, alternatively it may reflect a more complex situation associated 
with its location in the nucleocapsid. The isolation of a UL6- HSV-1 mutant has confirmed 
the essential nature of this protein for virus growth. This study also used a recombinant 
baculovirus system in which infected insect cells which expressed the seven known capsid 
proteins and UL6, were examined. In insect cells it was found that although UL6 was 
bound to the capsid, it was not necessary for capsid assembly, and in insect cells at least, 
UL6 binding to the capsid does not require any other viral proteins (Patel et al., 1996).
b) - UL12.
The UL12 ORF of HSV-1 encodes a deoxyribonuclease which is often referred to as 
the alkaline nuclease because of its unusually high pH optimum (Keir & Gold, 1963). The 
UL12 ORF appears to encode two polypeptides designated UL12 and UL12.5 (Draper et 
al., 1986). A deletion mutant of the UL12 locus has been shown to be capable of wt levels 
of DNA synthesis. Cleavage of the viral DNA occurs and levels of DNA packaging can be 
detected in the nucleus of infected cells. The capsids however, fail to egress from the 
nucleus suggesting that they or the DNA they contain may be aberrant in structure (Weller et 
al., 1990; Shao et al., 1993). The UL12 protein has a predicted molecular mass of 67.5 
KDa, it has both endonuclease and exonuclease activity and localisation studies have shown 
that the nuclease locates in the nucleus, but at locations distinct from those associated with 
DNA replication, supporting the idea that the nuclease is not involved in DNA synthesis 
(Weller et al., 1990 & Bronstein & Weber, 1996). The UL12.5 protein has an approximate 
molecular mass of 60 KDa and is transcribed, in the same frame as UL12, using a down
33
Introduction
stream methionine start codon. UL12.5 has been shown to have similar activity, pH 
optimum and requirement for divalent cations as UL12 but unlike the UL12 protein it has 
been identified as a component of B and C capsids. Despite the fact that both proteins have 
similar activities UL12.5 cannot complement a UL12* virus (Bronstein et al, 1997), 
indicating that it probably has a different biological function. It is tempting to suggest that 
the capsid associated UL12.5 is responsible for cleaving the viral DNA. There are however, 
several potential roles for the nucleases in the cleavage and packaging process. As in several 
other DNA viruses including bacteriophage T4, endonucleases have been shown to play a 
role in the resolution of intermediate structures generated by recombination prior to 
packaging. The UL12 protein has been implicated in the resolution of branched DNA 
structures which result from recombination between replicated concatemeric DNA. The 
importance of this role is seen by the fact that the viral yield of a UL12" virus is only 
0.1-1.0% of wt levels (Martinez et a l, 1996). The fact that virus was replicated at all is 
important because it indicates that UL12 is not absolutely required for virus maturation, an 
observation which would be unexpected for a nuclease responsible for generating genomic 
termini. Never the less, despite the weakness of the endonuclytic activity, it remains 
possible that the nuclease does play a role in the cleavage between directly repeated ‘a’ 
sequences. UL12 remains a candidate for the protein which binds to ICP1 in an ‘a’ 
sequence specific complex (Chou and Roizman, 1989). Finally, several of the packaging 
models have a requirement for the rapid degradation of termini lacking ‘a’ sequences, the 
nuclease having both endo- and exonuclease activity may be able to perform this function 
(Weller et al, 1990). One final point of note, regarding the alkaline nuclease, is that it is a 
phosphoprotein. A viral protein kinase has been identified which phosphorylates the 
nuclease in vitro. This serine threonine protein kinase, which is encoded by UL3, also has 
an alkaline pH optimum (Daikoku et al, 1995).
In summary the UL12 gene appears more likely to have an indirect role in packaging. 
Its various phenotypes are likely to be the result of the inefficient removal of branched 
structures from DNA prior to encapsidation which results in the packaging of aberrant DNA 
structures.
c) - UL15.
The UL15 gene was implicated in DNA packaging through the characterisation of a ts 
mutant, ts66.4 (Poon & Roizman, 1993). ts66.4 accumulates high molecular weight DNA 
and B capsids at the NPT. The UL15 gene is highly conserved among distantly related 
herpesviruses and it has been shown to share limited homology, including a putative ATP 
binding domain, with gpl7 of bacteriophage T4. gpl7 is the small subunit of the T4 
terminase enzyme (Weller et al, 1987). UL15 is unusual in two respects, unlike most other
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HSV-1 genes it is composed of two exons, which are separated by the coding region of two 
other genes and in addition it appears to encode multiple related polypeptides. The 
replacement of the two exons with a cDNA clone of the gene does not appear to affect the 
viability of the virus, suggesting that the splicing does not have a physiological role (Baines 
& Roizman, 1992). On the other hand the different polypeptides have been shown to have 
distinct properties.
The UL15 locus contains at least two independent ORFs. Several studies have 
identified two UL15 derived polypeptides of approximately 35 and 75 KDa. The 75 KDa 
(UL15) species is derived from the spliced 2.7 Kbp mRNA while the smaller 35 KDa 
species (UL15.5) is specified from the same reading frame of a 1.0 Kbp mRNA from the 
second exon (Baines et al., 1997). UL15.5 has been shown to be independently expressed 
indicating that it is not a proteolytic cleavage product of the full length UL15. Localisation 
studies have shown that the location of the UL15 protein changes during the course of 
infection. At 6 hours the protein is found mainly in the perinuclear space however by 12 
hours post infection the protein is found mainly in distinct nuclear structures (Baines et al., 
1994). A putative nuclear localisation signal is present in the protein which appears to 
explain its localisation. Subsequent studies have observed further forms of the UL15 
protein, Proteins of 79, 80 and 83 KDa which react with UL15 specific antibodies have 
been found associated with B capsids. Interestingly though, in the absence of other proteins 
implicated in the cleavage and packaging process, only the 83 KDa form was observed 
associated with the capsids. This suggests that the 80 and 79 KDa forms are involved in 
aspects of the cleavage and packaging process which require interactions with other proteins.
Mutants which express UL15.5 but not UL15, have also been found to accumulate 
high molecular weight DNA and B capsids. In several studies it was also observed that 
instead of accumulating in the nucleus or perinuclear space, B capsids were found in the 
cytoplasm (Baines et al., 1997; Yu et al., 1997). This observation indicates that UL15 plays 
a role in the mechanism which blocks aberrant capsids from further maturation (Vlazny et 
al., 1982). Another study showed that a plasmid which encoded UL15 but not UL15.5 was 
able to complement a UL15/UL15.5 null virus, indicating that UL15.5 is non essential in 
cell culture. Another mutant containing a mutation into the putative ATP binding domain of 
UL15 was unable to complement a UL15' virus indicating that the putative ATP binding 
motif is indispensable for UL15 function (Yu & Weller, 1998a).
Finally UL15 has been found to make a functional interaction with UL28 (Koslowski 
et al., 1999). The localisation of UL28 to the nucleus appears to be as a consequence of its 
interaction with UL15, as transiently expressed UL28 accumulates in the cytoplasm but fails 
to enter the nucleus in the absence of UL15. Conversely, the association of UL15 with B
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capsids has been shown to potentially involve UL6, UL17 and / or UL28, (Yu & Weller, 
1998b; Salmon & Baines 1998). The association of UL15 and UL28 with capsids has been 
observed for B capsids but not for mature C capsids or virions suggesting that the interaction 
is only a transient association as part of the cleavage and packaging process.
d) - UL17.
A UL17- virus has been identified which, as for the other packaging-impaired mutants, 
accumulates endless concatemeric DNA andB capsids in the nucleus (Salmon et al., 1998). 
The mutant virus was subsequently used in a confocal immunofluorescence study which 
found that in the absence of UL17 the major and minor capsid proteins as well as UL6 were 
not targeted to the replication compartments as they were in wt infections. This not only 
suggests that UL17 is involved in the targeting of these proteins to the replication 
compartment but also implies that this is the site of virion assembly (Taus et al., 1998). This 
observation conflicts with the observations of Ward et al. (1996) which were interpreted to 
indicate that replication and virion assembly occurred at discrete sites.
In a separate study UL17 was also shown to be involved, along with UL6 and UL28, 
in the localisation of UL15 with B capsids (Salmon and Baines, 1998).
e) - UL25.
The UL25 gene locus was implicated in the cleavage and packaging process prior to 
the publication of the full HSV-1 genome sequence. A ts mutant, tsl208, was isolated 
which had two distinguishable phenotypes. The first was that virions grown at the PT were 
found to be capable of strongly binding to the cell surface but were unable to penetrate at the 
NPT. Penetration could be facilitated by the addition of a fusogen or alternatively by a shift 
to the permissive temperature. The second phenotype was the accumulation of intermediate 
but not full capsids in the nucleus. The number of intermediate capsids was however lower 
than in other packaging mutants. This second phenotype suggests that the UL25 gene 
product is involved in the cleavage and packaging process (Addison et al., 1984). More 
recently the UL25 protein has been expressed in E. coli as a GST fusion protein. The 
identity of the over-expressed protein was confirmed by immunoprecipitation with an 
antibody raised against viral UL25. The kinetics of expression were examined revealing that 
UL25 is expressed as a late or leaky late gene in the HSV-1 life cycle. The protein has also 
been identified as a virion component, probably as a tegument protein (Ali et al., 1996). A 
UL25 mutant virus, which does not express the UL25 protein, due to the insertion of an 
inframe stop codon, successfully uncouples the cleavage and packaging processes. The 
mutant accumulates both A and B capsids in the nuclei but no C capsids. In addition pulse
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field gel electrophoresis has also identified genome-sized viral DNA which is DNase 
sensitive, i.e. unpackaged, in infected cell extracts. These observations indicate that UL25 is 
required for encapsidation, or at least the retention of capsid DNA, but not for cleavage of 
viral concatemers (McNab et a l, 1998). It is thought that the packaging defect in UL25 
mutants relates to their failure to retain packaged DNA within the capsid.
f) - UL28.
A role for UL28 in DNA packaging was also identified using a temperature sensitive 
mutant. The phenotype of the ts mutant at the NPT is similar to the other mutants, high 
molecular weight DNA accumulating in the nucleus along with B capsids. UL28 encodes the 
protein ICP18.5. Its molecular mass is predicted to be 85.5 KDa. UL28 like UL15 appears 
to be highly conserved between the herpesviruses (Addison et a l, 1990; Tengelsen et a l, 
1993). The UL28 protein has been identified as a minor component of B capsids and its 
interaction with the capsid is strong, even in the absence of other packaging proteins which 
suggests that UL28 interacts directly with the capsid proteins. Despite this strong interaction 
with B capsids less UL28 protein is associated with C capsids and it is undetectable in 
virions. This distribution suggests that UL28 is lost during the capsid maturation (Taus & 
Baines, 1998; Yu & Weller, 1998b). In addition to its interaction with B capsids, as 
described above, the UL28 protein has also been found to have a functional interaction with 
UL15. This interaction is currently thought to serve as a means of localising UL28 in the 
nucleus but as UL28 binding to the capsid appears to be at least partly responsible for UL15 
association with B capsids an extension to the role of the interaction cannot be ruled out (Yu 
& Weller, 1998b; Koslowski et al, 1999). By analogy with the bacteriophage terminases, 
and considering the homology between UL15 and the large subunit of the T4 Terminase, it is 
possible that UL28 represents the second subunit of an HSV-1 terminase. It is also 
interesting to note that this interaction has been observed between the HCMV homologs of 
UL15 and 28, suggesting that it is conserved in distantly related viruses (Krosky et a l, 
1998).
g) - UL32.
The UL32 locus has been implicated in DNA cleavage and packaging (Schaffer et al., 
1973; Sherman & Bachenheimer, 1987) and at one time it was also thought to be involved in 
the maturation and translocation of viral glycoproteins (Machtiger et al, 1980), but this is 
now thought not to be the case. The product of the UL32 ORF has been identified as a 67 
KDa protein which accumulates in the nucleus of infected cells. The protein has also been
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shown to bind zinc in vitro. Based on the predicted sequence of the protein it had been 
suggested that UL32 was a membrane bound aspartyl protease but its accumulation in the 
cytoplasm and mutagenesis of the putative aspartyl protease motif has shown that this is not 
the case (Chang et al, 1996). The function of UL32 has subsequently been more clearly 
defined using confocal immunofluorescence microscopy (Lamberti & Weller, 1998). This 
study showed that while UL32 staining was predominantly in the cytoplasm of infected 
cells, there was also some nuclear staining, which localised with the replication 
compartments. In addition it was observed that the localisation of the major capsid protein 
VP5 was also affected by UL32. In the presence of UL32 VP5 was also observed in the 
replication compartment but during infections with a UL32 mutant VP5 exhibited a more 
diffuse nuclear localisation. This result suggests that UL32 plays a role in the correct 
localisation of capsids within infected nuclei.
h) - UL33.
The importance of UL33 in DNA packaging was again identified using a ts mutant, 
this time ts 1233. The capsids formed at the NPT were intermediate capsids which lacked 
dense internal structures. DNA was again observed in a high molecular weight form in the 
absence of genome termini. This mutant is caused by a single point mutation and, again, a 
downshift to the PT also requires de novo protein synthesis to restore virus replication 
(Al-Kobaisi et al., 1991).
i) - UL36.
As mentioned earlier the UL36 gene has been implicated in the release of viral DNA 
from capsids (Batterson et al., 1983). Analysis of the UL36 open reading frame confirmed 
that it coded for the infected cell protein 1 (ICP1). ICP1 is a 270 KDa phospho-protein 
which is found in the tegument of mature virions. Approximately 150 copies of the protein 
are found tightly associated with each nucleocapsid. The tight association is likely to explain 
how the protein can affect genome release after the nucleocapsid has been transported to the 
nucleus. Computer-assisted analysis of the predicted amino acid sequence of ICP1 has 
revealed several putative domains; two leucine zipper domains and two ATP binding 
domains. Leucine zipper domains have previously been seen in the formation of homo and 
hetero dimers in other DNA binding proteins e.g. c-jun. The formation of a DNA binding 
hetero dimer which involves ICP1 has already been described. The ATP binding sites are 
arranged into a pocket which could potentially provide a local environment for ATP binding 
and hydrolysis (McNabb & Courtney, 1992). The functional significance of these 
predictions has yet to been shown experimentally, however it is interesting to speculate that
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these domains may be involved in the formation of a packaging complex and the hydrolysis 
of ATP in order to provide the necessary energy for the encapsidation of HSV-1 DNA.
This list is not exhaustive as many other proteins have indirect effects upon packaging. 
For example mutants of the capsid and scaffold proteins, which do not assemble viable 
capsids are impaired for DNA packaging (Weller et a l, 1987). This list does however, 
include those viral proteins which appear to have central roles in the cleavage and packaging 
process.
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Chapter 2: Materials and Methods.
Section 2 .1  Materials.
2.1.1 Chemicals and reagents.
Most analytical grade chemicals were purchased from Sigma Chemical Co. Ltd. The 
exceptions are listed below :
BDH Laboratory Supplies
Bio-Rad Laboratories
SmithKline Beecham Research 
Melford Laboratories Ltd 
Joseph Mills (Denaturants) Ltd 
Pharmacia Biotech 
Fluka Chemical ltd.
Gibco BRL
Fisher Scientific UK Ltd 
Pierce
-DMSO
-DMF
- Ammonium persulphate 
-TEMED
(N,N,N* ,N’tetramethylethylenediamine)
- Ampicillin (Penbritin)
- Caesium chloride
- Absolute alcohol 100
- dATP, dTTP, dGTP & dCTP
- Formaldehyde
- Acrylamide
- Acrylamide : N, N’-methylene-bis-acrylamide 19:1
- Ammonia solution
- Surfact-AmpsII NP 40
2.1.2 Miscellaneous materials.
The suppliers of miscellaneous materials were as follows:
Amersham International Pic 
Gibco BRL
Whatman International Ltd. 
Medicell International Ltd. 
Kodak Ltd 
Molecular Dynamics 
Pharmacia Ltd
- Hybond -N membrane (0.45|im)
- LipofectAcen
- Whatman 3 mm paper
- Dialysis tubing
- X-omat S film
- Phosphorimager screens
- Sephadex G-50
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1.3 Solutions.
Table 2.1 - Solutions.
Solution Composition
(3-galactosidase fix 2% formaldehyde, 0.2% glutaraldehyde in 
PBS
p-galactosidase stain 5 mM potassium ferricyanide, 5 mM 
potassium ferrocyanide, 2 mM MgCl2> 0.5 
mg ml'1 X-Gal, in PBS
blot wash 2 x SSC, 0.1% SDS
calf thymus DNA (denatured) 2 mg ml'1 in TE pre-incubated @ 100°C / 30 
minutes.
calf thymus DNA (transfections) 3 mg m l1 in TE
chloroform: isoamyl alcohol chloroform : isoamyl alcohol 24:1 v/v
CLB (2x) 10 mM Tris.HCl (pH 7.5), 1 mM EDTA, 
0.6% w/v SDS
Denhardt’s solution (50x) 1 % ficoll 400, 1 % polyvinylpyrolidone, 1 % 
BSA
DNase dilution buffer 50% glycerol, 50 mM NaCl
gel soak I 0.6 M NaCl, 0.2 M NaOH
gel soak II 0.6 M NaCl, 1.0 M Tris.HCl (pH 8.0)
H-mix 6 x SSC, 5 x Denhardt’s solution, 0.05% 
SDS, 50 jig ml"1 denatured CT DNA, 20 mM 
Tris.HCl (pH 7.5), 1 mM EDTA
HeBS 137 mM NaCl, 5 mM KC1,
0.7 mM Na2HP04, 5.5 mM D-glucose, 21 
mM Hepes, pH 6.95-7.15 with NaOH
Loening’s buffer 40 mM Na2P 04, 36 mM Tris.HCl, 1 mM 
EDTA
loading buffer dyes 50% w/v Sucrose, 0.25% bromophenol blue, 
in 5x running buffer
methyl cellulose 3% carboxymethylcellulose sodium salt in 
H20
nick translation (NT) buffer (lOx) 0.5 M Tris.HCl (pH 7.5), 0.1 M MgCl2, 10 
mM DTT, 0.5 mg ml’1 BSA
oligonucleotide elution buffer 0.1% w/v SDS, 0.5 M ammonium acetate, 10 
mM magnesium acetate
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PBS ABC (complete) 170 mM NaCl, 3.4 mM KC1, 10 mM 
Na2HP04, 1.8 mM KH2P 0 4, 6.8 mM CaCl2, 
4.9 mM MgCl2
PEG precipitation buffer 20% PEG, 2.5 M NaCl
Pol/Lig buffer (5x) 50 mM MgCl2, 100 mM Tris.HCl (pH 8.0), 
10 mM DTT, 2.5 mM dNTPs, 5 mM ATP
pre-hybridisation buffer 6 X SSC, 5 x denhardts solution, 0.1 % 
SDS, 20 jig ml"1 denatured CT DNA
RFI 100 mM RbCl, 50 mM MnCl2, 30 mM 
potassium acetate, 10 mM CaCl2, 15% v/v 
glycerol, pH 5.8
RFII 10 mM MOPS, 10 mM RbCl, 75 mM CaCl2, 
15% glycerol, pH 6.8
RSB 10 mM Tris.HCl (pH 7.5), 10 mM KC1, 1.5 
mM MgCl2
SOB 2% tryptone, 0.5% yeast extract, 10 mM 
NaCl, 2.5 mM KC1, 10 mM MgCl2, 10 mM 
MgS04
SOC 20 mM D-glucose in SOB
SSC (20x) 3 M NaCl, 0.3 M tri-sodium citrate
STET buffer 8% w/v sucrose, 0.5% v/v Triton X-100, 50 
mM EDTA, 10 mM Tris base
sucrose reagent 0.25M sucrose, 2 mM MgCl2, 50 mM 
Tris.HCl (pH 8.0)
TE 10 mM Tris.HCl (pH 7.5 or 8.0) 1 mM 
EDTA
TAE(lx) 40 mM Tris.acetate, 1 mM EDTA
TBE(lx) 90 mM Tris base, 89 mM boric acid, 1 mM 
EDTA
TM buffer 200 mM Tris.HCl (pH 8.0), 20 mM MgCl2
Triton reagent 0.5% Triton X-100, 62.5 mM EDTA, 50 mM 
Tris.HCl (pH 8.0)
trypsin 0.25% trypsin in Tris saline
TS 137 mM NaCl, 0.7 mM Na2HP04, 5 mM 
KC1, 1 mg ml’1 dextrose, 100 units ml’1 
penicillin, 100 fig ml"1 streptomycin
TSB 10 mM MgCl2, 10 mM MgS04, 10% w/v 
PEG 4000, 5% v/v DMSO, in L-broth
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TSB / glucose 20 mM D-glucose in TSB
versene 0.6 pM EDTA, 0.02% phenol red in PBS
2.1.4 Enzymes.
Unless otherwise stated restriction enzymes were supplied by New England 
Biolabs (NEB) or Boehringer Mannheim. Other enzymes are listed below :
Sigma Chemical Co. Ltd.
New England Biolabs
Boehringer Mannheim
- Protease XIV (pronase from S.griseus)
- Lysozyme (from chicken egg whites)
- RNase Tj (grade IV)
- RNase A (type Al)
- DNase I
- DNA polymerase I
- T7 DNA polymerase
- T4 DNA Ligase
- Calf intestinal phosphatase (alkaline phosphatase)
2.1.5 Radiochem icals.
All radiochemicals were supplied by Amersham International pic.
5’ [a-32P] deoxy ribonucleoside triphosphates @ 3000 Ci mmol’1 (10 pCi p i'1)
2.1.6 Cells and culture media.
Baby hamster kidney 21 clone 13 (BHK-21 C13) cells (Macpherson & Stoker, 1962) 
were used for almost all of the experimental work including the preparation of virus stocks. 
BHK-21 C13 stocks were obtained from the Institute cytology department and stored at 
-190°C.
Vero cells (Rhim & Schell, 1967) were also obtained from the Institute cytology 
department stocks.
The following reagents were used in the growth, maintenance and storage of cells : 
Glasgow modified Eagle’s
- Supplied by Gibco BRLMedium (GMEM) 
wash
EC5
ETC 10 (Vero)
- GMEM plus 100 units ml"1 penicillin and 100 pg ml"1 
streptomycin
- wash plus 5% NBCS
- wash plus 10% FCS and 7% tryptose phosphate 
broth
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ETC 10 (BHK) - wash plus 10% NBCS and 7% tryptose phosphate 
broth
- wash plus 20% NBCS and 10% glycerol
- 1.5% methyl cellulose, 0.9x wash supplemented 
with 5% NBCS, sodium bicarbonate and L-glutamine
- Supplied by Gibco BRL
BHK storage media 
methyl cellulose overlay
Optimem
2.1.7 Viruses.
Two herpes viruses were used in the course of the experimental work :
Herpes simplex virus type 1 (HSV-1) strain 17+ (McGeoch et al., 1985; McGeoch et al.,
1988).
Herpes simplex virus type 2 (HSV-2) strain HG52 (Dolan et al., 1998)
Both of these viruses were obtained from the Institute of Virology stocks.
Bacteriophage R408 (Russel et a l 1986) was used during the mutagenesis.
2.1.8 Bacterial strains and culture media.
Plasmids were manipulated and propagated in E.coli strain DH5a (Hanahan, 1985). 
As part of the site directed mutagenesis protocol two different strains of E. coli were used. 
Strain XL 1-BLUE was used to propagate the R408 bacteriophage and strain CJ236 was 
used to prepare the uridine rich ssDNA. The CJ236 bacteria have the genotype F ’ 
cat(=pCJ105;M13sCmr/dut ung1 thi-1 relAl spoTl mcrA) which means that their DNA 
contains an increased frequency of incorporated uridine in place of thymidine residues.
For high efficiency transformations, Library Efficiencyn DH5 competent cells were 
used. (Gibco BRL).
All bacteria were grown in L-broth, supplemented with 50 pg ml’1 ampicillin and 0.1 
mg ml"1 chloramphenicol when appropriate.
Bacteria containing plasmids were stored at -70°C in growth media supplemented with 
7% DMSO.
2.1.9 Plasmids.
The parental plasmid vector used in this work was pAT153 (Twigg and Sheratt, 
1980). pAT153 is a high copy number plasmid derived from pBR322. It contains 
ampicillin and tetracycline resistance loci. The ZscoRI, Hindlll and BamHl sites, were used 
in the construction of the plasmids. pAT153 is the parent of all the following plasmids except 
pELacZ and the pTZ based plasmids.
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The following plasmids were provided by Dr N.D.Stow. 
Table 2.2 - Parent plasmids._______________________
Plasmid Name Description
pSl pAT153 with a 500 bp HSV-1 Oris fragment cloned into the BamHl site 
(Stow and McMonagle, 1983).
pYl pSl with a 1762 bp HSV-1 fragment (125644-127405)containing a 
single ‘a’ sequence (Stow etal., 1983). The insert was cloned between 
the EcoRl and Hindlll sites.
pZl pSl with a 2161 bp HSV-1 fragment (125644-127405) containing two 
tandemly repeated ‘a’ sequences (Stow eta l, 1983). The insert was 
cloned between the EcoRl and Hindlll sites.
pSAl pSl with a novel 200 bp HSV-1 sequence containing the junction 
between two tandemly repeated ‘a’ sequences (uc-DRl-ub fragment) (see 
figure 3.31). The insert was cloned between the EcoRl and Hindlll 
sites.
pELacZ pCMVIO containing the LacZ gene under the regulation of the CMV 
major immediate early promoter.
pTZ18U An fl origin containing plasmid based on pUC19. pUC19 contains 
ampicillin resistance loci and an MCS, as well as universal and reverse 
sequencing primer sites.
The numbers shown in brackets for pYl and pZl indicate the location of the Hinfl restriction 
enzyme sites used to clone these fragments (McGeoch et al., 1988)
uc-DRl-ub mutants were prepared and sequenced in pTZ18U derived plasmids (pTZ 
series of plasmids). The EcoRl / HindUI inserts were transferred to a pSl backbone to 
derive mutant amplicons (pPH series of plasmids). Both the pTZ derived plasmid and the 
mutant amplicon produced are listed together in the table below. Further details are provided 
in the results section.
Table 2.3 - Mutanl Plasmids
Mutation, pTZ 
and pPH number
Description
2 wt HSV-1 stain 17 uc-DRl-ub fragment
3 pac2 deletion
4 p ad  deletion
6 DR1 substitution
7 p ad  T element substitution
8 p ad  T element deletion
9 pac2 T element substitution
10 pac2 T element deletion
11 p a d  GC distal element deletion
12 p ad  GC distal element substitution
15.1 pac2 GC element deletion
15.2 pac2 GC element deletion + other pac2 deletion
16 pac2 GC element substitution
17 pac2 consensus deletion
18 pac2 consensus substitution
19 pac2 unconserved deletion
20 pac2 unconserved substitution
21 p a d  proximal GC element deletion
22 pac 1 proximal GC element substitution
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2.1.9 O ligonucleotides.
The sequences of the mutagenic oligonucleotides used in the site directed mutagenesis 
are shown below :
Table 2.4 - Oligonucleotides.
Mutation
number
Mutation Oligonucleotide sequences
6 DR1 substitution CGCGCCCGCGGGGGGCAATAGTACTCCGCCGCCACCGCTT
7 pacl T element 
substitution
GCGACCCCCGGGGGGGCTCGAGGGGGGGGGGCCCGTTT
8 pacl T element 
deletion
GCGACCCCCGGGGGGGGGGGGGGCCCGTTT
9 pac2 T element 
substitution
GGACCGCCGCCCGCCCTCGAGGCGCGCGCGCGCGCC
10 pac2 T element 
deletion
GGACCGCCGCCCGCCGCGCGCGCGCGCGCC
11 pacl GC distal 
element deletion
CGGGGGGTGTGmTITITCGGCGTCI GGC
12 pacl GC distal 
element substitution
CGGGGGGTGTGTTTTCCCAGTACTGCCTTTTCGGCGTCTGG
C
15 pac2 GC element 
deletion
CCGCCCGCCTTTTTTCCGCGGGGGGCCCGG
16 pac2 GC element 
substitution
CCGCCCGCCTTTTTTCG AGT ACTC ACGT ACCGCGGGGGGCC 
CGG
17 pac2 consensus 
deletion
CCCGCCCCCCACGCCCGCGCGCACGCCGCC
18 pac2 consensus 
substitution
CCCGCCCCCCACGCCGAGTACTCGCGCGCACGCCGCC
19 pac2 unconserved 
deletion
CCCCACGCCCGCCGCGTTTTTTGCGCGCGCGC
20 pac2 unconserved 
substitution
CCCCACGCCCGCCGCGGACGTAACAAGCACATCTCGAGGT
GTGAGGGTTTTTTGCGCGCGCGC
21 pacl proximal GC 
element deletion
GGGGGGCCCGGGCTGCTGTGTTTTGGGGGGGGC
22 pacl proximal GC 
element substitution
GGGGGGCCCGGGCTGCTTGTAGGGGATGAGGTCTCCCCTG
GCGCACAGCTCGAGTACATTGTGIITIGGGGGGGGC
For a comparison of the mutation-containing oligonucleotides and the viral sequence
see Table 3.6 in the results section.
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Section 2 .2  METHODS.
Unless otherwise stated BHK and Vero cells were incubated throughout at 37°C in an 
atmosphere supplemented with 5% C 02.
2.2.1 - Tissue culture and preparation of virus stocks.
2.2.1.1 - Serial passage of cells.
BHK and Vero cells were passaged in ETCIO(BHK) and ETClO(Vero) respectively.
2 6 175 cm tissue culture flasks were inoculated with not less than 1.5x10 cells. Confluent
monolayers were washed with versene (20 ml) and then with versene : trypsin (1:1 v/v)
before being resuspended in 10 ml of the appropriate ETC 10. Cells were occasionally stored
o/n at 4°C, more usually however, an aliquot of resuspended cells was used immediately to
seed another 175 cm flask. Cells were discarded after approximately 30 passages.
2.2.1.2 - Long term storage of BHK cells.
The cells from an 80% confluent 175 cm flask were resuspended in 9 ml of BHK 
storage medium. The resuspended cells were then divided into 1 ml aliquots, cooled slowly 
to -70°C before being transferred to liquid nitrogen storage (-190°C)
The cells were recovered from long term storage by thawing, pelleting the cells (1000 
rpm, Beckman GPR centrifuge for 5 minutes) and resuspending the pellet in fresh ETC 10 
prior to inoculating a fresh 175 cm2 flask.
2.2.1.3 - Preparation of wt stocks of HSV-1 and HSV-2.
BHK monolayers (approximately 80% confluent) in 175 cm2 culture flasks were 
infected with approximately 4xl06 pfu virus in 4 ml of EC5. The virus was allowed to 
adsorb for 1 hour at 37°C before 40 ml of EC5 was then added. The flasks were then 
returned to 37°C for between 3 and 5 days. Once extensive cpe was evident the cells were 
harvested using sterile glass beads. The cells were spun down at 2000 rpm (Beckman 
GPR centrifuge) for 2 minutes and the supernatant decanted. In the preparation of HSV-1 
the supernatant was spun at 4°C at 12,000 rpm for 240 minutes (Sorvall GSA rotor). The 
pellet was resuspended in 10 ml EC5, sonicated and stored at -70°C as cell released virus 
(CRV) stock. The HSV-2 supernatant was discarded.
The pelleted cells from the first spin were resuspended in 5 ml EC5 and sonicated 
extensively. The cell debris was pelleted at 2000 rpm for 5 minutes (Beckman GPR
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centrifuge) and the supernatant was decanted and stored at -70°C as cell associated virus 
(CAV) stock.
2.2.1.4 - Titration of HSV-1 and HSV-2.
Virus titrations were carried out on 90-95% confluent BHK cell monolayers in 35 mm 
dishes. The plates were inoculated with 0.1 ml of virus stock dilution of 10’4, 1 O'5, 10’6,
7 810 and 10' . The virus was allowed to adsorb for 1 hour at 37°C before being overlaid 
with methyl cellulose overlay to prevent secondary plaque formation. Incubation was 
continued at 37°C for 3 days. The monolayers were fixed and stained with giemsa stain for 
24 hours at 4°C. The stain was removed with running water and the plaques counted using 
a dissecting microscope.
2.2.1.5 - Sterility checks.
Sterility checks were carried out by streaking BHK or virus stocks onto blood agar 
plates. The plates were then incubated at 37°C for up to 5 days.
2.2.1.6 - Preparation of R408 bacteriophage.
A single R408 plaque on an E. coli (XLl-Blue) lawn was picked into 1.5 ml of 
L-broth containing 20 jlxI of E. coli (XLl-Blue) overnight culture. The phage culture was 
incubated in an orbital shaker overnight at 37°C. After approximately 16 hours 2 ml of fresh 
E. coli (XLl-Blue) culture and the phage overnight culture were added to 100 ml of L-broth 
and incubated at 37°C in an orbital shaker. After 24 hours the remaining bacteria in the 
culture were heat inactivated at 55°C for 1 hour and the culture was centrifuged at 5000 rpm 
for 10 minutes (Sorvall GSA rotor). The supernatant was then decanted and re-spun as 
described above. The supernatant from this final spin was divided into aliquots and stored at 
4°C as bacteriophage stock.
2.2.1.7 - Titration of R408 bacteriophage.
Serial dilutions of bacteriophage stock were made (10'5-10’7). 100 (il of each dilution 
was plated out onto L-broth agar plate. After being allowed to adsorb the phage was 
overlaid with 3 ml of top agar containing 200 |il of E.coli (XLl-Blue) overnight culture. 
Plates were incubated overnight at 37°C and plaques counted the following day.
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2.2.2 - Preparation of plasmid DNA.
2.2.2.1 - Large scale plasmid preparation (CsCl banding).
5 ml overnight cultures containing appropriate antibiotics were inoculated with a single 
colony picked from an LB-agar plate or 10 jul of bacterial stock (stored in 7% DMSO at 
-70°C). Cultures were shaken overnight at 37°C and then used to inoculate 400 ml LB 
cultures in 2 litre conical flasks, again containing appropriate antibiotics. 400 ml cultures 
were grown to an Agoo of 0.7 and 1 ml chloramphenicol (34 mg ml"1) was added. Incubation 
was continued overnight at 37°C. After approximately 16 hours the bacteria were pelleted at 
8000 rpm for 10 minutes at 4°C (Sorvall GS3 rotor). The bacteria were washed with 8 ml 
TE (pH 7.5) and re-pelleted at 5000 rpm for 5 minutes 4°C (Sorvall GS3 rotor). The pellet 
was resuspended in 2 ml sucrose reagent, 400 pi of fresh lyzozyme (20 mg ml'1) was added 
and the reaction was incubated at 4°C for 30 minutes. 800 pi EDTA (0.25M) and 3.2 ml 
triton reagent was then added and the lysis reaction was returned to 4°C for a further 15 
minutes.
The lysed bacteria were spun at 35,000 rpm for 30 minutes, 4°C (Sorvall T865). The 
supernatant was decanted and its volume adjusted to 7.5 ml using 200 pi EtBr (10 mg ml"1) 
and distilled water. 7.5 g of CsCl was then added to give a final density of 1.55-1.60 g 
ml’1. The mixture was transferred to cellulose nitrate tubes and capped with paraffin oil. 
Tubes were centrifuged at 44,000 rpm 15°C for 36 hours (Sorvall T1270 rotor). The 
supercoiled DNA band in the gradient was extracted using a hypodermic needle and a 2 ml 
syringe. The ethidium bromide was removed by repeated extraction with 1.5 ml of isoamyl 
alcohol and the CsCl removed by dialysing the DNA preparation against 2 x 2  litres of TE 
(pH 7.5). Plasmid DNA preparations were stored at -20°C.
The concentration of the DNA was established by measuring UV absorbance at 260 
nm (an absorbance of 1.0 corresponds to 50 pg ml"1 dsDNA). The quality of the DNA was 
examined by measuring its absorbance at 280 nm and by running 0.5 pg of linearised DNA 
on a 0.8% agarose minigel. Generally the A260 : A280 ratios were close to 2.0.
2.2.1.2 - Qiagen preparation.
DNA for ds plasmid sequencing was prepared using the Qiagen plasmid midi kit 
(Qiagen).
5 ml LB cultures containing the appropriate antibiotic were inoculated with either a 
single colony picked from an LB-agar plate or 10 pi of bacterial stock (stored in 7% DMSO 
at -70°C) and incubated overnight. 1 ml of overnight culture was added to 100 ml of LB 
media containing the appropriate antibiotic. The culture was grown to an A^ oo of
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approximately 1.0 and 0.3 ml chloramphenicol (34 mg ml'1) was added. The culture was 
incubated at 37°C for a further 16 hours, the cells were pelleted at 9000 rpm (Sorvall GSA 
rotor) for 15 minutes at 4°C and resuspended in 4 ml buffer PI. 4 ml buffer P2 was then 
added. After 5 minutes incubation at room temperature 4 ml of buffer P3 was added and the 
incubation continued for 15 minutes on ice. The bacterial lysate was centrifuged at 10,000 
rpm for 30 minutes at 4°C (Sorvall SS34 rotor). The supernatant was decanted and re-spun 
at 10,000 rpm for 15 minutes, 4°C. Meanwhile a Qiagen Tip-100 was equilibrated with 
buffer QBT. The supernatant from the bacterial lysate was applied to the tip which was then 
washed with 2 x 10 ml buffer QC. The plasmid was eluted from the column with 5 ml of 
buffer QF and the DNA precipitated with 3.5 ml of isopropanol. The precipitate was spun at
10.000 rpm for 30 minutes at 4°C (Sorvall SM24 rotor). The pelleted DNA was washed 
twice with 70% ethanol and resuspended in dH20 . The DNA yield and quality were 
determined as described in section 2.2.2.1
2.2.2.3 - Small scale plasmid preparation (miniprep) (Sambrook et al . ,
1 989).
5 ml LB cultures, containing the appropriate antibiotic, were inoculated with either a 
single bacterial colony picked from an LB agar plate or lOpl of bacterial stock (stored in 7% 
DMSO at -70°C and shaken overnight at 37°C. 1 ml was removed and the cells pelleted at
13.000 rpm for 1 min (MSE microfuge). The supernatant was discarded and the bacterial 
pellet was resuspended in 100 pi STET buffer. 16 pi of fresh lysozyme (10 mg ml'1) was 
added for 30 seconds and the samples were boiled for 1 min. After boiling the lysed bacteria 
were immediately centrifuged at 13,000 rpm for 10 minutes (MSE microfuge). The soft 
lysis pellet was removed and the DNA precipitated with 100 pi of isopropanol for 5 minutes 
at -20°C. The DNA was pelleted at 13,000 rpm for 10 minutes (MSE microfuge) and 
resuspended in 100 pi TE (pH 8.0) containing lx RNase mix.
Miniprep DNA was stored at -20°C and 30 pi aliquots were used for restriction 
enzyme digests.
2.2.3 - Transfection of cells with plasmid DNA.
2.2.3.1 - Calcium phosphate transfection of BHK cells.
1 ml of HeBS (optimised pH) was mixed with 0.25-6 pg of plasmid DNA, an 
optimised amount of calf thymus DNA usually 12-16 pg and 70 pi, 2M CaCl2. The mixture 
was vortexed and allowed to precipitate at room temperature for 5 minutes. Confluent BHK
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cell monolayers in 35 mm dishes (set up the previous day) were washed and drained prior to 
adding 0.4 ml of precipitate. The monolayers were incubated at 37°C for 40 minutes, 
overlaid with 3 ml EC5 and returned to 37°C. 4 hours post transfection the cells were 
washed with 2 ml of wash and treated with 2 ml 25% DMSO in HeBS for 4 minutes. The 
monolayers were then washed to remove the DMSO and overlaid with 2 ml EC5 before 
being returned to the incubator at 37°C/5% CO2.
2.2.3.2 - Lipofection of BHK cells.
Approximately 1.5xl05 BHK cells were used to seed 35 mm plates 24 hours prior to 
lipofection yielding approximately 25% confluent monolayers.
0.25-6 pg of plasmid DNA was mixed with 0.5 ml Optimem. 15 pi of 
LipofectACE]l was mixed with 0.5 ml Optimem in a separate tube. The DNA and 
liposomes were mixed and allowed to stand at room temperature for 10 minutes. Meanwhile 
the monolayers were washed with Optimem and drained. The liposomes / DNA mix was 
then added to the monolayer and the plates incubated at 37°C. 4 hours post transfection 2 ml 
of EC5 was added to each plate.
2.2.4 - Staining Monolayers.
2.2.4.1 - Staining for P-galactosidase expression in transfected cells
Monolayers transfected with the plasmid ipELacZ were stained for expression of 
p-galactosidase as an indicator of transfection efficiency. 24 hours post transfection 
monolayers were washed in PBS/ABC then fixed with p-galactosidase fix for 5 minutes. 
The fix was removed by washing with PBS/ABC. 1 ml of p-galactosidase staining solution 
was applied to each plate and the cells were incubated at 37°C for 24 hours. Cells 
expressing P-galactosidase stain blue. The number of blue cells were counted and the 
percentage of positive cells calculated.
2.2.5 - Transient replication and packaging assay.
2.2.5.1 - Transient replication assay.
a) Transfection / superinfection protocol.
BHK-21 C13 monolayers in 35 mm dishes were transfected with 3 |ig of plasmid 
DNA using either the calcium phosphate or lipofection procedures described in section
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2.2.3. 6 hours post-transfection the cells were infected with wfHSV-1 strain 17, at an MOI 
of 10.0. The virus was allowed to adsorb for 1 hour before being overlaid with 2 ml of 
EC5. Monolayers were maintained at 37°C throughout the assay protocol.
b) Preparation of total cellular DNA.
16 hours post-infection the medium was removed from the transfected monolayers, 2 
ml of 1 x CLB containing 0.5 mg ml"1 protease was added and the plates were incubated at 
37°C for 6 hours. The nucleic acids were then sequentially extracted with phenol and 
chloroform : isoamyl alcohol, precipitated with 2.5 volumes of ethanol and resuspended in 
150 jil TE pH 8.0 containing 1 x RNase mix.
30 jllI of the resuspended DNA (l/5th plate) was digested with EcoRl and Dpril. The 
products were resolved on a large 0.8% agarose gel in lx Loening’s buffer and the presence 
of replicated plasmid sequences was detected by Southern blotting and hybridisation to a 32P 
labelled probe.
2.2.5.2 - Transient packaging assay.
a) Transfection / superinfection protocol (used in initial experiments).
BHK-21 C13 monolayers in 35 mm dishes were transfected with 3 jig of plasmid 
DNA using the calcium phosphate procedure described in section 2.2.3.1. At 6 hours 
post-transfection the cells were infected with utfHSV-1 strain 17 at an MOI of 10.0. The 
virus was allowed to adsorb for 1 hour before being overlaid with 2 ml of EC5. Monolayers 
were maintained at 37°C throughout the assay protocol.
b) Transfection / superinfection protocol (optimised conditions).
BHK-21 C l3 or Vero monolayers in 35 mm dishes were transfected with 1 |ig of 
plasmid DNA using the calcium phosphate procedure described in section 2.2.3.1. At 30 
hours post-transfection the cells were infected with w/HSV-1 strain 17 or w?HSV-2 strain 
HG52 at an MOI of 1.0. The virus was allowed to adsorb for 1 hour before being overlaid 
with 2 ml of EC5. Monolayers were maintained at 37°C throughout the assay protocol.
c) Preparation of DNase resistant (packaged) DNA.
16 hours post-infection the medium was removed from the transfected monolayers and 
the cells resuspended in 2 ml RSB. The cells from each plate were divided into two aliquots.
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To the first aliquot (DNase resistant DNA) 55 pi NP40 (10%) and 10 pi DNase I (10 mg 
ml’1) was added. To the second aliquot (total cellular DNA) 55 pi NP40 (10%) was added. 
Both preparations were incubated at 37°C. After 2 hours 1 ml of 2xCLB containing 1 mg 
ml'1 protease was added to each preparation. This was followed by a further 2 hour 
incubation at 37°C. The nucleic acids were then sequentially extracted with phenol and 
chloroform : isoamyl alcohol, precipitated with 2.5 volumes of ethanol and resuspended in 
75 jul TE pH 8.0.
30 pi of the resuspended DNA (corresponding to that recovered from l/5th of the 
cells) was digested with EcoRl and Dpnl. The products were resolved on a large 0.8% 
agarose Loening’s buffer gel and the presence of replicated plasmid sequences was detected 
by Southern blotting and hybridisation to a 32P labelled probe
2.2.5.3 - Assay for the serial propagation of amplicons.
BHK cell monolayers in 35 mm dishes were transfected with 1 pg of plasmid DNA 
using the calcium phosphate procedure described in section 2.2.3.1. At 30 hours 
post-transfection the cells were infected with wfHSV-1 strain 17 at an MOI of 1.0. The
virus was allowed to adsorb for 1 hour before being overlaid with 2 ml of EC5. 16 hours
later the cells were resuspended in the medium and divided into two portions. Half was used 
to prepare total cellular DNA (pre-passage) as described in section 2.2.5.2b, except that 
incubation in the presence of NP40 was omitted. The remaining half was used to prepare a 
virus stock. The cells were sonicated in a sonicating waterbath for 5 minutes and the cell 
debris pelleted by centrifugation (5 minutes 2000 rpm, Beckman GPR centrifuge). The 
supernatant was removed and stored at -70°C as a virus stock. Half of this virus stock was 
subsequently used to infect a confluent BHK cell monolayer in a 35 mm dish. The virus 
was allowed to adsorb for 1 hour and the cells were overlaid with 2 ml of EC5. 16 hours
later total cellular DNA (post-passage) was prepared as described in section 2.2.5.1b. All
monolayers were maintained at 37°C throughout the assay protocol.
30 pi aliquots of both pre and post-passaged total cellular DNAs were digested with 
£coRI and Dpnl. The products were resolved on a large 0.8% agarose Loening’s buffer gel 
and the presence of plasmid sequences was detected by Southern blotting and hybridisation 
to a 32P labelled probe as described in section 2.2.6.
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2.2.6 - Southern blotting and hybridisation.
2.2.6.1 - Southern blot transfer (Southern, 1975).
The restriction enzyme products for Southern blotting were electrophoresesed through 
a 0.8% 0.5 cm thick slab gel in lx Loening’s buffer containing 0.5 pg m l1 ethidium 
bromide. Typically gels were run overnight at approximately 15 volts. Prior to blotting the 
gel was photographed under long wave UV light to confirm that the samples were 
consistently recovered and digested. The DNA was denatured by gentle agitation in gel soak 
I for 45 minutes, and then neutralised prior to blotting in gel soak II for 45 minutes. The 
DNA was blotted for 6-16 hours onto Hybond-N membrane using 6 x SSC, Whatman 3 mm 
chromatography paper and a weighted stack of paper towels. The DNA was crosslinked to 
the membrane using a Stratagene UV crosslinker (1200 Jem ).
2.2.6.2 - Preparation of radio-labelled probe for Southern blot hybridisation
Approximately 500 ng of pAT153 was labelled with 10 pCi each of [a32P] dGTP and 
[a32P] dCTP using nick translation protocol (Rigby et al. 1977). The incorporation reaction 
(28 pi) also contained 50 pM dATP and dTTP, 1 unit of E.coli DNA polymerase I, 10"7 mg 
ml"1 DNase I and lx nick translation buffer. The reaction was carried out for 90 minutes at 
16°C. Radio-labelled probe was separated from the unincorporated nucleotides using a G50 
sephadex column. Just prior to hybridisation the probe was denatured in 0.15M NaOH (1 
ml) and after 10 minutes neutralised with HC1 and mixed with 8.6 ml of pre-warmed 
hybridisation mix immediately prior to hybridisation.
2.2.6.3 - Southern blot hybridisation.
The dried Hybond-N membrane was sealed inside a hybridisation bag with 100 ml of 
pre-soak solution and shaken in a water bath at 68°C. After 2 hours the pre-soak solution 
was discarded and replaced with 10 ml of hybridisation mix containing the denatured nick 
translated probe. The hybridisation bag was then resealed and returned to the 68°C water 
bath for a further 6-16 hours.
The membrane was then removed and washed twice in 1 litre of blot wash for 1 hour. 
After this the blot was dried and exposed to either autoradiography film or a phosphorimager 
screen.
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2.2.6.4 - Visualising Southern blots.
a) Autoradiography.
The Southern blot membrane was exposed to X-omat S film for 3-16 hours, using an 
intensifier screen. The film was developed in an automated processor.
b) Phosphorimager.
The Southern blot membrane was exposed to the phosphorimager screen for 3-16 
hours and was scanned into the computer using a Molecular Dynamics scanner and the 
ImageQuant software package.
c) Quantitative analysis.
Quantitative measurements of the amount of replicated or packaged DNA were made 
using the ImageQuant software package (Molecular Dynamics). The scanned 
phosphorimage files were used for the analysis which measures the values of ‘positive’ 
pixels within a given area.
For each analysis the volume integration function was used, which sums the pixel 
values within a given object and subtracts the summed background pixel values. Identically 
sized rectangles were drawn around each of the objects for which intensities were to be 
calculated. An identically sized rectangle was also positioned somewhere on the blot, 
outwith the sample or marker lanes, this rectangle was used to calculate the background 
volume. The volumes of each of the object rectangles was then calculated, subtracting the 
volume of the background.
In experiments which were quantified, the intensity of each band is given as the value 
calculated by the volume integration function described above.
2.2.7 - DNA manipulation and propagation.
2.2.7.1 - Restriction enzyme digestion.
Restriction enzyme digestions were carried out using commercial restriction enzymes 
and the buffers supplied. Generally approximately 1 pg of DNA was incubated at the 
recommended temperature for 3 hours, with 5-10 units of enzyme. The final reaction 
volume was between 20-35 pi in 1 x reaction buffer.
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2.2.7.2 - Purification of DNA fragments.
Where it was necessary to specifically purify an individual DNA fragment this was 
achieved by excising the appropriate band and purifying the DNA by electoelution and 
passage over an affinity column.
The restriction enzyme digest was first run on a 1 x TAE agarose gel. The DNA was 
visualised using long wave UV light and the required DNA band excised. The excised band 
was placed inside dialysis tubing with 2 ml 1 x TAE, and then electroeluted at 200 volts for 
approximately 2 hours. The DNA containing buffer was removed and spun at 13000 rpm 
(MSE microcentrifuge) for 1 minute to remove the remaining gel fragments. The DNA 
containing buffer was then applied to a DEAE sephacel column. The column was washed 
with 5 ml TE pH 8.0 containing 0.1 M NaCl, the DNA was eluted using 1 ml of TE pH 8.0 
containing 1 M NaCl, was precipitated with 2.5 vols. of ethanol, washed with 70% ethanol 
and resuspended in a suitable volume of TE pH 8.0.
2.2.7.3 - Ligation of DNA fragments.
Prior to ligation restriction enzyme products were sequentially extracted with phenol 
and chloroform : isoamyl alcohol, ethanol precipitated and resuspended in TE pH 8.0. 
Where possible the plasmid backbone was dephosphorylated with calf intestinal phosphatase 
to prevent recircularisation.
During the ligation reaction an excess of insert with respect to plasmid backbone was
incubated together with 1 unit of T4 DNA ligase in 1 x ligation buffer. The reaction was
made up to 20 |il with dH20  and incubated either overnight at RT or for 48 hours at 4°C. 
Ligation products were sequentially extracted with phenol and chloroform : isoamyl alcohol, 
ethanol precipitated and resuspended in TE pH 8.0 prior to transformation into E. coli.
2.2.7.4 - Preparation and transformation of competent E. coli.
a) TSB competent E. coli. (C hung et al., 1989)
A 50 ml L-broth culture of E. coli was grown to an A^ oo of 0.9. 20 ml of this culture 
was pelleted at 2300 rpm for 10 minutes at 4°C (Sorvall SS-34). The pelleted bacteria were 
resuspended in 2 ml of chilled TSB / DMSO and incubated on ice for 10 minutes. 100 jliI 
aliquots were flash frozen and stored at -70°C.
Transformation was achieved by adding < 1 jig of DNA to 100 pi of bacteria. The 
bacteria were incubated on ice for 30 minutes, 900 pi of TSB/glucose was then added and
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the incubation continued in an orbital shaker at 37°C for 1 hour. 100 jul was then plated out 
onto L-broth agar plates containing the appropriate antibiotic.
b) Super competent E.coli (Hanahan, 1985).
A 100 ml SOB culture of E.coli was grown to an A550 of 0.5. The culture was then 
chilled and transferred to centrifuge tubes. The cells were pelleted at 1000 rpm for 15 
minutes (Sorvall SS34) and the supernatant removed. The cells were resuspended in RFI 
(l/3rd original volume) and incubated on ice for 60-120 minutes. The cells were then 
repelleted as above and resuspended in RFII (1/12.5 original volume). This suspension of 
bacteria was divided into 200 pi aliquots, which were flash frozen and stored at -70°C.
Transformation was achieved by adding < 20 pi (< 50 ng) of DNA to 200 pi of cells 
and incubating on ice for 60 minutes. The cells were heat shocked at 42°C for 90 seconds 
and then immediately chilled and 800 pi of SOC added. The bacteria were then incubated in 
an orbital shaker at 37°C for 1 hour. Dilutions were made of this culture (typically 
10'2-10‘5)and 100 pi plated out onto L-broth agar plates containing the appropriate antibiotic.
c) Commercial super-competent E. coli DH5a (Hanahan, 1985).
Transformation was achieved using the suppliers recommended conditions (essentially 
as described in section 2.2.6dii ). Less than 50 ng of DNA was added to 100 pi of cells. 
The cells were incubated on ice for 30 minutes, heat shocked at 42°C for 45 seconds and 
chilled on ice for 2 minutes. 900 pi of SOC was then added and the bacteria incubated in an 
orbital shaker for 1 hour. Dilutions were made and 100 pi plated out onto L-broth agar 
plates containing the appropriate antibiotic.
2.2.8 - Site Directed Mutagenesis.
2.2.8.1 - O ligonucleotides.
a) Synthesis of mutagenic oligonucleotides.
Oligonucleotides were synthesised ‘in house’ using a Cruachem PS250 synthesiser.
The newly synthesised oligonucleotides were supplied still attached to their synthesis 
column. They were removed using 1.5 ml of concentrated ammonia solution. 0.2 ml 
aliquots were pushed through the column at 20 minute intervals. The oligonucleotides were 
deprotected at 55°C for 5 hours and lyophilised overnight. The desiccated oligonucleotides
57
Materials & Methods
were then resuspended in a suitable volume of distilled water and their concentrations were 
established by measuring their absorbance at 260 nm.
b) Phosphorylation of mutagenic oligonucleotides.
Each mutagenic oligonucleotide was 5’ phosphorylated using T4 polynucleotide 
kinase in the presence of lx polynucleotide kinase buffer and 1 mM ATP. The 
phosphorylation reaction was carried out at 37°C for 40 minutes. The polynucleotide kinase 
enzyme was heat inactivated at 70°C for 10 minutes and the phosphorylated oligonucleotides 
stored at -20°C.
2.2.8.2 - Preparation of uracil rich single stranded (ss) DNA.
Uracil rich ssDNA copies of plasmids for mutagenesis were prepared from E. coli. 
CJ236 (dut, ung ) transformants infected with the ssDNA bacteriophage R408.
An overnight culture of bacteria was grown up in L-broth including 50 jug ml"1 
ampicillin and 100 pg ml"1 uridine. 4 ml of this overnight culture was used to inoculate a 
200 ml L-broth culture , which also contained 50 pg ml"1 ampicillin and 100 jug ml"1 uridine. 
This large culture was shaken at 37°C for 30 minutes before 1011 pfu of R408 bacteriophage 
was added. The culture was shaken for a further 9 hours at 37°C. Phage particles 
containing ss DNA were recovered after first pelleting the remaining bacteria at 9000 rpm 
(Sorvall GSA rotor). The phage were precipitated from the supernatant, by adding 0.25 
volumes (vols.) of 20 % PEG 6000 / 2.5 M NaCl incubating on ice for 30 minutes and 
pelleting at 12,000 rpm for 15 minutes (Sorvall GSA rotor). The pellet was resuspended in 
5 ml of TE pH 8.0 and reprecipitated and pelleted using the PEG / NaCl mix. Following the 
second precipitation all of the supernatant was removed and the pellet was resuspended in 2 
ml TE pH 8.0. The ssDNA was recovered from the phage like particles using 2 ml of 
equilibrated phenol. The phenol was vigorously mixed with the resuspended pellet for 1 
hour before the aqueous phase was removed. This aqueous phase was repeatedly extracted 
(until no interphase was observed) with an equal volume of phenol : chloroform : isoamyl 
alcohol (24:24:1). Finally the DNA was extracted with an equal volume of chloroform : 
isoamyl alcohol (24:1) and ethanol precipitated in the presence of 320 mM NaCl / 4 mM 
EDTA. The DNA was pelleted at 7000 rpm for 20 minutes (Sorvall SM24), washed with 
70% ethanol and resuspended in 100 pi of dH2Q.
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2.2.5.3 - Modified Kunkel mutagenesis (Kunkel et al., 1991).
a) Annealing.
Approximately 1 jag of uracil rich ss DNA was mixed with 2 jil of TM buffer and 36 
ng of phosphorylated oligonucleotide in a total volume of 20 jil. The annealing reaction was 
then placed in a water bath containing 250-300 ml of water. The waterbath was heated to 
95°C and allowed to cool slowly to RT.
b) Second strand synthesis.
To each annealing reaction, 10 |il of 5x Pol / Lig buffer, 1 unit of T7 DNA polymerase 
and 1 unit of T4 ligase was added. The total volume was adjusted to 50 |il and the reaction 
incubated at RT for 1 hour and then at 37°C for 1 hour.
The DNA from the synthesis reaction was then sequentially extracted with phenol and 
chloroform : isoamyl alcohol, ethanol precipitated with 2.5 volumes of ethanol and 
resuspended in 10-20 jul of distilled water.
3 (xl of the resuspended DNA was then used to transform competent E.coli. DH5a 
(idut+, ung+).
2.2.8.4 - Screening for mutants.
Mutations constructed using the method described above were identified by preparing 
DNA from transformed colonies picked from agarose plates (see section 2.2.2.3) and 
screening the DNA either for engineered restriction enzyme sites or changes in the size of 
particular restriction fragments.
2.2.9 - Gel electrophoresis of nucleic acids.
2.2.9.1 - Non denaturing agarose gels.
Two different sizes of slab gel were used, large gels (215 x 165 x 7 mm) and minigels 
(80 x 70 x 9 mm). All gels were made with 0.8% agarose in lx running buffer which 
contained 0.5 |ig ml"1 ethidium bromide. Samples were loaded into the wells of the gel in lx 
loading buffer.
The running buffer used for a particular gel was dependent upon the circumstances. 
Large gels for Southern blotting were run slowly overnight at 10-25 volts, therefore 
Loening’s buffer was used because of its high buffering capacity. In the majority of cases
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minigels were run in lx TBE and run at 40-60 volts for 2-4 hours.. The exception to this 
was when bands were to be purified from the gel, in this case lx TAE was used.
2.2.9.2 - Non denaturing polyacrylamide gels.
In order to resolve small DNA fragments, 1.5 mm thick vertical slab gels made with 
8% polyacrylamide (acrylamide : bis acrylamide 59:1) were used. The acrylamide : bis 
acrylamide was polymerised with 0.01 volumes of 10% ammonium persulphate and 0.001 
volumes of TEMED. The gels were run in 1 x TBE. DNA samples were loaded in lx TBE 
loading dye and the gels were stained in lx TBE containing 1 |ig ml’1 ethidium bromide. 
Polyacrylamide gels were typically run at 100 volts for 1-2 hours.
2.2.10 - Sequencing.
Plasmid DNA was sequenced directly using a Perkin Elmer automated sequencer. 
Double stranded plasmid DNA was prepared using Qiagen midi columns™ (see section 
2.2.2.2 ) .  DNA samples were provided for sequencing at a concentration of 0.2 fig j l lI1 with
1.6 pmol primer. All of the sequencing was carried out, in the pTZ series of vectors, by 
Lab200 (Leslie Taylor and Aiden Dolan). The sequencing reactions utilised the -20 16mer 
universal priming site present in these vectors. The sequence of the universal primer used 
was, TGACCGGCAGCAAAATG.
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Chapter 3 - Results.
Section 3 .1   ^Optimisation o f  a transient packaging assay for H S V -1 .
3.1.1 - Introduction.
The data presented in this section relate to the optimisation of a transient packaging 
assay for HSV-1, described initially by Stow et a l (1983).
The transient packaging assay involves transfecting a plasmid, containing a viral origin 
of DNA replication and packaging signal, into a cell line permissive for HSV-1. The cells 
are subsequently super-infected with wfHSV-1, which provides the helper functions 
necessary for the replication and packaging of plasmid sequences. Approximately 16 hours 
post-infection the cells are lysed in the presence of DNase I, so that only the DNA that has 
been packaged into viral capsids, and therefore protected from DNase digestion, is 
recovered. In the experiments described here the harvested DNA is digested with EcoKL and 
Dpnl and the products are resolved on an agarose gel. The presence of DNase-resistant 
(packaged) plasmid DNA is detected by Southern blotting and hybridisation to a 32P labelled 
probe (figure 3.1).
Digestion with ZscoRI (which cuts once in every plasmid used in this study) resolves 
the concatemeric DNA, produced by virus-directed replication, into unit length species. 
Dpnl digestion allows a distinction to be made between the input DNA delivered by 
transfection and the products of virus-directed replication. This distinction is based on the 
requirement for Dpnl digestion that its recognition / cleavage site (GATC) is methylated at 
the A residues. The input DNA, which is prepared from dam+ E.coli strains, is methylated 
and therefore susceptible to digestion; while the DNA which is replicated in eukaryotic cells 
during the course of the assay contains unmethylated GATC sequences and is, therefore, 
resistant to digestion.
In all the transient assay experiments described here the ethidium bromide stained gel 
was examined prior to blotting using a UV light box to check that recovery of DNA from all 
samples was consistent, and to confirm that the DNA had been properly digested.
The principal parent plasmid used in these experiments was pSl (Stow et a l ., 1983). 
pSl is derived from the high copy number plasmid pAT153 (Twigg & Sherratt, 1980) 
(figure 3.2 A). In addition it contains a 539 bp insert containing the HSV-1 Oris, which is 
cloned into the BamHl site (figure 3.2 B). In order for the replicated plasmid to be packaged 
during the transient packaging assay a packaging signal is also necessary. Putative 
packaging signals were cloned between the £coRI and Hindlll sites of pSl (e.g. pSAl,
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Figure 3.2 - Plasmid constructs used in the transient packaging assay.
All of the plasmids used during the transient packaging assay were based on 
pAT153 (A). pAT153 is derived from pBR322 (Twigg & Sherratt, 1980). The 
plasmid contains the p-lactamase gene for ampicillin resistance and a bacterial 
origin of replication.
pSl (B) is an HSV-1 replicon. It contains 539bp of HSV-1 Oris cloned into the 
BarriHl site of pAT153.
pSAl (C) is an HSV-1 amplicon. The packaging signal (in this case the 200bp 
uc-DRl-ub fragment) is cloned between the EcoRI and Hindlll of pSl.
pELacZ (D) is the plasmid used as a transfection marker, it contains the LacZ 
gene under the control of the HCMV immediate early gene promoter.
Results
figure 3.2 C). All of these plasmids also contain a functional B-lactamase gene which was 
used for the purpose of selection in bacteria.
Plasmids which contain functional HSV-1 signals that allow their replication, or 
replication and packaging, during the transient packaging assays are frequently referred to as 
replicons or amplicons respectively; where appropriate these names will be used.
3.1.2 - Linear relationship between the amount of plasmid DNA and the 
signal detected by the phosphorimager.
The probed membrane from each of the Southern blots, which were generated as part 
of this work, were exposed to a phosphorimager screen and the image captured using a 
specialised scanner (Molecular Dynamics).
In order to establish that there was a linear relationship between the amount of DNA 
loaded onto the gel and the value ascribed to the corresponding band by the phosphorimager 
software (Molecular Dynamics), a range of plasmid DNA amounts (0.25, 0.5, 1.0, 2.0, 
4.0, 8.0 and 16.0 ng) were Southern blotted and analysed using the software.
The phosphorimage for this blot is shown in figure 3.3 panel A. The intensity of each 
band was analysed using the phosphorimager software (Molecular Dynamics), as 
described in the methods, to quantify the radioactivity contained in each band. This data has 
been plotted graphically in figure 3.3 panel B. The relationship between the amount of DNA 
and the corresponding band intensity is approximately linear over the range tested.
3.1.3 - Comparison of three different fragments containing HSV-1 
packaging signals, in the transient packaging assay.
The aim of this section was to compare the ability of three different DNA fragments, 
containing HSV-1 packaging signals, to direct cleavage and packaging in a transient 
packaging assay.
The three different fragments were all cloned between the EcoRl and Hindlll sites of 
pSl (figure 3.2 B). The packaging signals were contained within; a 1762 bp HSV-1 DNA 
fragment from the junction between the L and S segments of the genome, which contains a 
single ‘a’ sequence (pYl), a 2161 bp HSV-1 DNA fragment from the same region of the 
genome, which contains two tandemly repeated ‘a’ sequences separated by a single DR1 
repeat (pZl), and a 200 bp sequence which contains sequences which span the junction 
between two tandemly repeated ‘a’ sequences (pSAl) (figure 3.2 C). The 200 bp sequence 
cloned into pSAl contains the uc and ub regions of the ‘a’ sequences on either side of the 
junction, plus the DR1 repeat which separates them. It is the uc and ub elements which
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Figure 3.3 - Linear relationship between the amount of plasmid DNA and the signal 
detected by the phosphorimager.
Panel A, lanes 1-7 contain; 0.25, 0.5, 1.0, 2.0, 4.0, 8.0 and 16.0 ng of linear pSAl 
respectively. The DNA was resolved on a 0.8% agarose gel. The gel was Southern 
blotted and the membrane probed with 32P labelled pAT153. Panel B, shows a graphic 
representation of the densitometry data from the phosphorimager.
Results
contain the regions of the ‘a’ sequence which have been shown to be particularly well 
conserved at the termini of other herpesviruses. The structure of this element is referred to 
as uc-DRl-ub. The structure of each packaging signal is shown in figure 3.4.
3 jig of each plasmid were transfected into BHK-21 cells using the calcium phosphate 
procedure. Helper functions were provided by HSV-1 superinfection (MOI, 10.0), at 6 
hours post-transfection. Total and packaged DNA were prepared 16 hours later, digested 
with EcoRl and Dpnl and Southern blotted as described in the methods section.
In agreement with previous results all three plasmids were replicated and packaged, 
indicating that both the Oris fragment and all three packaging signals are functional (figure 
3.5 Lanes 3-8). The DNA from cells transfected with pSAl (Lanes 3 & 4) generates a single 
unit length band, which comigrates with linear pSAl. Lanes 5-8, which contain DNA 
harvested from cells transfected with pYl (lanes 5 & 6) and pZl (lanes 7 & 8), contain major 
bands consistent with the unit length species for each plasmid. They also, contain minor 
bands of a smaller size (marked *), which represent the large terminal fragments which are 
generated as a consequence of the restriction enzyme digestion of packaged DNA (figure 
3.5). Terminal fragments are generated by two cleavage events in the terminal unit of the 
concatemer generated by the virus (figure 3.6). The first cleavage occurs in vivo as the viral 
proteins package the viral concatemer. The second cleavage event is carried out as the 
harvested DNA is digested with EcoRl. The EcoRI cleavage releases unit lengths from the 
middle of the replicated concatemers, but at the termini smaller fragments are released. The 
size of these fragments is therefore dependent upon the position of the EcoRl site with 
respect to the site of viral cleavage. In pSAl these 2 sites are 65 bps apart, which produces 
two fragments of 65 bp and 4318 bp. The smaller fragment is not detected because it does 
not contain any vector sequences, while the larger 4318 bp fragment would comigrate with 
the 4383 bp monomer. For pYl and pZl however, as more sequence separates the viral 
cleavage site from the ZscoRI site, the large terminal fragments are significantly smaller than 
the monomer. This significant size difference allows the large terminal fragments to be 
clearly seen.
Quantification of the level of replication and packaging for each plasmid was carried 
out using the phosphorimager (Molecular Dynamics) to measure the radioactivity in the 
monomer bands. The data for this experiment (experiment 1) and a repeat experiment is 
shown in table 3.1. The amount of packaged DNA is also given as a percentage of the total 
DNA harvested from the cells.
The data clearly show that for each plasmid the proportion of replicated amplicon DNA 
packaged into viral capsids is very similar. This shows that uc-DRl-ub packaging signal in 
pSAl functions as efficiently as the larger packaging signals in pYl and pZl and is therefore
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Figure 3.5 - Comparison of three different packaging signals in the transient 
packaging assay.
BHK 21 C13 monolayers were transfected with 3 pg of either pSAl, pY 1 or pZl using a 
calcium phosphate precipitate. Monolayers were DMSO boosted at 4 hours post­
transfection and super-infected with wfHSV-1 strain 17, (MOI, 10.0) at 6 hours post­
transfection. 16 hours post-infection total and packaged DNA was harvested from the 
cells. The DNA was EcoRl and Dpnl digested and the products resolved on a 0.8% agarose 
gel. The gel was Southern blotted and the membrane was probed with ,2P labelled 
pAT153.
The labelled blot was then exposed to a phosphorimager screen to produce the image 
above. Lanes 3 and 4 contain total and packaged DNA from cells transfected with pSAl. 
pSAl contains a 200 bp packaging signal (uc-DRl-ub) which spans the junction between 
two tandemly repeated ‘a’ sequences. Lanes 5 and 6 contain total and packaged DNA 
from cells transfected with pY 1, which contains 1.7 kbp of HSV-1 DNA within which is a 
single ‘a’ sequence. Lanes 7 and 8 contain total and packaged DNA from cells transfected 
with pZl, which contains 2.1 kbp within which are two tandemly repeated ‘a’ sequences, 
separated by a single DRl repeat.
The bands in lanes 5-8 (pY 1 and pZl marked *), represent the large terminal fragments 
produced by viral cleavage and subsequent FcoRI cleavage. Lanes 1 and 10 (M) contain 4 
ng of linear pSAl.
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Figure 3.6 - Generation of large and small terminal fragments.
Terminal fragments are produced by two successive cleavage events in the 
concatameric DNA, generated by virus directed replication. The input plasmid (1) is 
replicated by the virus generating a concatameric product (2), which consists of head to 
tail repeats of the amplicon. This concatamer is the substrate for DNA packaging and, 
as such, the concatamer will be cleaved at a site corresponding to the virus genome 
termini (3). This product is subsequently harvested and digested with FcoRI, which 
releases unit lengths from the middle of the concatamer. However, from the ends 
terminal fragments are produced, which are smaller than unit length (4). The size of 
the terminal fragments is a product of the location of the FcoRI site with respect to the 
site of viral cleavage.
Results
a suitable template for site-directed mutagenesis (see section 3.2). pSAl was consequently 
used for all subsequent optimisation experiments.
Table 3.1 - Comparison of three different packaging signals in the transient 
packaging assay.__________________________________________________________
Experiment 1 Experiment 2
Plasmid Band Intensity Total Band Intensity Packaged Band Intensity Total Band Intensity Packaged
DNA xlO5 DNA xlO5 DNA xlO5 DNA xlO5
pSAl 299 69.8
(23.3%)
15.4 4.6
(30.1%)
pYl 236 58.4
(24.8%)
249 77.1
(30.9%)
pZl 159 27.3
(17.1%)
93.3 28.5
(30.5%)
The amount of replicated and packaged DNA was quantified by Volume' analysis using 
the phosphorimager (arbitrary units). The percentage of total DNA which is packaged is 
shown in brackets. All data is shown to 3 significant figures.
3.1.4 - Comparison of transfection methods.
The level of pSAl replication in the transient assay was compared using two different 
transfection methods, calcium phosphate precipitation and lipofection. Hepes buffered saline 
(HeBS) was used in forming the calcium phosphate precipitate and lipofection was achieved 
using LipofectACE(BRL).
0.25 jig, 0.5 jug, 1.0 jig, 2.0 jig, and 6.0 jig of pSAl were transfected into BHK 21 
C l3 cells using LipofectACE, and 0.25 jig, 0.5 jig, 1.0 jig and 2.0 fig of pSAl were 
transfected into BHK 21 C l3 cells using the calcium phosphate procedure. Helper functions 
were provided by utfHSV-1 super-infection (MOI, 10.0) at 6 hours post-transfection and 
total DNA was harvested 16 hours later. The harvested DNA was then digested with EcoRl 
and Dpnl and Southern blotted as described in the methods.
The phosphorimage (figure 3.7) shows that for lipofected plates (lanes 2-6) increasing 
the amount of input DNA results in an increased amount of replicated DNA. However, the 
level (even at 6 jig per plate) never reaches that obtained from plates transfected using the 
calcium phosphate procedure (lanes 8 - 11), which remain fairly constant across the range of 
input amounts. Interestingly, the smaller bands, produced by Dpnl cleavage of unreplicated 
pSAl, were more prominent in lipofected cells and increased with increasing amount of 
input DNA. The presence of these bands suggests that lipofected monolayers contain 
plasmid DNA in relatively large amounts, which may not be available for replication.
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Figure 3.7 - Transient replication assay comparing calcium phosphate precipitation 
with lipofection.
BHK 21 C13 monolayers were transfected using either LipofectAC H (lanes 2-6) or a 
calcium phosphate procedure (lanes 8-11). Lipofected plates were transfected with 
0.25,0.5,1.0,2.0 or 6.0 pig of pSAl as indicated. Calcium phosphate transfected plates 
were transfected with 0.25,0.5,1.0 or 2.0 pig of pSAl. Monolayers were DMSO boosted at 
4 hours post-transfection and super-infected with w/HSV-1 strain 17, (MOI, 10.0) at 6 
hours post-transfection. 16 hours post-infection total DNA was harvested from the cells. 
The DNA was and Dpnl digested and the products resolved on a 0.8% agarose
TBE gel. The gel was Southern blotted and the membrane was probed with ,2P labelled 
pAT 153. Lanes 1,7 and 12 (M) contain 4 ng of linear pSAl.
Results
Whether this DNA is bound to the cell surface or is trapped somewhere in the cell remains 
unclear.
Based on these observations, in subsequent experiments each monolayer was 
transfected with 1 \ig of plasmid DNA using the calcium phosphate procedure.
3.1.5 The effect of multiplicity of infection of w fH SV -1.
The amount of helper virus applied to the cells was previously shown to influence the 
yield of packaged DNA by a group interested in HSV-1 amplicon packaging for gene therapy 
purposes (Wu et al, 1995). Therefore, an experiment was performed using wrHSV-1 
superinfection at a variety of different multiplicities, in order to optimise the packaging of 
pSAl sequences.
BHK 21 C13 monolayers were transfected with 1 jig of pSAl using the calcium 
phosphate procedure. Helper functions were supplied by wtHSV-1 super-infection at 6 
hours post-transfection. Helper virus was applied to individual plates at one of the following 
MOIs; 0, 0.01, 0.05, 0.1, 1.0, 5.0, or 10.0 p.f.u ce ll1. Total and packaged DNA were 
harvested from each plate 16 hours post-infection. Harvested DNAs were then digested with 
EcoRl and Dpnl and Southern blotted as described in the methods section.
The phosphorimage (figure 3.8) shows that both total (lanes 2 - 8 )  and packaged (lanes 
11 - 17) amplicon increases with increasing helper virus up to a certain point before 
beginning to decline. The intensity of the bands was measured using the phosphorimager 
software (Molecular Dynamics). The data for this experiment (experiment 1) and a 
repeat experiment are shown in table 3.2. The data from experiment 1 is also expressed 
graphically in figure 3.9, where the intensity of each band has been plotted against the MOI 
on a log scale.
Table 3.2 - Effect of multiplicity of infection of wtH SV -1.
MOI
Experiment 1 Experiment 2
Band Intensity  
Total DNA xlO5
Band Intensity  
Packaged DNA xlO^
Band Intensity  
Total DNA xlO5
Band Intensity  
Packaged DNA xlO^
0.00 0.412 0.143 (34.7%) 8.38 4.90 (58.5%)
0.01 0.585 0.126 (21.5%) 44.2 21.9 (49.5%)
0.05 2.49 0.288 (11.6%) 87.0 35.3 (40.6%)
0.10 3.27 0.997 (30.5%) 167 85.6 (51.3%)
1.0 19.6 6.86 (35.0%) 410 147 (35.9%)
5.0 29.4 5.19 (17.7%) 537 133 (24.8%)
10.0 13.0 4.22 (32.5%) 166 53.7 (32.3%)
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Figure 3.8 - Transient packaging assay examining the effect of multiplicity of 
infection (with HSV-1) on replication and packaging efficiency.
BHK 21 C13 monolayers were transfected with 1 pg of pSAl using the calcium 
phosphate procedure. Monolayers were DMSO boosted at 4 hours post-transfection and 
super-infected with w/HSV-1 strain 17, (MOI of; 0, 0.01, 0.05, 0.1, 1.0, 5.0 or 10.0) at 6 
hours post-transfection. 16 hours post-infection total (lanes 2-8) and packaged (lanes 11- 
17) DNA was harvested from the cells. The DNA was EcoRl and Dpnl digested and the 
products resolved on a 0.8% agarose TBE gel. The gel was Southern blotted and the 
membrane was probed with 32P labelled pAT153. Lanes 1,9,10 and 18 (M) contain 4 ng 
of linear pSAl.
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Figure 3.9 - Graphic representation of HSV-1 multiplicity of infection data.
The band intensity data from the phosphorimager was plotted against multiplicity of 
infection on a log scale.
Result*
All data is shown to 3 significant figures. The percentage of total DNA which is packaged 
is shown in brackets.
In both experiments the optimum for replication is 5, but for packaging it is 1. For this 
reason an MOI of 1 was used in all subsequent experiments.
3.1.6 - Delayed super-infection.
The work of Wu et a l (1995) also suggested that delaying super-infection with wt 
virus increased the amount of packaged amplicon that could be recovered. This was 
examined for the transient packaging assay using duplicate plates which were infected with 
wrHSV-1 24 hours apart.
BHK-21 C l3 monolayers were transfected with 1 jig pSAl using a calcium phosphate 
procedure. The plates were DMSO boosted at 4 hours post-transfection and 6 hours 
post-transfection one plate was super-infected with wtfHSV-1 (MOI, 1.0). 16 hours later
packaged DNA was harvested. A second plate was super-infected with wfHSV-1 (MOI,
1.0) at 30 hours post-transfection and again packaged DNA was harvested 16 hours later. 
The DNAs from both plates were then digested and Southern blotted as described in the 
methods section.
Figure 3.10 shows the phosphorimage from this experiment. Lane 3 contains DNA 
harvested from the plate which was super-infected at 6 hours post-transfection. Lane 2 
contains DNA harvested from the plate transfected at 30 hours post-transfection. The 
intensity of the respective bands was measured using the phosphorimager software 
(Molecular Dynamics). The data demonstrated that delaying super-infection by 24 
hours increases the amount of packaged DNA by approximately 1.7 fold. However, in 
separate experiments it has been observed that the number of cells in the 35 mm dish 
increased during the additional 24 hours, from 1.72x10^ to 3.00x10^ an increase of 1.7 
fold. This suggests that, at an appropriately corrected MOI, the increase in packaged DNA 
may simply reflect the increased number of cells on the plate.
3.1.7 - The effect of the DMSO boost on transient packaging assay 
effic ien cy .
The treatment of a monolayer of cells with a solution of 25% DMSO (DMSO boost) 
has been shown to significantly increase the efficiency of calcium phosphate transfection as 
measured by either infectivity of viral DNA (Stow and Wilkie, 1976) or expression of a 
marker gene (such as LacZ) from a transfected plasmid (personal communication, N.Stow). 
The aim of this section was to establish whether the application of a DMSO boost was
6 6
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Figure 3.10 - Investigating the effect of delayed super-infection with helper virus, on 
packaging assay efficiency.
BHK 21 C13 monolayers were transfected with 1 pig of pSAl, using a calcium 
phosphate procedure. Monolayers were DMSO boosted at 4 hours post-transfection and 
super-infected with w/HSV-1 strain 17, (MOI, 1.0) at 6 (lane 3) or 30 (lane 2) hours post­
transfection. Packaged DNA was harvested from the cells 16 hours post-infection. The 
DNA was £h?RI and Dpnl digested and the products resolved on a 0.8% agarose TBE 
gel. The gel was Southern blotted and the membrane was probed with 32P labelled 
pAT153. Lanes 1 and 4 (M) contain 4 ng of linear pSAl.
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relevant in the context of the transient packaging assay, which does not require gene 
expression from the transfected DNA. The effect of a DMSO boost on LacZ expression 
from a transfected plasmid is shown in the experiment below.
A plasmid (pELacZ, see figure 3.2 D) which contains the LacZ gene under the control 
of the immediate early HCMV promoter was transfected into duplicate BHK 21 C13 
monolayers, using a calcium phosphate procedure. At 4 hours post-transfection one plate 
was boosted for 4 minutes with a 25% DMSO solution in HeBS. The other plate was mock 
boosted with wash. 24 hours post-transfection both plates were fixed and then stained to 
determine the expression of B-galactosidase (section 2.2.4). The number of cells which 
stained blue were then counted using a microscope. The data is shown in table 3.3.
Table 3.3 - Effect of DMSO on [3-galactosidase expression.
Observation
DMSO Boost No DMSO Boost
Blue cells per field 
of vision
Blue cells per field 
of vision
1 138 5
2 142 7
3 115 0
4 122 1
5 109 3
6 135 3
7 126 5
8 131 9
9 129 7
10 133 11
Average 128 5.1
Blue cells per plate 48256 1923
% efficiency 2.80±0.07% 0.11±0.02%
The number of blue cells were counted in 10 representative fields of vision and an average
calculated. The area of a single field of vision is 1/377 the area of a 35 mm dish (962 mm^ ) 
at 200 x magnification. From this the number of blue cells per plate could be calculated.
Using a Heamatocytometer the number of BHK cells per plate was determined as 1.72x10^,
(24 hours after seeding with 6x10^ cells). Using this figure the percentage of the cells 
transfected was calculated. The standard error for the calculation was calculated using the
formula se= dn-!/Vn.
This data is expressed as a bar chart in figure 3.11 A. The DMSO boost increases the 
number of cells expressing B-galactosidase more than 25 fold.
To test whether the DMSO boost also had an effect upon the efficiency of the transient 
packaging assay, duplicate BHK 21 C13 monolayers were transfected with 1 pg of pSAl 
using a calcium phosphate procedure. One plate was DMSO boosted with 25% DMSO in 
HeBS at 4 hours post-transfection. The other plate was mock boosted with wash. Both sets 
of plates were super-infected with w/HSV-1 (MOI, 1.0) at 30 hours post-transfection. 
Packaged DNA was harvested 16 hours later. The DNAs were digested and Southern 
blotted as described in the methods section.
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Figure 3.11 - Graphical representations of the effect of the DMSO boost.
Panel A., shows a graphical representation of the data from table 3.3. Showing the 
effect of a 25% DMSO boost on the number of cells expressing p-galactosidase, 
following calcium phosphate transfection of a plasmid containing the LacZ gene.
Panel B., shows shows a graphical representation of the data from figure 3.12. 
Showing the effect of a 25% DMSO boost on transient packaging efficiency.
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The Phosphorimage from this experiment is shown in Figure 3.12. Lane 3 contains 
DNA from a mock boosted plate and lane 4 contains DNA from a boosted plate. The 
intensity of these bands was analysed using the phosphorimager software (Molecular 
Dynamics) and data is presented graphically in figure 3.11 B. This data indicates that a 
DMSO boost has no significant effect on the yield of packaged DNA.
A similar experiment was performed to examine the effect of DMSO on the transient 
packaging assay in BHK cells and a second cell line - Vero cells. Vero and BHK 21 C13 
monolayers were again transfected with 1 pg of pSAl using the calcium phosphate 
procedure. 4 hours post-transfection half the plates were DMSO boosted for 4 minutes with 
25 % DMSO in HeBS. The remaining plates were ‘mock boosted’ with wash. Where 
appropriate the plates were mock infected or infected with wrHSV-1 (MOI, 1.0) at 30 hours 
post-transfection. Total and packaged DNA was harvested 16 hours later. The harvested 
DNAs were then digested and Southern blotted as described in the methods section. The 
phosphorimage from this experiment is shown in figure 3.13. Lanes 3-8 contain DNA 
harvested from Vero cells and lanes 11-18 contain DNA harvested from BHK cells. Again, 
in this experiment no correlation was found between the DMSO boost and assay efficiency in 
BHK cells. The level of replicated DNA in Vero cells appears to be slightly increased by 
DMSO treatment but there was little effect upon the amount of packaged DNA. In Vero cells 
the DMSO boost had a similar effect on LacZ expression from a transfected plasmid as that 
observed in BHK cells (data not shown). These observations combined suggest that the 
DMSO boost has little effect on the efficiency of the transient packaging assay in either cell 
line.
3.1.8 The uc-D R l-u b sequence serves as a cleavage and packaging signal for 
H SV -2.
A complicating factor in assessing the effects of mutations in the HSV-1 uc-DRl-ub 
element on packaging efficiency was considered to be the possibility of recombination 
between the amplicon and the helper virus to repair mutated sequences. One way to reduce 
recombination in the transient packaging assay might be to reduce the homology between the 
amplicon and the helper virus. The aim of this section was therefore to establish whether 
HSV-2 could replace HSV-1 in the transient packaging assay. Overall HSV-1 and HSV-2 
share 83% identity at the nucleotide level, however, an alignment of the uc-DRl-ub sequence 
cloned into pSAl with the corresponding regions of HSV-2 reveals only 54% nucleotide 
identity (figure 3.14). Nevertheless the ‘a’ sequences of HSV-1 and HSV-2 have previously 
been shown to be functionally interchangeable (Smiley et a l, 1992). Similarly, the HSV-1
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lane 1 2  3 4
Figure 3.12 - Transient replication assay examining the effect of the DMSO boost on 
packaging efficiency.
BHK 21 C13 monolayers were transfected with 1 pig of pSAl, using the calcium 
phosphate procedure. At 4 hours post-transfection one monolayer (lane 4) was DMSO 
boosted with 25% DMSO in HeBS for 4 minutes. Another monolayer (lane 3) was mock 
boosted with wash. Each monolayer was super-infected with w/HSV-l strain 17, (MOI,
1.0) at 30 hours post-transfection. Total DNA was harvested from the cells 16 hours 
post-infection. The DNA was E’coRI and Dpn\ digested and the products resolved on a 
0.8% agarose gel. The gel was Southern blotted and the membrane was probed with 32P 
labelled pAT153. Lane 1 (M) contains 1 ng of linear pSAl.
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Figure 3.13 - Transient packaging assay examining the effect of the DMSO boost in 
vero and BHK cells.
Identical transient packaging assays were performed in either Vero (panel A) or BHK 
cells (panel B). Monolayers were transfected with 1 pg of pSAl, using the calcium 
phosphate procedure. At 4 hours post-transfection half the plates for each cell type were 
DMSO boosted with 25% DMSO in HeBS for 4 minutes (lanes 3-5 & 13-15). The other 
half (Lanes 6-8 & 16-18) were mock boosted with wash.
At 30 hours post-transfection experimental plates (3, 4, 6, 7, 13, 14, 16 and 17) were 
super-infected with wrHSV-1 strain 17, (MOI, 1.0). The control plates were mock- 
infected (MIT). 16 hours post-infection total (lanes 3, 5, 6, 8, 13, 15, 16 & 18) and 
packaged (lanes 4, 7, 14 & 17) DNA was harvested from the cells. The DNA was £cy;RI 
and Dpn\ digested and the products resolved on a 0.8% agarose TBE gel. The gel was 
Southern blotted and the membrane was probed with 32P labelled pAT153. Lanes 1,10,11 
and 20 (M) contain 1 ng of linear pSAl.
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Results
Oris region present in pSAl exhibits only 56% sequence identity with the corresponding 
region of the HSV-2 genome (Figure 3.15).
The ability of HSV-2 to utilise the HSV-1 Oris and uc-DRl-ub packaging signals in the 
transient packaging assay was examined in the experiment described below.
Duplicate BHK 21 C13 monolayers were transfected with 1 |xg of pSAl or pSl using 
the calcium phosphate procedure. The plates were DMSO boosted at 4 hours 
post-transfection and helper functions were provided at 30 hours post-transfection. One 
plate was super-infected with wfHSV-1 strain 17 at an MOI of 2.0. The other plate was 
super-infected with wfHSV-2 strain HG52 at an MOI of 2.0. Total and packaged DNA was 
harvested 16 hours later. The harvested DNA was digested with EcoRl and Dpnl and 
Southern blotted as described in the methods section.
Figure 3.16 shows the phosphorimage of the blot from this experiment. Lanes 3 and 4 
contain total DNA from cells transfected with pSAl and super-infected with HSV-1 and 
HSV-2 respectively. Both lanes contain replicated DNA, although the total amount of 
replication appears slightly reduced when HSV-2 is used. Lanes 5 and 6 contain packaged 
DNA from cells transfected with pSAl and super-infected with HSV-1 (lane 5), or HSV-2 
(lane 6). Both viruses packaged DNA at approximately the same level. Lanes 8 - 11  contain 
DNA harvested from pSl transfected cells. Again, HSV-1 replicated pSl to a slightly higher 
level than HSV-2 (lanes 8 and 9). As expected, neither virus packaged any plasmid DNA 
(lanes 10 and 11) since pSl lacks a packaging signal.
This experiment confirms that HSV-2 can utilise the HSV-1 Oris and uc-DRl-ub 
elements with similar efficiency to HSV-1. However, the reduced sequence homology 
between these signals and the corresponding region of HSV-2, would be expected to reduce 
the probability of recombination between amplicon and helper virus.
3.1.9 - Effect of HSV-2 multiplicity of infection on replication and
packaging efficiency.
Having established that HSV-2 can utilise HSV-1 replication and packaging signals, 
the optimal MOI using HSV- 2 in the transient packaging assay was investigated.
BHK cell monolayers were transfected with 1 (ig of pSAl using the calcium phosphate 
procedure. The cells were DMSO boosted at 4 hours post-transfection and helper functions 
were provided by wfHSV-2 Strain HG52 at 30 hours post-transfection. Each plate was 
infected at one of the following MOIs; 0, 0.01, 0.05, 0.1, 1.0, 5.0, 10.0, or 20.0. Total 
and packaged DNA were harvested from each plate 16 hours post-infection. Harvested 
DNAs were digested with EcoRl and Dpnl and then Southern blotted as described in the 
methods section.
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Figure 3.16 - The HSV-1 uc-DRl-ub sequence serves as a cleavage and packaging 
signal for HSV-2.
BHK 21 C13 monolayers were transfected with 1 pg of pSAl (lanes 3-6) or pSl (lanes 
8-11), using the calcium phosphate procedure. Monolayers were DMSO boosted 4 hours 
post-transfection and super-infected with either w/HSV-1 strain 17, (lanes 3,5,8 & 10) or 
wrHSV-2 strain HG52 (lanes 4,6,9 & 11) (MOI, 2.0) at 30 hours post-transfection. 16 
hours post-infection total (lanes 3,4,8 & 9) and packaged (lanes 5,6,10 & 11) DNA was 
harvested from the cells. The DNA was EcoK\ and Dpnl digested and the products 
resolved on a 0.8% agarose TBE gel. The gel was Southern blotted and the membrane 
was probed with 32P labelled pAT153. Lane 1 and 13 (M) contain 4 ng of linear pSAl.
Results
Table 3.4 - Effect of multiplicity of infection with HSV-2.
MOI Band Intensity  
Total DNA 
x l O 5
Band Intensity  
Packaged DNA 
x l O 5
0.00 0.857 0.812 (n/a)
0.01 2.91 0.207 (7.1%)
0.05 15.2 9.88 (65.0%)
0.10 24.1 15.5 (64.5%)
1.0 42.4 12.2 (28.8%)
5.0 10.4 5.57 (53.6%)
10.0 12.8 6.48 (50.6%)
20.0 8.00 6.51 (81.4%)
All data is shown to 3 significant figures. The percentage of total DNA which is 
packaged is shown in brackets.
The phosphorimage (figure 3.17) shows a similar pattern to that seen with HSV-1. 
The amount of total (lanes 2-9) and packaged (lanes 12-19) DNA initially increased with 
increasing helper virus and then declined. The intensity of the bands was measured using 
the phosphorimager software (Molecular Dynamics) and the data is shown in table 3.4. 
and figure 3.18.
The results show that maximum efficiency for replication was obtained at 1.0 pfu cell'1 
and the maximum packaging (both in terms of absolute amount and the proportion of 
replicated DNA, packaged) was obtained at 0.1 pfu cell1.
3.1.10 - Alternative method of harvesting total and packaged DNA.
The method for harvesting total and packaged DNA from cells involves multiple steps, 
culminating in phenol and chloroform extractions and ethanol precipitation. The extraction 
of multiple samples in this way can be extremely time consuming especially when the 
experiment has a large number of samples. With this in mind an attempt was made to 
simplify the method, by replacing the phenol and chloroform extractions and ethanol 
precipitation with a single isopropanol precipitation. Isopropanol precipitation offers a fast 
and efficient method of DNA precipitation from cell lysates, e.g. precipitation of DNA from 
small scale DNA preparations and Qiagen purifications.
A BHK cell monolayer was transfected with 1 pg of pSAl using calcium phosphate 
procedure. The cells were DMSO boosted at 4 hours post-transfection and helper functions
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Figure 3.17 - Transient packaging assay examining the effect of multiplicity of 
infection (with HSV-2) on replication and packaging efficiency.
BHK 21 C13 monolayers were transfected with 1 pig of pSAl using a calcium phosphate 
procedure. Monolayers were DMSO boosted at 4 hours post-transfection and super­
infected with wrHSV-2 strain HG52, (MOI of; 0, 0.01, 0.05, 0.1, 1.0, 5.0, 10.0 or 20.0) at 
30 hours post-transfection. 16 hours post-infection total (lanes 2-9) and packaged (lanes 
12-19)DNA was harvested from the cells. The DNA was £h?RI and Dpnl digested and 
the products resolved on a 0.8% agarose TBE gel. The gel was Southern blotted and the 
membrane was probed with 32P labelled pAT153. Lanes 1, 10, 11 and 20 (M) contain 4 
ng of linear pSAl
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Figure 3.18 - Graphic representation of HSV-2 multiplicity of infection data.
The band intensity data from table 6 was plotted against multiplicity of infection on 
a log scale.
Results
were provided by wfHSV-1 at 30 hours post-transfection. 16 hours later total and packaged 
DNA were harvested. Following incubation, with 1 x CLB and 0.5 mg ml-1 protease, the 
nucleic acids were precipitated using an equal volume of isopropanol. The harvested DNAs 
were then digested with EcoRI and Dpnl and Southern blotted as described in the methods 
section.
Figure 3.19 shows the phosphorimage from this experiment. Prior to Southern 
blotting, when the agarose gel was visualised using a UV lamp, the DNA appeared 
incompletely digested - the cellular DNA being largely near the wells as opposed to evenly 
distributed down the lane. This observation was confirmed when the Southern blot was 
inspected. Lanes 2 and 3 (which contain total and packaged DNA respectively) contain 
multiple high molecular weight bands which correspond to the partially cleaved concatemeric 
molecules produced by rolling circle replication. These intermediates would normally be 
resolved to unit lengths by complete £coRI digestion. In this case, a possible cause of 
inefficient digestion of the harvested DNA was that the DNA pellet was contaminated with 
protease from the lysis stage.
In an attempt to circumvent this problem another transient packaging assay was 
performed, exactly as described above except that duplicate plates were used. The DNA 
from one plate was harvested as described above, and the resuspended DNA was then 
treated with 67 jiM PMSF (PMSF is a potent protease inhibitor). The second plate was 
harvested as usual, with a phenol and chloroform extraction and ethanol precipitation.
The DNA from both plates was then digested with EcoKL and Dpnl and Southern 
blotted as described in the methods section (data not shown). Efficient digestion was 
observed in the presence of PMSF, however, the yields of replicated and packaged DNA 
was significantly reduced compared to the yields achieved with the standard protocol. This 
and subsequent experiments showed that, while good recovery of total DNA could be 
achieved using the isopropanol precipitation method, consistent recovery, especially of the 
small amount of packaged DNA, was a problem. For this reason the DNA in subsequent 
experiments was extracted with phenol and chloroform and ethanol precipitated.
3.1.11 - Comparison of original and modified protocols for the transient 
packaging assay.
The modified protocol, incorporating the various changes described above was 
compared to the original transient packaging assay in a single experiment.
One BHK cell monolayer (original protocol) was transfected with 3 p,g of pSAl using 
the calcium phosphate procedure. The monolayer was DMSO boosted at 4 hours 
post-transfection and then super-infected (at a multiplicity of 10.0) with wfHSV-1 at 6 hours
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Figure 3.19 - The transient packaging assays using isopropanol precipitation of 
nucleic acids as opposed to phenol, chloroform and ethanol precipitation.
BHK 21 C13 monolayers were transfected with 1 pg of pSAl using the calcium 
phosphate procedure. Monolayers were DMSO boosted at 4 hours post-transfection and 
super-infected with w/HSV-1 strain 17 (MOI, 2.0) at 30 hours post-transfection. Total 
and packaged DNA were harvested from the cells 16 hours post-infection and precipitated 
with an equal volume of isopropanol. The DNA was EcoRl and Dpnl digested and the 
products resolved on a 0.8% agarose TBE gel. The gel was Southern blotted and the 
membrane was probed with 32P labelled pAT153.
Lane 2 contains total DNA and Lane 3 contains packaged DNA. The ladder of bands is 
indicative of incomplete digestion which is possibly caused by protease carried over from 
the cell lysate. Lanes 1 and 4 (M) contain 4 ng of linear pSA 1.
Results
post-transfection. Total and packaged DNA was prepared 16 hours later, phenol and 
chloroform extracted, ethanol precipitated and resuspended in TE pH 8.0. A duplicate 
monolayer (optimised conditions) was transfected with 1 jug of pSAl using the calcium 
phosphate procedure. The monolayer was DMSO boosted at 4 hours post-transfection and 
then super-infected (at a multiplicity of 1.0) with w/HSV-1 at 30 hours post-transfection. 
Total and packaged DNA was prepared 16 hours later, phenol and chloroform extracted, 
ethanol precipitated and resuspended in TE pH 8.0. The harvested DNAs were digested 
with EcoRl and Dpnl and Southern blotted as described in the methods section.
The phosphorimage of this blot is shown in figure 3.20. Lanes 3 and 4 contain 
packaged and total DNA respectively, prepared using the original protocol. Lanes 6 and 7 
contain packaged and total DNA respectively, prepared using the optimised protocol. The 
intensity of each band was measured using the phosphorimager software (Molecular 
Dynamics) and the data from this experiment (experiment 1) and a repeat experiment is 
shown in table 3.5. The intensity of each band is given and the percentage increase between 
the two protocols is also shown.
Table 3.5 - Comparison of the original and optimised protocols for the
transient packaging assay.
Conditions
Experiment 1 Experiment 2
Band Intensity 
Total DNA 
xlO^
Band Intensity 
Packaged DNA
x lO 5
Band Intensity 
Total DNA 
x lO 5
Band Intensity 
Packaged DNA
x lO 5
Original 74.9 23.1 (30.8%) 9.03 3.82 (42.3%)
Optimised 115 45.3 (39.1%) 35.0 9.09 (26.0%)
fold increase 1.53 1.96 3.87 2.38
The percentage of total DNA w rich is packaged is shown in brackets.
This data shows that the optimised protocol results in a significant increase in the 
efficiency of the assay. These conditions were therefore used in all subsequent experiments.
3.1.12 - Discussion.
3.1.12.1 - Functional packaging signals.
The observation that the HSV-1 packaging signals in pYl, pZl and pSAl are all 
functional, while agreeing with the published data (Stow et al., 1983; Nasseri & Mocarski, 
1988), raises the question of which sequence represents the functional signal in vivo. The 
minimum functional packaging signal so far identified is the uc-DRl-ub sequence. In this 
arrangement the essential p ad  and pac2 homologies are brought into close proximity, the 
cleavage occurring between the two. It has been proposed that this element constitutes the 
wt cleavage and packaging signal, as this arrangement of sequences occurs between two 
tandemly repeated ‘a’ sequences and cleavage would generate genomic termini which
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Figure 3.20 - Comparison of original and optimised protocols for the transient 
packaging assay.
Lanes 3 and 4 contain total (lane 3) and packaged (lane 4) DNA from a monolayer 
which was transfected with 3 pig of pSAl using a calcium phosphate procedure. The 
monolayer was DMSO boosted at 4 hours post-transfection and super-infected with 
wrHSV-1 strain 17 (MOI, 10.0) at 6 hours post-transfection. 16 hours post-transfection 
the DNA was harvested using a phenol chloroform extraction and ethanol precipitation.
Lanes 6 and 7 contain total (lane 6) and packaged (lane 7) DNA from a monolayer 
which was transfected with 1 pig of pSAl using a calcium phosphate precipitate. The 
monolayer was DMSO boosted at 4 hours post-transfection and super-infected with 
wrHSV-1 strain 17 (MOI, 1.0) at 30 hours post-transfection. 16 hours post-infection the 
DNA was harvested using a phenol chloroform extraction and ethanol precipitation. The 
harvested DNAs were EcoRl and Dpnl digested and the products resolved on a 0.8% 
agarose TBE gel. The gel was Southern blotted and the membrane was probed with 32P 
labelled pAT153. Lane 1 (M) contains 4 ng of linear pSAl.
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terminate in ‘a’ sequences (Nasseri and Mocarski, 1988). However, while pSAl and pZl 
contain this arrangement of sequences, pYl (which contains a single ‘a’ sequence) does not. 
If the uc-DRl-ub sequence represents the functional packaging signal in vivo then pYl must 
have gained either all, or part of, an ‘a’ sequence in order to generate this arrangement. 
Alternatively, the cleavage and packaging mechanism may not have an absolute requirement 
for the p ad  and pac2 homologies to be in close proximity allowing the single ‘a’ sequence 
of pY 1 to direct cleavage and packaging.
Some insight into the mechanism of cleavage and packaging can be obtained by 
considering the terminal fragments seen in section 3.1.3. pYl generates a single terminal 
band while pZl generates two. This suggests that pYl contains one cleavage site and pZl 
contains two (at the time of cleavage and packaging). The size of the fragments may provide 
further insight. Input plasmid pYl contains two DR1 repeats where virus directed cleavage 
may potentially be occurring. Cleavage at these DR1 repeats would be predicted to give rise 
to two large terminal fragments of 4430 and 4829 bp respectively. However, only one 
terminal fragment is observed and estimates of its size, based on the distance the band has 
migrated on the agarose gel suggests that it is 4829 bp in size. For p Z l, three putative large 
terminal fragments are predicted from the location of the DR1 repeats. These are 4430, 4829 
and 5228 bp in size. In fact, only two are observed and their sizes are consistent with the 
expected locations of the two largest fragments. The estimation of fragment sizes was made 
by comparing the relative migration of the terminal fragments and fragments of known size 
such as the linearised markers. The smallest, predicted, fragments which are not observed, 
would be produced by cleavage in the DR1 repeat closest to the Hindlll site in the plasmid 
producing a concatemer which lacks an ‘a’ sequence at its terminus. These data are 
compatible with the pac2 sequence in uc being necessary for the generation of the long 
terminus of pYl andpZl molecules, as the common feature of the long termini observed is 
an adjacent uc sequence (figure 3.21). Although no experiments were done to analyse the 
opposite terminus of these packaged molecules, it is possible that the p ad  sequence in ub 
might have a function in the generation of packaged DNA molecules containing an ‘a’ 
sequence at this terminus.
Provided that the input amplicon is the same as the packaged amplicon, then pY 1, with 
its single ‘a’ sequence, will generate one terminus lacking an ‘a’ sequence for every terminus 
which possesses one. Two possible scenarios regarding DNA packaging can be derived 
from this. On the one hand, DNA packaging may initiate at an ‘a’ sequence and terminate at 
the next ‘a’ sequence, cleaving the viral concatemer in such a way as to give a packaged 
terminus which lacks an ‘a’ sequence and an unpackaged concatemer which terminates with 
an ‘a’ sequence (figure 3.22 A). Thus unpackaged concatemer would then be the substrate
73
pYl.
pZl
Small terminal fragment Detected - Long terminal fragment. (4829 bp).
Not detected - Short terminal fragment (4430 bp).
t"t - C O -f't
Small terminal fragments
Detected - 2 Longest terminal fragments (5228 & 4829 bp).
Not detected-Shortest terminal fragment(4430 bp).
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.. ■ , e e e
Figure 3.21 - Predicted packaged products of pYl and pZ l in the 
transient packaging assay.
The terminal fragments generated during the transient packaging assays 
with pYl or pZl are shown. Of note is the observation that only large 
terminal fragments with uc terimi were observed.
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for subsequent packaging events. This mechanism possibly operates to produce R-0 
GPCMV genomes which lack the terminal repeat at one end (McVoy et al., 1997). 
However, HSV-1 always has at least one ‘a’ sequence at each terminus so this mechanism is 
unlikely to operate in HSV-1. An alternative scenario is the ‘theft’ model of DNA packaging 
(Varmuza & Smiley, 1985). In this model cleavage occurs before the first ‘a’ sequence, at 
least one unit length is then packaged and a second cleavage event occurs after the next ‘a’ 
sequence. The packaged molecule thus contains an ‘a’ sequence at each end but the free end 
of the concatemer lacks an ‘a’ sequence (figure 3.22 B). Packaging might resume at the next 
‘a’ sequence in the concatemer but the intervening DNA would need to be degraded or 
excised. This appears to represent a wasteful method of DNA packaging which the virus 
probably manages to avoid. This is because the virus genome contains at least one ‘a’ 
sequences at each terminus which are linked together when the viral genome circularises. 
The presence of tandem ‘a’ sequences in the replicated concatemer would allow cleavage to 
produce both packaged molecules and concatemer ends containing ‘a’ sequences. In the case 
of the transient packaging assay using pYl the theft mechanism would not be as wasteful as 
it would be for the viral genome, which may explain why pYl does not appear to be 
impaired with respect to pZl and pSAl. The pYl plasmid is considerably smaller than the 
viral genome and concatemers containing as many as 40 copies of pY1 may be packaged into 
one viral capsid. After a cleavage event which produced a concatemer lacking a terminal ‘a’ 
sequence, only one unit length would be lost before a functional terminus was regenerated, 
(i.e. 1/40 of the amount packaged). Therefore, if pYl were packaged via the theft of an ‘a’ 
sequence from a neighbouring molecule it would probably not appear to be noticeably 
impaired with respect to pZl and pSAl.
An alternative is that pYl has gained all or part of an ‘a’ sequence in order to generate a 
uc-DRl-ub sequence arrangement. From this work the possibility that this is occurring 
cannot be totally eliminated, however, a number of observations suggest that it is unlikely. 
If high frequency recombination were occurring between the pYl plasmid and helper virus, 
or even between pY 1 molecules, then plasmid monomers which are greater than unit length 
would be observed. The addition of an entire ‘a’ sequence to pYl would generate a 
sequence similar to that present in pZl, and as a consequence multiple large terminal 
fragments would be expected to be observed. Since these effects were not observed the 
possibility that pY 1 has gained any sequence seems unlikely.
Finally, cleavage could be occurring via the staggered nick model (Varmuza & Smiley, 
1985). This mechanism requires that a nick be introduced at either end of the ‘a’ sequence, 
on alternate strands, so that either strand separation or repair synthesis could effectively 
generate an approximately 400 bp long cohesive end. This, however, would suggest a
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continued amplification of the ‘a’ sequence which is not observed during natural infection or 
the passaging of defective genomes.
Despite all of the uncertainties it is clear that the Uc-DRl-ub sequence can act as a 
functional cleavage and packaging signal for HSV-1, and, as the smallest sequence available 
represents an ideal template with which to conduct a mutagenesis study.
3.1.12.2 - The variation in efficiency between lipofection and calcium  
phosphate transfection assays.
The observation that calcium phosphate precipitation results in more efficient 
replication and packaging than lipofection is surprising. When a LacZ containing plasmid 
was used, lipofection reproducibly resulted in far higher numbers of cells expressing 
13-galactosidase than with calcium phosphate. It is possible that differences between the 
relative number of plasmid molecules delivered to the cells, or the nuclear sites to which they 
are delivered, may account for this difference. Another possible explanation may be that the 
process of lipofection has a detrimental effect on the subsequent expression of helper 
functions by super infecting virus.
3.1.12.3 - Multiplicity of infection.
The difference between the optimal MOI for replication and packaging, using HSV-1 
or HSV-2, probably reflects a fine balance between providing sufficient amounts of the 
proteins necessary for the replication and packaging and competition for the proteins between 
the amplicon and viral genomes. It is worth remembering that for HSV-1 the particle to pfu 
ratio is between 10:1 and 50:1 (Stow & Stow, 1986). This means that for every genome 
which is delivered to the cell and goes on to establish a successful infection, as many as 50 
genomes may also be delivered but, for some reason, fail to establish a productive infection. 
A proportion of this pool of viral genomes may also be able to sequester the viral proteins 
necessary for efficient DNA packaging.
There were two reasons for repeating the multiplicity of infection experiments with 
HSV-2. The origin of replication and the packaging signal in pSAl are both from HSV-1 
and although HSV-2 can functionally substitute for HSV-1 as helper virus, the interactions 
between these elements and the viral proteins may not be optimal. Secondly, HSV-1 helper 
virus was prepared as a cell released virus (CRV) preparation, i.e. virus particles released 
from the cell. For HSV-2, as less virus is actually released into the media, the vims was 
prepared as a cell associated vims (CAV) preparation. It was observed that the application of
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CAV at a given MOI resulted in a far higher cpe than the same MOI applied with CRV, 
possibly due to the effects of intra cellular proteins.
The observed optimal multiplicities of infection with HSV-2 were lower than those 
observed for HSV-1, and this may have several causes. The higher cpe observed using 
HSV-2 probably plays a role in reducing the optimal multiplicity, because at higher MOIs 
increasing numbers of cells detach from the plate. It is also possible that the higher particle 
to pfu ratio for HSV-2 has a role. The protein expression from the larger number of non 
infectious genomes delivered by HSV-2 may elevate the level of viral proteins in vivo, with 
the corresponding effect of reducing the multiplicity required for maximum efficiency 
replication or packaging.
3.1.12.4 - Delayed super infection.
An increase in the efficiency of replication and packaging was associated with delayed 
super infection with wild type virus . It seems likely that the majority of the increase seen is 
a consequence of the increase in the number of cells available as centres for viral replication 
and packaging. When the cells divide after transfection the transfected pSAl would be 
expected to divide randomly between the two daughter cells. This means that theoretically, 
provided transfected cells contain a reasonable number of plasmid molecules (e.g. 20), it is 
highly probable that both daughter cells will receive some plasmid DNA. As it is does not 
appear that the number of plasmid molecules per cell is a limiting factor in the yield of the 
transient assays (see section 3.1.4), spreading the same amount of DNA between a larger 
number of potential centres for viral replication will have the effect of increasing the overall 
amount of plasmid which is replicated and packaged.
3.1.12.5 - The DMSO boost.
The results presented in section 3.1.7 showed that although DMSO increased gene 
expression from a p-galactosidase expressing plasmid which was delivered to the cells by 
the calcium phosphate technique it had little effect on plasmid replication.
DMSO has a range of biological effects. It is commonly used as an antifreeze for 
proteins, an additive to cell storage media, and inducer of cellular differentiation (Nomura & 
Oishi, 1983). In vitro it has been shown to up-regulate transcription (Juang & Liu, 1987), 
as well as increasing the infectivity of viral RNAs and DNAs (Tovell & Coulter, 1969; Stow 
& Wilkie, 1976).
The mechanism by which DMSO, when employed in conjunction with the calcium 
phosphate technique, is able to increase the infectivity of viral DNA and increase the level of
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expression from transfected DNA is not clearly understood. However, the failure of DMSO 
to increase plasmid replication in this assay provides evidence that it may act at the level of 
gene expression rather than directly on DNA delivery.
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Section 3 .2  - Site directed mutagenesis o f  the HSV-1 packaging s ignal.
u .-D R l-U h
3.2.1 - Introduction.
The ‘a’ sequence of HSV-1 is composed of a number of repeat regions and two quasi 
unique regions called ub and uc. Parts of these quasi unique regions have attracted particular 
attention as similar sequences have been identified at the termini of a wide variety of 
herpesviruses (Spaete & Mocarski, 1985; Diess et al, 1986; McVoy et al, 1998). The 
observation that these same two regions are essential for cleavage and packaging of the viral 
genome has directly implicated them in the cleavage and packaging process and has lead to 
them being labelled the p ad  and pac2 homologies (Deiss et al, 1986). Comparison of the 
terminal sequences from many different herpesviruses, including those which lack terminally 
redundant sequences, has lead to a proposed breakdown of the pad  and pac2 homologies 
into a number of different elements (Deiss & Frenkel, 1986). Figure 3.23 shows these 
different elements in the arrangement found in the 200 bp packaging signal present in 
amplicon pSAl. This sequence spans the junction between two tandemly repeated ‘a’ 
sequences. It is proposed that for HSV-1 p ad  comprises 3 distinct elements; 2 GC rich 
elements of 43 and 12 bp separated by a T rich element of 8 bp. Deiss et a l (1986) 
proposed that the pac2 homology of HSV-1 is composed of 4 distinct elements; a 7 bp 
consensus sequence (CGCCGCG), 31 bp of unconserved sequence, a 6 bp T rich element 
and a 14 bp GC rich element. The pad-containing ub and pac2-containing uc sequences are 
separated by a single DR1 repeat region which contains the site of viral cleavage, although 
the actual sequence of the DR1 repeat has been shown to be non-essential for cleavage to 
occur (Varmuza and Smiley, 1985)
The aim of the work described in this section was to alter the uc-DRl-ub packaging 
signal by constructing specific substitution and deletion mutations. The mutated packaging 
signals would then be tested in the transient packaging assay described in section 3.1 to 
evaluate the roles of the various sequence elements.
The substitution and deletion mutations of the uc-DRl-ub packaging signal were 
largely based on the individual elements proposed by Deiss & Frenkel (1986). In addition 
the entire p ad  and 2 homologies were individually deleted and a substitution mutation at the 
site of viral cleavage in the DR1 repeat was constructed. A complete list of the designed 
mutations is shown in table 3.6.
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Table 3.6 - Designed mutations in the uc-D R l-u b sequence.
Mutation Element
S ize
p ad  deletion 63 bp
pac2 deletion 59 bp
DR1 substitution 20 bp
p ad  T element substitution 8 bp
pad  T element deletion 8 bp
pac2 T element substitution 6 bp
pac2 T element deletion 6 bp
p ad  GC distal element deletion 12 bp
p ad  GC distal element substitution 12 bp
pac2 GC element deletion 14 bp
pac2 GC element substitution 14 bp
pac2 consensus deletion 7 bp
pac2 consensus substitution 7 bp
pac2 unconserved region deletion 32 bp
pac2 unconserved region substitution 32 bp
p ad  proximal GC element deletion 43 bp
p ad  proximal GC element substitution 43 bp
The deletion of the complete p ad  and pac2 regions could be achieved using restriction 
enzyme digestion, the remainder of the mutations were introduced into the packaging signal 
using a modified Kunkel mutagenesis method (Kunkel et al., 1991). This method involves 
the synthesis of a uracil-rich single-stranded copy of the plasmid containing the region to be 
mutagenised. The sequence to be mutagenised is placed in a plasmid which contains the f 1 
origin of replication, and the plasmid is propagated in a dut~ ung~ strain of E. coli, which is 
unable to repair uridylate residues incorporated into the DNA in place of thymidylate. Upon 
subsequent infection with an fl-related bacteriophage the plasmid will be replicated and 
packaged (like the phage genome) as a single stranded copy. The phage particles can then be 
harvested and the single stranded DNA recovered. Bacteriophage R408 is used to infect the 
bacterial culture as it has a reduced efficiency to package its own DNA, thus reducing the 
amount of bacteriophage DNA in the final preparation (Russel et al., 1986). The site 
directed mutagenesis involves synthesising the second strand of the plasmid in vitro. An 
oligonucleotide primer is used to prime DNA synthesis, the primer contains the mutation of 
choice flanked by approximately 15 bases which are complementary to the template. Once 
the second strand has been synthesised the plasmid DNA is used to transform a dut+ ung+
19
Results
strain of E.coli. These bacteria are able to recognise the uridine residues incorporated in the 
parental strand, which they remove and repair using the mutated second strand as a template. 
This procedure thus enriches the proportion of bacterial colonies that contain the desired 
mutation. A flow diagram of this method as applied to the mutagenesis of the HSV-1 
uc-DRl-ub sequence is shown in figures 3.24 & 3.25.
3.2.2 - Cloning the uc-D R l-u b sequence from pSAl to pTZ18U.
pSAl does not contain an fl origin, therefore it was necessary to re-clone the 
uc-DRl-ub sequence into a suitable vector in order to produce ss plasmid DNA. The plasmid 
chosen for this purpose was pTZ18U (figure 3.26) as it contains all of the necessary features 
for in vitro mutagenesis and DNA sequencing.
pSAl was digested using EcoRl and Hindlll, which releases the uc-DRl-ub insert 
from the plasmid backbone. The digested DNA was then run on an agarose gel alongside 
pAT153 / Hinfl markers (figure 3.27 panel A). The lower band of 200 bp was excised from 
the gel and electroeluted. The electroeluted band was then further purified over a DEAE 
sephacel column, and precipitated with ethanol. The precipitated DNA was resuspended and 
an aliquot was run on an agarose gel (figure 3.27 panel B).
pTZ18U was digested with EcoRl, Hindlll and CIP. After digestion the DNA was 
phenol chloroform extracted and ethanol precipitated. The precipitated DNA was 
resuspended and an aliquot run on an agarose gel, (figure 3.27 panel C).
The purified fragments were ligated together using T4 DNA ligase, in the presence of 
an excess of insert. The products of the ligation were sequentially extracted with phenol and 
chloroform and used to transform E.coli DH5a cells. Small scale plasmid preparations were 
made from ampicillin resistant colonies, the DNA was digested with Drain and run on an 
agarose gel. D rain cuts once in pTZ18U and a successful ligation of a single insert would 
yield a single band 200 bp larger than the linearised pTZ18U. Figure 3.28 shows the 
ethidium bromide stained gel of this digest and shows that lanes 2-12 contain a single band 
of the expected size. Lane 13 contains multiple bands which may be consistent with 
undigested plasmid DNA. Colony 18.7 was grown up and stored at -70°C. The plasmid 
was designated pTZ2. Cleavage of pTZ2 with EcoRl and Hindlll yielded fragments which 
co-migrated with the 200 bp pSAl insert and the linearised pTZ18U DNA. The identity of 
the insert was confirmed by DNA sequencing which revealed that the sequence was identical 
to that expected (see figure 3.31)
80
Pr
od
uc
tiv
e 
in
fe
ct
io
n
O00COXCl00 O
01 oocoCO-D
f
o o
C
’Si) -3d •C .
73 ^  OS
'S ^  Q55 oo >0 
3^ c 3 oo
Gh '5 O g
(N c3 5  w3 C 73 Q-H o c oo
Q< (J  (0 w
—00
_c
’ot
73cCO
C /3
oo
to
co
’d.
oou.
00§C*
ES.O O o J*
XO 00 ■ p *—ITt
• — T3o ■ -
« -5"O <D C ,Cc0 *3
f . .
on O
X
co
73 Xu 5?00 > t« M 2X 00 -c
°  71 
<7 . E  O
E G73 CO .3
5*7 <u 00 73 00 %00 CO g0 £  ii 
3  C l  00
1  % 
a .  .£  co
75 x 0000CO
X
C -o
cO
■e00 *->COCO 00 00X) s  
^ w
H o .5 x
<o
tii
cOco
(N>—>
u
oox
H
s
co |  73c ^
e S 
£ x
o Eu. -r
oo
2 ‘300 CO 
£ 3
a
§  c
§ £—J g 00
U co 'C
a * o
2 8 C
t  « 50
5/5 £  X■~3 4-1
8 'oo -£
t*J § £
<N
N ao 
H x
CL ^
5 S
J2 _c
E3
'-a oo oo
E
O 10 oo
00 o 9
S  co 3
00 COa3 003O"00C/)
c n  r -H
.2 oD- CO
00 o JO 
c  c c i  3•a « j,
i l §
C O  > 3
Eo
x
7 300 •u. < />
c 0
Q _00
—
" o
i -
C L . ‘E
c 0
C /3 o .
< 7 300
z C /5C O
_ o oQ
c / 3 00
C /) L .
00 3 o» 001
3
£
ua
<
Q
CAt/3
CmO
coVC9s-3Cl00s-2m
<*3
oou
33D Th
is 
flo
w 
di
ag
ra
m
 
ill
us
tr
at
es
 
the
 
pr
oc
ed
ur
e 
us
ed
 
to 
ob
ta
in
 
ur
id
in
e 
ric
h 
ss 
pT
Z2
 
pl
as
m
id
 
D
N
A
, 
us
ed
 
in 
the
 
m
od
ifi
ed
 
K
un
ke
l 
m
et
ho
d 
of
 
sit
e-
di
re
ct
ed
 
m
ut
ag
en
es
is
.
1) The mutagenic 
oligonucleotide is 
annealed to the ss 
DNA template.
2) In vitro DNA 
synthesis.
3) Continuing in vitro 
DNA synthesis and 
ligation.
5) In vivo the 
uridine residues are 
repaired using the 
mutagenic strand as 
a template.
w
►
6) The mutation 
is conserved on 
both strands.
Figure 3.25 - Site directed mutagenesis usi
4) The products are 
used to transform dut+ 
ung+ E.coli.
7 )Bacteria containing 
the plasmid produce an 
ampicillin resistant 
colony, 
a modified Kunkel method.
This flow diagram illustrates the procedure used to make site specific mutations in the 
uc-DRl-ub sequence, using the modified Kunkel method (Kunkel et al., 1991).
1) An oligonucleotide containing the mutation and 30 complementary flanking 
nucleotides is annealed to the single stranded template. 2) The products of the annealing 
reaction are used as a template for in vitro DNA synthesis using T7 DNA polymerase. 3) 
The ends of the completed new DNA strand are then ligated together by T4 DNA ligase. 
4) The products of the in vitro DNA synthesis and ligation are used to transform dut+ 
ung+ E.coli DH5a, 5) The dut+ ung+ E. coli DH5a remove the uridine residues in the 
parental strand of the plasmid, using the mutagenic strand as a template for repair 
synthesis. 6) This has the effect of copying the mutation onto both strands. 7) The 
plasmid is then isolated from an ampicillin resistant colony.
Universal primer site
pTZ 18U 
2863 bp
EcoRl
Sad
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Xma\
BamHI
Xba\
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Ampicillin resistance gene
Figure 3.26 - pTZ18U, phagemid cloning vector, used for site directed mutagenesis 
and sequencing.
pTZ18U is a multi functional plasmid, designed to permit DNA cloning, dideoxy DNA 
sequencing, in vitro mutagenesis and in vitro transcription. It has the pUC18 MCS 
inserted into a lacZ gene, which is under the control of the T7 promoter. Just upstream of 
the T7 promoter and the MCS is a binding site for the universal sequencing primer. The 
plasmid also contains a fi-lactamase gene for selection purposes.
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Figure 3.27 - Cloning the uc-DRl-ub fragment from pSAl into pTZ18U.
Panel A lanes 2 and 3, contain 50//g of EcoRl, Hindlll digest of pSAl. The lower band 
(labelled *) is the 200 bp uc-DRl-ub fragment. This band was excised from the gel, 
electroeluted and purified over a DEAE-Sephacel column. Lanes 1 and 4 contain pAT153 / 
Hinfl markers.
Panel B lane 1, contains pAT153 / Hinfl markers. Lane 2 contains 0.4 pig of purified 
uc-DRl-ub fragment.
Panel C lane 1, contains pAT153 / Hinfl markers. Lane 2 shows OApig EcoRl, Hindlll 
and CIP digested pTZ18U.
Figure 3.28 - Screening bacterial colonies transformed with pTZ18U, uc-DRl-ub 
ligation.
DNA from the colonies indicated in lanes 2-13 was digested with Dralll and the 
products resolved on a 0.8% agarose TBE gel. Dralll digestion will cut once in the 
backbone of pTZ18U based plasmids. Colonies which contain pTZ18U with the 
uc-DRl-ub sequence inserted between the LcoRI and Hindlll sites will consequently be 
200 bp larger than linearised pTZ18U.
Colonies in lanes 2-12 contain a single band which is slightly larger than the linearised 
pTZ18U, consistent with the insertion of the 200 bp insert. The origin of the extra bands 
in lane 13 is not certain but may represent partially digested plasmid molecules. Lanes 
1 and 14 contain 0.4 fig of linearised pTZ18U. Clone 18.7 was selected, grown up and 
stored at -70°C. The plasmid was designated pTZ2.
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3.2.3 - Deletion mutagenesis of the uc-D R l-u b sequence using restriction 
enzym es.
The use of restriction enzymes allowed the p ad  and pac2 elements to be individually 
deleted from the uc-DRl-ub sequence (figure 3.23).
Using S a d I, a fragment containing the pac2 element plus a further 18 bp of uc and 4 
bp of the DR1 repeat was excised from pSAl. Similarly, using Banll, 8 bp of the DR1 
repeat and all but 2 bp of p a d  was excised from pTZ2.
The plasmids were digested with the appropriate enzyme, extracted sequentially with 
phenol and chloroform and precipitated with ethanol. The DNA was re-ligated using T4 
DNA ligase. The products of the ligation were then used to transform E. coli DH5a, small 
scale DNA preparations were made from ampicillin resistant colonies and the DNA was 
digested with restriction enzymes in order to identify colonies containing plasmids with the 
required deletions.
Figure 3.29, panel A, shows the screening of pac2 deletion colonies with £coRI and 
Hindlll. The fragment inserted between the two sites, which spans the uc-DRl-ub sequence, 
is 200 bp in pSAl but is predicted to be 80 bp shorter in the deletion mutant. Lanes 2-11 
and lane 13 contain DNA, containing the required mutation, the 120 bp fragment is marked 
with an arrow, lane 12 appears to contain the parental undeleted fragment (marked *). The 
regeneration of the Sad i site was also confirmed. A stock of clone 3.1 was stored at -70°C 
and the plasmid from this clone is subsequently referred to as pPH3. For sequencing 
purposes this deletion mutant of the uc-DRl-ub sequence was also recloned into pTZ18U. 
The resulting plasmid was grown up and stored at -70°C as pTZ3 stock.
Figure 3.29, panel B, shows the screening of p ad  deletion colonies. The required 
deletion mutant lacks one of four Dral sites in the pTZ2 plasmid and screening was based on 
the loss of this site. Dral digestion of the pTZ2 plasmid produces 4 fragments, the two 
largest being 1217 and 1081 bp. The loss of the Dral site in the mutant means that only three 
fragments are produced; the two large fragments being replaced by a single one of 2218 bp. 
The DNA from the colonies in lanes 4,5,7,9,11,13 and 14 all show the mutant pattern. The 
remaining clones (Lanes 6,10,12 and 15) have the profile expected for the parent plasmid. 
Clone 4.1 was grown up and stored at -70°C. The plasmid from this clone is subsequently 
referred to as pTZ4.
The structure of both of these mutants was later confirmed by sequencing the region of 
the pTZ plasmid containing the uc-DRl-ub sequence.
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Figure 3.29 - p a d  and pac2 deletion mutagenesis of the uc-DRl-ub packaging 
signal.
Panel A shows £<%>RI plus Hindlll digested DNA, (on an 8% acrylamide TBE gel) 
from pac2 deletion colonies. The expected size of the insert is 120bp as opposed to the 
200bp insert in the parent plasmid. The DNA in lanes 2-11 and 13 all contain an insert 
of the expected size (marked with an arrow). The colony labelled 3.7 (lane 8) appears 
not to contain an insert and the colony labelled 3.11 (lane 12) contains a 200bp insert 
(labelled *). Lane 1 (M) contains 0.5 pg of DcoRI, Hindlll digested pSAl (the parent 
plasmid) and lane 14, (M*) contains pAT153 / Hinfl marker.
Panel B shows Dral digested DNA (on a 0.8% agarose TBE gel) from pad deletion 
colonies. The loss of a single Dral site from the parent plasmid, caused by the deletion 
of pad, results in the loss of 2 fragments (1217 & 1081 bp) and the appearance of a 
larger fragment (2218 bp) in the mutant.
Lanes 4, 5, 7-9, 11,13 & 14 contain mutated plasmids. Lanes 6, 10, 12 and 15 show 
the parental pattern of bands. Lanes 1 and 17 (M) contain XI Hindlll markers and lanes 
2 and 18 (M*) contain pAT153 / Hinfl marker.
Results
3.2.4 - Preparation of uracil rich ss DNA from pTZ2.
In order to construct the remaining mutants it was necessary to produce uracil rich 
single stranded pTZ2 DNA as a template for the modified Kunkel method of site directed 
mutagenesis. The ss DNA was prepared in E.coli strain CJ236. This strain of E.coli has the 
dut~ ung~ genotype, which means it is deficient in the mechanism which inhibits the 
accumulation of uridine in the cell’s DNA, and also in the repair pathway which recognises 
and excises the incorporated uridine. For this reason uridine residues accumulate in the 
DNA of cells, especially when they are grown in a uracil rich media.
The bacteria containing the pTZ2 plasmid, were grown up as an overnight culture from 
which an aliquot was used to inoculate a larger culture. The large culture was subsequently 
infected with the ss bacteriophage R408 (Russel et al., 1986). The phage particles released 
during productive infection contain either ss bacteriophage DNA or single stranded plasmid 
DNA, which has been replicated and packaged as a consequence of containing the f 1 origin 
of replication. The phage-like particles were harvested and their DNA extracted, an aliquot 
of which was visualised on an agarose gel.
In the experiment, shown in figure 3.30, three cultures were grown and infected with 
R408 in parallel. Lane 1 contains the DNA harvested from a culture of E.coli strain CJ236 
which did not contain the pTZ2 plasmid. Lanes 2 and 3 contain DNA harvested from two 
parallel E.coli strain CJ236 cultures containing pTZ2. Lane 4 contains M l3 genomic DNA, 
a close relative of the R408 bacteriophage. From this gel it is clear that the upper band in 
lanes 2 and 3 is R408 phage DNA (approximately 5900 bp) while the lower band is ss pTZ2 
plasmid DNA (3063 bp). The reason for the variation in the levels of single stranded pTZ2 
and R408 DNA between preparations is not clear. It is probable, however, that the variation 
reflects slight differences in the density of the bacterial culture at the time of infection with 
R408. Both DNA preparations were used equally successfully as a template for the site 
directed mutagenesis reactions.
3.2.5 - Site directed mutagenesis.
Specific substitution and deletion mutations in the uc-DRl-ub packaging signal were 
constructed based on the elements proposed by Deiss & Frenkel (1986). As described in the 
introduction to this section, the site directed mutagenesis was carried out using a modified 
Kunkel method (Kunkel et al. 1991) - using oligonucleotides which would specifically 
substitute or delete each of the seven elements proposed for pad  and pac2 homologies. An 
additional oligonucleotide which would substitute 9 residues at the usual site for viral 
cleavage in the DR1 repeat was also designed.
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Figure 3.30 - Preparation of uracil enriched ss DNA.
Uracil enriched ss DNA was produced in E.coli strain CJ236 containing the pTZ2 
plasmid. The bacteria were infected with the packaging-deficient ss bacteriophage R408 
and the resultant phage particles harvested.
Lane 1 contains ss DNA harvested from a control culture of E.coli Strain CJ236 which 
lacked the pTZ2 plasmid. Lanes 2 and 3 contains ss DNA harvested from parallel 
cultures of E.coli strain CJ236 which contained the pTZ2 plasmid. Lane 4 contains 0.5 
/ig of M13 ss bacteriophage DNA.
Results
The sequences of the mutagenic oligonucleotides and their positions with respect to the 
wild type sequence are shown in table 3.7 and figure 3.31. Each substitution mutation was 
designed to include a chosen restriction enzyme site to facilitate the identification of mutant 
colonies. In order to reduce nucleotide identity between the wild type and mutant sequences, 
both Seal and Xhol were used. For the smaller substitutions (e.g. T rich elements) the 
remaining sequence was chosen to avoid identical residues occupying the same location in 
the wild type and mutant sequences. For the longer substitutions (e.g. pac2 unconserved 
region) sequences were generated using a random number generator to avoid any 
unintentional bias in the sequence. A series of random numbers was generated using a 
pocket calculator and the numbers 1-4 were ascribed to the residues G(l), A(2), T(3) and 
C(4). Each time a number between 1 and 4 was encountered in the series of random 
numbers the corresponding residue was added to the substitution sequence. This was done 
until the required number of bases had been generated.
In the experiment shown in figure 3.32 two mutagenesis reactions were set up using 
mutagenic oligonucleotide 6. The oligonucleotide was annealed to the template DNA in 
both, polymerase and ligase enzymes were then added to one reaction but not the other, both 
reactions were incubated at RT and 37°C and the products were used to transform competent 
E. coli DH5a. After the polymerisation step an aliquot from each reaction was removed and 
run on an agarose gel. Figure 3.31 shows this gel. Lane 2 contains the sample taken from 
the reaction which lacked polymerase and ligase enzymes and lane 3 contains the sample take 
from the reaction where the enzymes were included. The pattern of DNA was significantly 
altered when the annealed oligonucleotide and template were incubated in the presence of 
polymerase and ligase, suggesting that synthesis of the second strand had occurred. 
However, the profile of the DNA is not consistent with a simple shift of single stranded 
pTZ2 to double stranded un-supercoiled form, although a faint band corresponding to this is 
present comigrating with the upper band of the plasmid DNA (lane 4). The main shift in the 
DNA profile has been of the R408 DNA which has almost exclusively moved to a higher 
molecular weight (lower mobility) form. This shift may be consistent with the synthesis of 
R408 second strand, however, R408 second strand synthesis is initiated by a phage encoded 
messenger RNA which is not present in the in vitro reaction. It is possible that second 
strand synthesis has been initiated by double stranded regions of the genome
Second strand synthesis was performed using all 15 mutagenic oligonucleotides and 
the products were used to transform E.coli DH5a . Ampicillin resistant colonies were then 
screened for the presence of the appropriate mutation.
83
Ta
bl
e 
3.7
 
- S
eq
ue
nc
es
 o
f 
m
ut
ag
en
ic
 
ol
ig
on
uc
le
ot
id
es
 c
om
pa
re
d 
to 
te
m
pl
at
e 
se
qu
en
ce
.
o  0
0  uu  0  o o  o o
Eh Eh
u  u  
&H Eh 0 O 
0 0 0 o a o  
u  u
o u O 0
big  0 0
0 0
0 0 0 0
0 0 
0 00 0 
0 0 
0 0
0 0
0 0 O 00 0 0 0
0 0 0 0
0 0 
0 0
0 0
0 0
0 0 
0 <
0 0 
0 0
S S
0 0
S o  
0 0 
0 0 
0 0 
0 0
0 0
0 0 0 0
0 0
0 0 
0 0 0 0 
Eh Eh 
0 0 
Eh Eh 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0
0 0
o oU 00 0 0 0 0 0 0 0 0 0 0 0 0 0
0
0 0 J 0 0 0 0 0 0 0 0 00 0
0 0 0 0 0 0 
0 0
0 0
0 0 
0 0
0 0 O 0
0 00 0 
0 0 
0 0
0 0 0 0 
0 00 0 0 0 0 00 0
(N C/5CN c/5 CN c/5 
CD cm
3
cd <d 0,’d
CN c/5
cd <D CL.T3Oh c/1 C3 <D cd CD cd <D Oh CDCD c/5 CD <DC D  c/5 CD c/5CD <D CD <D
Th
e 
te
m
pl
at
e 
se
qu
en
ce
 
is 
sh
ow
n 
in 
gre
y 
and
 
the
 
ol
ig
on
uc
le
ot
id
e 
se
qu
en
ce
 i
s 
sh
ow
n 
be
lo
w
. 
... 
de
no
te 
de
let
ed
 
nu
cl
eo
tid
es
 a
nd
 
the
 
sit
es 
of 
m
ut
at
io
n 
are
 
un
de
rli
ne
d.
 F
or 
m
ut
ati
on
 
6 
the
 
re
sid
ue
 w
hic
h 
is 
at 
the
 
S 
te
rm
in
us
 o
f 
the
 v
ira
l 
ge
no
m
e 
is 
sh
ow
n 
in 
bo
ld
. 
Th
e 
m
ut
ati
on
 
nu
m
be
r 
co
rre
sp
on
ds
 t
o 
th
e 
pl
as
m
id
 
nu
m
be
r 
in 
bo
th 
pT
Z 
and
 
pPH
 
se
rie
s.
g0)
<N gO 0) 
& ® 
U
o
G
*3 aG <U
V
C3
a
<No
G
GO
'53d<D( - i
T3a)
£Oh a>
CO
Go o 
G  
G
co
G
_ ,  co<a ay <u5 CO
& i  f loo
0uoauo
0
IT
00o<u
0u000
0
0
0
0
0
0
0
0
0
0
0
0P.
r l !
C!
i I
3;o*
?!
4 4
3*3o. o
8:
J, hJo o
.2 St3 D
Ga>
^  S^ ag «Q-i o
Oaa
G<U
6
CD
13
U
O
13
S
’*
2
O h
ga)&<ut-H
^■H
04
Q
pP
P
P
0
P
0
p ~ .
4 4
0
0
P
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
/ N j
4 4
? !
S -a* 2o» o
VoGV 
G0<o>to
XIS
Q
o>-C-m
CmO
GO• P*
G
r>
u
GWD
0 
0 
0 
0 
0 
0 
p  
0 
r j 
P
0
0
0
0
0
0
P
0
P
0
Th
is 
dia
gra
m 
sho
w 
the
 
se
qu
en
ce
 
of 
the
 
uc
-D
Rl
-u
b 
fra
gm
en
t, 
wi
th 
the
 
po
sit
io
ns
 o
f 
th
e 
m
ut
ag
en
ic 
ol
ig
on
uc
le
tid
es
 m
ar
ke
d.
 
pa
c2
 
se
qu
en
ce
s 
are
 
sh
ow
n 
in 
bl
ue
, 
the
 
DR
1 
re
pe
at 
is 
sh
ow
n 
in 
red
 
and
 
the
 
pad
 
se
qu
en
ce
s 
are
 
sh
ow
n 
in 
gr
ee
n.
Figure 3.32 - Stages o f m utagenesis.
Lane 1 contains 2 //I of the ss DNA preparation used in this mutagenesis reaction. Lane 
2 contains 5 jt\ of mutagenesis reaction, following annealing of a mutagenic 
oligonucleotide and incubation with polymerisation / ligation buffer for 30 minutes at RT 
and 30 minutes at 37°C. Lane 3 is identical to lane 2 except that T7 DNA polymerase 
and T4 ligase were also added following the annealing of the mutagenic oligonucleotide. 
Lane 4 contains 0.5 jig of uncut ds pTZ2.
Results
3.2.6 - Screening bacterial colonies for mutants.
Initial identification of colonies which contained mutagenised uc-DRl-Ub sequences 
was achieved in one of two ways. Substitution mutants were screened on the basis of the 
specifically engineered restriction enzyme sites which were present in the mutagenic 
oligonucleotides. Deletion mutants were screened on the basis of changes in the size of the 
uc-DRl-ub fragment by digesting the plasmids with EcoRl and Hindlll.
Small scale DNA preparations were prepared from ampicillin resistant colonies, which 
had been transformed with the products of the mutagenesis reactions, and the DNA was 
digested with appropriate enzymes. The restriction enzymes used to screen for each 
mutation are shown in table 3.7.
Figure 3.33 shows two representative agarose gels. Panel A contains DNA from 
colonies resulting from mutagenesis using oligonucleotide 6 (substitution of the cleavage site 
in the DR1 repeat). The DNA has been digested with Seal, which cleaves once in the parent 
plasmid and is expected to cleave twice in the mutant. Lanes 1, 3 and 5 show the parental 
pattern of a single linearised band. Lanes 2 and 4 appear to contain a mixed population of 
parental and mutated plasmids; digestion with Seal giving rise to both linear plasmid and also 
the 2 fragments consistent with the presence of the additional engineered site. In reality 
however, this was a frequently observed phenomenon when Seal was used. It appears more 
likely that this pattern of bands reflects partial digestion of mutated plasmid DNA. Colony
6.6 (lane 6) contains the pattern of bands expected from a mutated plasmid, this colony was 
selected, grown up and stored at -70°C as the pTZ6 stock.
Panel B contains DNA prepared from colonies transformed with the products of a 
mutagenesis reaction using oligonucleotide 9 (pac2 T rich element substitution). The DNA 
has been digested with Xhol, which does not cut the parent plasmid but cuts once in 
plasmids carrying the required mutation. Lanes 1 and 3 contain unmutated plasmid DNA. 
Lanes 2, 4, 5 and 6 all contain plasmid DNA carrying the mutated sequence. Clone 9.2 (lane
2) was selected, grown up and stored at -70°C as the pTZ9 stock.
Figure 3.34 shows a representative acrylamide gel used for identifying deletion 
mutants. Lanes 2-9 contain small scale DNA preparations from ampicillin resistant colonies, 
transformed with the products of mutagenesis reactions. These colonies have been 
transformed with products prepared using either oligonucleotide 11 (pad distal GC element 
deletion) or oligonucleotide 15 (pac2 GC element deletion), (labelled 11.1-4 and 15.1-4 
respectively). The DNA was digested with EcoRl and Hindlll and run on a non-denaturing 
polyacrylamide gel. The wt fragment in the parental plasmid is 200 bp, mutated plasmids are 
predicted to contain inserts of 188 and 186 bp. The DNA in lanes 2-5 (11.1-4) show 3 
inserts without deletions (lanes 2,3 and 5) and one insert containing a deletion (lane 4).
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Figure 3.33 - Screening colonies, derived from mutagenesis, for the presence of 
engineered restriction enzyme sites.
DNA was prepared from the colonies indicated. The DNA was digested with Seal 
(panel A) or Xhol (panel B) and the products resolved on a 0.8% agarose gel.
In Panel A, lanes 1-6, a profile containing 2 bands is indicative of a mutated plasmid. 
Lanes 1, 3 and 5 contain DNA with the parental pattern of bands. Lanes 2 and 4 appear 
to contain a mixed population of plasmid molecules and lane 6 contains plasmid DNA 
carrying the required mutation. Lanes 8 and 9 contain 0.5 //g of Seal digested pTZ18U 
(M) and pAT153 / Hinfl markers (M*) respectively.
In Panel B, lanes 1-6, the presence of a single linearised plasmid band is indicative of 
successful mutagenesis. Lanes 1 and 3 contain DNA with the parental sequence while 
lanes 2 and 4-6 contain plasmid DNA with the mutated sequence. Lanes 7 and 8 are 
empty and lane 9 contains uncut small scale pTZ9 DNA preparation.
Figure 3.34 - Screening colonies, derived from mutagenesis, for the presence of 
deletions.
DNA was prepared from the colonies indicated in lanes 2-9 and digested with FcoRI 
and Hindlll. The products were resolved on an 8% acrylamide TBE gel.
The parental fragment is 200 bp in size, deletion mutants therefore contain a smaller 
insert.
Lanes 2, 3, 5 and 9 contain parental 200bp inserts. Lanes 4 and 7 contain deletion 
mutations of approximately the expected size, lane 6 contains a mutant with a deletion 
significantly larger than expected. Lane 8 appears to lack either one of the restriction 
enzyme sites or an insert. Lane 1 contains pAT153 / Hinfl markers (M).
Results
Clone 11.3 was therefore selected, grown up and stored at -70°C as pTZl 1 stock. The DNA 
in lanes 6-9 shows a range of differently sized inserts. Lane 9 appears to contain the parental 
fragment (albeit faintly) and lane 8 does not appear to contain an EcoRl, Hindlll insert. The 
DNA in Lanes 6 and 7 both appear to contain deletion mutations, however clone 15.1 (lane 
6) appears to contain a deletion which is significantly greater than the 14 bp expected. Clone
15.2 (lane 7) contains a deletion of approximately the expected size. It was decided that in 
this case both clones warranted further investigation so both were grown up and stored at 
-70°C as pTZ15.1 and pTZ15.2 stocks.
All of the required mutants except one were obtained in this way, the exception being 
the deletion of the p ad  T rich element using oligo 8. Despite screening in excess of 80 
colonies, gel purifying and then re-synthesising the oligonucleotide, this mutation remained 
elusive.
3.2.7 - Sequencing of mutations made in the uc-D R l-u b sequence.
In order to ensure that the mutated uc-DRl-ub mutants contained the specifically 
designed mutation and that no additional mutations were present, each mutant was sequenced 
using an Perkin Elmer automated sequencer.
The appropriately selected plasmids were prepared using Qiagen midi columns™ and 
the double stranded DNA was resuspended at 0.2 |ig fxl“l . An aliquot of this solution was 
then provided to the Institute of Virology sequencing service which sequenced the double 
stranded template using the M13 forward ‘universal’ primer.
The sequence spanning the uc-DRl-ub region was provided both as a printed sequence 
and as an electropherogram. Figure 3.35 shows the electropherogram for the sequencing of 
pTZ15.1. The ZscoRI and Hindlll sites which flank the uc-DRl-ub sequence have been 
marked in red and the sites of the two deletions have been marked with *. pTZ15.1 contains 
two deletions, the engineered deletion of 14 bp marked (*) at position 86 and a second 
spontaneous deletion of 35 bp also marked (*) at position 72.
The sequencing of the remaining mutants showed that each mutant contained the 
designed mutation with no other deviation from the wild type sequence.
3.2.8 - Cloning mutated uc-D R l-u b sequences into pSl.
In order to assay the mutated uc-DRl-ub sequences for their ability to direct cleavage 
and packaging in a transient packaging assay, it was first necessary to re-clone the mutated 
packaging signals back into the pS 1 vector. This could have been achieved by individually
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Figure 3.35 - Sequencing data from the Perkin Elmer automated sequencer.
The above electropherogram shows the results from the automated sequencing of 
pTZ15.1. Each coloured peak corresponds to the position of either an A(Green), T(Red), 
G(black) or C(Blue) residue in the sequence. The E cy;RI and Hindlll sites which flank 
the uc-DRl-ub sequence have been marked in red. The sites of the mutation have been 
marked (*). The spontaneous deletion at position 72 is 35 bp long and spans the pac2 
consensus sequence and most of the pac2 unconserved region, the deletion at position 86 
is the engineered deletion of the 14 bp pac2 GC rich element. The sequence of both 
deleted regions is also shown above.
Results
gel purifying each mutated uc-DRl-ub fragment. However, considering the number of 
fragments involved an alternative strategy, avoiding fragment purification, was employed.
The mutated pTZ plasmids were digested with EcoRl, Hindlll and Hinfl. The iscoRI 
and Hindlll enzymes excise the uc-DR 1 -ub sequence from the plasmid backbone and Hinfl 
cuts multiple times in the pTZ plasmid, which will prevent it from re-circularising. This 
digestion produces a population of DNA fragments, the majority of which have Hinfl sticky 
ends. Only one fragment (containing the uc-DRl-ub sequence) has an EcoRl and a Hindlll 
sticky end. The pSl plasmid was prepared by digesting it with EcoRl, Hindlll and CIP. 
The CIP de-phosphorylates the 5’ and 3’ termini, preventing the vector from circularising 
without a phosphorylated insert.
The restriction enzyme digests were sequentially extracted with phenol and 
chloroform, ethanol precipitated and the DNA resuspended. An aliquot of the digested DNA 
was then run on an agarose gel (figure 3.36 panel A).
Ligation reactions with T4 DNA ligase were performed using amounts of vector and 
pTZ DNA determined from inspection of the ethidium bromide stained gel. The products 
were used to transform competent E. coli DH5a. Small scale DNA preparations were then 
prepared from ampicillin resistant colonies and the DNA examined for the presence of the 
appropriate insert. Figure 3.36 panel B shows EcoRl and Hindlll digested small scale DNA 
preparation from colonies transformed with the products from ligating pTZ19 fragments to 
pSl. Lanes 3 and 5-15 all contain an insert of the appropriate size(169 bp) released by 
EcoRl and Hindlll digestion. Lane 4 contains plasmid DNA which does not appear to 
contain an insert, either as a result of vector re-circularisation in the absence of an insert or, 
more likely, the illegitimate insertion of a DNA fragment which did not regenerate both 
EcoRl or Hindlll sites, i.e. the insert of a fragment which contains at least one Hinfl 
terminus. Colony 19.1 was grown up and stored at -70°C and the plasmid was 
subsequently referred to as pPH19. The lowest band in the sample lanes (3-14) is an artefact 
produced by the presence of 0.3% SDS in the samples loaded onto the gel. SDS was added 
to the loading buffers following the observation that with small scale DNA preparations the 
small EcoRl and Hindlll fragments frequently exhibited a band shift effect when run on 
acrylamide gels. This was probably the result of bacterial DNA-binding proteins binding to 
the fragment and impeding its progress through the gel.
All 17 inserts from the pTZ series of plasmids were successfully transferred to pSl to 
generate the corresponding pPH plasmids.
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Figure 3.36 - Cloning mutated uc-DRl-ub fragments into pSl.
The indicated mutant plasmids were digested with EcoRl, Hindlll and Hinfl (panel A 
lanes 1-6). pSl was digested with EcoRl, Hindlll and CIP (panel A lane 7). An aliquot 
of the products was then resolved on a 0.8 % agarose TBE gel.
Following ligation and transformation into competent bacteria, DNA was prepared from 
the colonies. Panel B shows 14 colonies isolated following transformation with the 
pTZ19 ligation products. The DNA was digested with EcoRl and Hindlll and the 
products resolved on an 8 % acrylamide gel. The insert of a 200 bp fragment, in lanes 3 
and 5-14 is indicative of a successful ligation. The lowest band in the sample lanes is an 
artefact caused by the presence of 0.3% SDS in the samples. Lane 1 contains pAT153 / 
Hinfl markers (M).
Results
3.2.9 - Discussion.
3.2.9.1 - Isolation of mutants.
As described above 17 mutants of the uc-DRl-Ub sequence were successfully isolated 
and transferred to the pS 1 plasmid so that their ability to direct cleavage and packaging could 
be assessed. The cause of the difficulties encountered in isolating the p ad  T rich element 
deletion mutant were not identified during the course of this work. Examination of the 
uc-DRl-ub sequence, however, reveals that successfully generating this mutation would 
generate a poly G tract 14 bp long (see figure 3.31). There is no evidence whether this 
might interfere with the mutagenesis reaction but this single feature differentiates this mutant 
from the other 14 which were successfully isolated using the modified Kunkel method. The 
presence of the poly G tract in the mutagenic oligonucleotide may have precluded correct 
annealing to the single stranded DNA. An alternative is that the required product containing 
the poly G tract might be deleterious to or unstable in E.coli. It should be possible to design 
and test other oligonucleotides to introduce this mutation. For example, correct annealing 
could be investigated by performing di-deoxy sequencing reactions on the products of the 
annealing reaction.
3.2.9.2 - Double deletions.
The cause of the double deletions which were occasionally observed also remains 
unclear. They were observed for mutants prepared using oligonucleotides 15 and 21. In 
mutant 15.1 the additional mutation deletes 35 nucleotides spanning the consensus sequence 
and most of the unconserved region of pac2. In mutant 21A (data not shown) 84 nucleotides 
from 1 base into the pac2 unconserved region through to 9 bases into the pad  proximal GC 
element were deleted. No correlation between the site of deletion and the oligonucleotide 
sequence is apparent and no direct repeats are found flanking the spontaneously deleted 
regions. The only common features are that both these additional deletions remove, all or 
most of the pac2 unconserved region and both have a single A residue at one end.
The ability of each of the mutants described above, to direct cleavage and packaging in 
the transient packaging assay for HSV-1 is described in the following section.
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Results
Section 3 .3  - A nalysis o f  mutated packaging s ignals.
3.3.1 - Introduction.
As described in section 3.2 seventeen mutants of the uc-DRl-ub sequence were 
isolated, sequenced and cloned into pSl to generate the pPH series of plasmids. It was then 
possible to assay the mutated packaging signals for their ability to direct cleavage and 
packaging, using the optimised conditions for the transient packaging assay described in 
section 3.1.
In order to address the possibility that some mutants might be able to direct packaging 
only because the mutation had been corrected as a result of recombination with the helper 
virus, two investigations were carried out. The substitution mutations with an engineered 
Xhol marker were tested to see whether the packaged DNA still contained the restriction 
enzyme site. The continued presence of the site would indicate that the sequence at the site 
of mutation remains intact. In addition 16 mutants (i.e. all mutants except pPH15.1) were 
assayed using the optimised transient packaging assay with HSV-2 as the helper virus, in an 
attempt to reduce the possibilities for recombination between the plasmid and the helper 
virus..
The functions of the elements contained within the uc-DRl-ub sequence were further 
examined using a transient passaging assay system. This enabled the behaviour of the 
mutated packaging signals to be assessed in an assay which required packaged amplicon 
DNA to re-enter a productive round of replication i.e. to be re-circularised and act as a 
template for virus directed DNA replication.
The passaging assay used was described by Stow et al, (1983). Using this assay it is 
possible to identify those sequences which enable defective genomes to be serially passaged 
in the presence of a helper virus, i.e. not only the sequences which are necessary to direct the 
encapsidation of the genome but also any sequences which are required for entry into a 
second round of replication. The assay is similar to the transient packaging assay, except 
that a virus stock is prepared from the transfected and superinfected cells. This virus stock is 
used to infect a second monolayer of cells and, after allowing time for the replication of the 
virus, total cellular DNA is harvested. The presence and level of defective genome 
sequences in the second monolayer is indicative of the ability of the uc-DRl-ub variant to 
direct DNA packaging into virus particles and also to facilitate re-entry into a productive 
round of replication.
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3.3.2 - Transient packaging assays using amplicons containing mutated
uc-D R l-u b sequences.
In these experiments the mutant packaging signals described in section 3.2 were used 
to dissect the functional elements contained within the uc-DRl-ub sequence. This was 
achieved by testing each mutant in the transient packaging assay, using the optimised 
conditions described in section 3.1.
BHK-21 C13 monolayers were transfected with pSAl, pSl or one of the pPH 
plasmids (except the double deletion mutant pPH15.1) using the calcium phosphate 
procedure. The monolayers were DMSO boosted at 4 hours post-transfection and 
superinfected (multiplicity of 1.0) with wfHSV-1 at 30 hours post-transfection. Total and 
packaged DNA were prepared 16 hours later. The harvested DNAs were digested with 
EcoRl and Dpnl before the products were resolved on an agarose gel. The ethidium bromide 
stained gel was then examined using long wave UV light to ensure that the samples had been 
recovered at a consistent level and that the restriction enzyme digestion had been completed 
successfully. The gel was then Southern blotted as described in the methods section. The 
ethidium bromide stained gels and the phosphorimages from an experiment conducted in this 
way are shown in figures 3.37 and 3.38.
Figure 3.37 shows the ethidium stained gels which were blotted to generate the 
Southern blots in figure 3.38. The ethidium bromide stained gels show that the recovery of 
the different samples was reasonably consistent and that the restriction enzyme digestion was 
successful. The ethidium bromide stained gels for other experiments in this section are not 
shown but those presented in figure 3.37 are a representative example.
Figure 3.38 A shows the total DNA harvested from cells transfected with pSAl, pSl 
or one of the pPH plasmids. The DNA in lane 3 is from cells transfected with pSAl and 
mock infected, the remaining sample lanes contain DNA harvested from cells transfected 
with pSAl, pS 1 or one of the mutant plasmids (as labelled) and infected with w^HSV-1. As 
expected, each plasmid has been replicated at a similar efficiency enabling a good 
comparison of the levels of packaging. Figure 3.38 B shows the accompanying packaged 
samples for this experiment. Again, Lane 3 contains DNA harvested from cells transfected 
with pSAl and mock infected. The remaining sample lanes contain DNA from cells 
transfected with pSAl, pSl or one of the mutant plasmids (as labelled) and infected with 
wfHSV-1. pSAl (lane 4), which is the positive control and parent plasmid, has been 
packaged, while pSl, which is the negative control, has been unable to direct its own 
packaging. Visual inspection indicates that, 6 mutants are significantly impaired for 
packaging, these being pPH3, 4, 9, 10, 15.2 and 19 (lanes 6, 7, 10, 11, 17 and 21 
respectively). These mutants contain the pac2 deletion (pPH3), pad  deletion (pPH4), the
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Figure 3.37 - Ethidium  brom ide stained gels prior to Southern blotting.
The gels above were Southern blotted to give the phosphorimages shown in 
figure 3.38.
Panel A corresponds to panel A of figure 3.38 and contains the total DNA 
samples for the experiment. The amount of DNA in each lane is reasonably 
uniform indicating consistent recovery.
Panel B corresponds to panel B of figure 3.38 and contains the packaged DNA 
samples for this experiment; again recovery is fairly consistent.
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Figure 3.38 - Transient packaging assay with pPH series plasmids - 1.
BHK 21 C13 monolayers were transfected with either pSAl, pSl or one of the pPH 
plasmids as indicated in lanes 3-12 and 16-24 A and B. Monolayers were DMSO 
boosted 4 hours post transfection. All monolayers, except the control (MI) plate 
(lanes 3), were super-infected with w/HSV-1 strain 17 (multiplicity of 1.0) at 30 hours 
post transfection. 16 hours post infection total (A) and packaged (B) DNA was 
harvested. The DNA was £coRI and Dpnl digested and the products resolved on a 
0.8% agarose TBE gel. The gel was Southern blotted and the membrane probed with 
32P labelled pATl53. Lanes 1, 14, 26 A and B, and 13 B contain 1 ng of linear pSAl.
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substitution and deletion mutations of the pac2 T rich element (pPH9 and 10), the deletions 
of the pac2 GC rich element (pPH15.2) and the pac2 unconserved region (pPH19). The 
results of this experiment were further analysed by measuring the intensity of each band 
using the phosphorimager software (Molecular Dynamics), which enabled a quantitative 
comparison of the packaging efficiencies to be made. The data from this experiment, and a 
number of smaller experiments using mutant amplicons, are shown in table 3.8.
These data clearly identify the importance of the p ad  and pac2 homologies in the 
cleavage and packaging process, both pPH3 and pPH4 being severely impaired in their 
levels of packaging. It is, however, apparent that greater amounts of these plasmids are 
packaged than of the negative control amplicon (pSl).
The importance of the pac2 T rich element is directly indicated by two of the mutants. 
The deletion or substitution of this element results in a reduced or abolished ability to direct 
packaging (pPHIO and pPH9, respectively). pPHIO which contains the deletion mutation is 
reduced in its ability to direct packaging to a level comparable with that of the whole pac 
element deletions (pPH3 and pPH4). pPH9 which contains the substitution mutation is 
significantly reduced in its ability to direct packaging but, interestingly, it consistently 
packages slightly more DNA than the deletion mutant. There are two possible interpretations 
of this observation. The substitution mutation has one nucleotide which is the same as the 
wild type sequence and thus the substituted sequence may potentially retain some limited 
activity. Alternatively, and probably more likely, it is possible that the deletion of the T rich 
element has, in addition to deleting an important element, also disrupted some other 
important feature such as the spacing of other elements within the packaging signal.
Two further mutants are impaired in their ability to direct packaging, these being the 
deletion of the pac2 GC rich element (pPH15.2) and the deletion of the pac2 unconserved 
region (pPH19). These mutations do not affect DNA packaging simply through the absence 
of important sequences, because the substitution of these elements does not affect their 
ability to direct packaging. It appears instead that by deleting these elements some spatial 
arrangement within the packaging signal is affected, and this disrupts the ability of the 
mutant to direct packaging.
The pPH15.1 plasmid was also assayed using the transient packaging assay. This 
plasmid, which contains a uc-DRl-ub sequence from which the pac2 GC rich region and the 
majority of the pac2 unconserved region have been deleted, was seriously deficient in its 
ability to direct cleavage and packaging (data not shown). This is not surprising because 
individual deletion mutations of these regions were also shown to be deficient in their ability 
to direct cleavage and packaging (see table 3.8).
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Results
3.3.3 - Apparent variation in the replicative ability of pPH plasmids.
The result seen in figure 3.38, where total DNA levels were fairly constant for all of 
the mutants tested, contrasts with some results from other experiments which were typically 
similar to those shown in figure 3.39. Again, 16 mutants were assayed using the optimised 
conditions for the transient packaging assay described in section 3.1. However, it is 
immediately apparent that there is a quite noticeable variation between the apparent levels of 
DNA replication for individual plasmids. Lanes 3 and 4 contain DNA from cells transfected 
with pSAl and pSl, the positive and negative controls respectively. pSAl (lane 3) appears 
to have been replicated successfully. pSl, which is identical to pSAl except that it does not 
contain the uc-DRl-ub sequence, appears by contrast to be noticeably impaired with respect 
to its replication. The correlation between apparent replication level and the presence of a 
functional cleavage and packaging signal continues for the mutated plasmids. The intensity 
of the total and packaged bands for this experiment was analysed using the phosphorimager 
software (Molecular Dynamics) and the data is shown in table 3.8. The data show that, 
although the absolute level of replication and packaging varies considerably between 
plasmids, the same plasmids as in Fig 3.38 show most efficient packaging of their replicated 
DNA. The one exception to this is pSAl, which in this experiment has packaged only a 
small proportion of its total DNA. This was explained when the photograph of the packaged 
DNA gel was examined: the photograph shows that the recovery of packaged DNA (as 
judged by the intensity of helper virus bands) was lower in this sample than it was for the 
others. The low level of packaged pSAl, therefore, represents an anomaly confined to this 
experiment.
This experiment is particularly interesting because it was performed in parallel with the 
experiment in figure 3.38. With one exception the experiments were performed identically, 
using the same cell clone, the same plasmid preparations, and the same calcium phosphate 
precipitate. The transfections were carried out only minutes apart and the DNA was prepared 
in an identical fashion. The only difference between the two experiments was in the way that 
the BHK 21 C13 monolayers were prepared. For the experiment shown in figure 3.38 the 
BHK monolayers were seeded with 6xl05 cells from a subconfluent 175 cm2 flask, the 
monolayers were then incubated at 37°C for 24 hours prior to transfection. The BHK21 
C13 monolayers used in the experiment shown in figure 3.39 were seeded with 6xl05 cells 
from a confluent 175 cm2 flask, the monolayers were then incubated at 31°C for 48 hours 
prior to transfection. At the time of transfection both sets of monolayers were almost 
confluent and the cells appeared to be in good health.
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Figure 3.39 - Transient packaging assay with pPH series plasmids - II.
BHK 21 C13 monolayers were transfected with either pSAl, pSl or one of the pPH 
mutated plasmids as indicated in lanes 3-11 and 16-24 A and B. Monolayers were 
DMSO boosted 4 hours post transfection and super-infected with wrHSV-1 strain 17 
(multiplicity of 1.0) at 30 hours post transfection. 16 hours post infection total (A) 
and packaged (B) DNA was harvested. The DNA was FcoRI and Dpn\ digested and 
the products resolved on a 0.8% agarose TBE gel. The gel was Southern blotted and 
the membrane probed with 32P labelled pAT153. Lanes 1,13,14 and 26 A and B 
contain 1 ng of linear pSAl.
Results
Table 3.9 - Transient packaging assays - II.
Plasmid Plasmid Description Band 
Intensity 
Total DNA 
xlO5
Band 
Intensity 
Packaged 
DNA xlO5
Percentage
Packaged
1 ng Marker 153 153 n/a
pSAl parental uc-DRl-ub sequence 368 17.0 4.6
pSl negative control plasmid 114 0.776 0.7
pPH3 Pac2 deletion 138 2.25 1.6
pPH4 p ad  deletion 106 5.15 4.9
pPH6 DR1 substitution 586 110 18.8
PPH7 p ad  T element substitution 1911 367 19.2
pPH9 pac2 T element substitution 187 13.9 7.4
pPHIO pac2 T element deletion 92.1 8.02 8.7
pP H ll p ad  GC distal element deletion 514 130 25.3
pPH12 p a d  GC distal element substitution 790 55.4 7.0
pPH15.2 pac2 GC element deletion 101 13.3 13.2
pPH16 pac2 GC element substitution 759 136 17.9
pPH17 pac2 consensus deletion 428 86.4 20.2
pPH18 pac2 consensus substitution 649 217 33.4
pPH19 pac2 unconserved region deletion 216 15.8 7.3
pPH20 pac2 unconserved region substitution 842 261 31.0
pPH21 p ad  proximal GC element deletion 631 120 19.0
pPH22 p ad  proximal GC element substitution 405 97.3 24.0
The total and packaged DNA samples were run on separate gels and so data has been 
standardised against the intensity of the 1 ng marker. All the data is shown to 3 
significant figures.
The source of the variability in the amount of replicated plasmid DNA detected was 
considered in some detail. The photograph of the total DNA gel prior to Southern blotting 
was examined in order to confirm that the DNA recovery had been consistent. An attempt 
was also made to check that each plasmid had been transfected into the cells with 
approximately equal efficiency. This was achieved by digesting an aliquot of total DNA 
from the experiment in figure 3.39 with EcoRL and DpnU and then Southern blotting as 
described in the methods section. Dpnll cuts DNA containing the sequence GATC, 
providing that the A residue is unmethylated. This leaves just the input plasmid DNA as 
ZscoRI monomers. No correlation between the apparent level of replication and either the 
level of DNA recovery or the transfection efficiency was apparent (data not shown).
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It appears likely, therefore, that the peculiar variation between these two experiments is 
somehow related to the ‘condition’ of the cells (see discussion).
3.3.4 - Possible repair of mutated sequences by recombination.
The possibility that some of the mutated packaging signals direct cleavage and 
packaging as a consequence of being repaired by recombination with the helper virus, was 
investigated in two ways. Firstly, the substitution mutants which contained an engineered 
Xhol restriction enzyme site at the position of the mutation were screened for the presence of 
the marker site in the packaged DNA. The presence of the marker would indicate that the site 
of mutation remained unaltered. Secondly, the pPH mutants (except pPH15.1) were 
re-assayed using the transient packaging assay with wfHSV-2 strain HG52 as the helper 
virus.
3.3.4.1 - Restriction enzyme analysis.
An aliquot of packaged plasmid DNA for each of the mutants which contained an 
engineered Xhol site was digested with Ahdl and Xhol restriction enzymes, the products 
were resolved on an agarose gel and Southern blotted as described in the methods section. 
The restriction enzyme AMI cuts once in the parental plasmid at a location approximately 1.1 
Kbp from the site of mutation. The Xhol site is not present in the corresponding region of 
wt HSV-1 DNA, so cleavage at this second site indicates the continued presence of the 
substitution mutation. Digestion of mutant plasmid DNA which still contains the Xhol site 
produces two bands of approximately 3.3 Kbp and 1.1 Kbp, dependant on the position of 
the mutation within the uc-DRl-Ub sequence. If the mutation has been repaired by 
recombination with the helper virus the Xhol site would be missing and only a single band,
4.4 Kbp in size, would be observed.
Plasmids pPH7, pPH9, pPH20 and pPH22 contain the engineered Xhol restriction 
enzyme site. Packaged DNA from these plasmids plus an aliquot of packaged pSAl was 
digested as described above and the products were resolved on an agarose gel and Southern 
blotted as described in the methods section. Figure 3.40 shows the phosphorimage of this 
experiment. Lanes 3 & 5-8 contain the digested samples (as labelled). As the Southern blot 
shows, those plasmids which were packaged retained the engineered restriction enzyme site. 
For pPH9 (lane 6), which is significantly impaired in its ability to direct packaging, it is just 
possible to see the 3.3 and 1.1 Kbp bands which indicate that even the small amount which 
is packaged still contains the engineered mutation.
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Figure 3.40 - Ahdl / Xhol digestion of packaged mutants.
Panel A shows packaged DNA from pSAl, pPH7, pPH9, pPH20 and pPH22 (lanes 
3, 5, 6, 7 and 8 respectively) which was digested with Ahdl and Xhol and the products 
resolved on a 0.8 % agarose TBE gel. The presence of the Xhol site in the mutated 
plasmids gives rise to the profile containing two bands, as opposed to the one for the 
parent plasmid. Lane 1 contains 1 ng of linear pSAl (M).
Panel B shows a diagrammatic representation of a pPH7. The engineered Xhol site 
being approximately 1.1 Kbp from the Ahdl site, as shown in the diagram.
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This approach was also attempted to test the integrity of the substitution mutations 
containing the Seal restriction enzyme marker. However, conclusive results using this 
enzyme were not obtained due to the difficulties in achieving 100% digestion with this 
enzyme.
3.3.4.2 - Reducing the opportunity for homologous recombination with the 
helper virus.
As described earlier, one way to reduce the possibility of mutations being repaired by 
recombination with the helper virus is to reduce the degree of homology between the mutant 
and the helper virus. This was achieved by testing the ability of the mutated plasmids to be 
packaged using wfHSV-2 Strain HG52 as the helper virus and the results are shown in 
figure 3.41.
In this experiment, which unfortunately exhibits the phenomenon of reduced levels of 
replicated plasmid in the total DNA fraction, most of the plasmids exhibit the same behaviour 
with HSV-2 as the helper virus as with HSV-1. This again suggests that homologous 
recombination is unlikely to be occurring between plasmids and helper virus (figure 3.4IB). 
If homologous recombination was rescuing mutant plasmids when HSV-1 was used as the 
helper virus it would be expected that some mutant plasmids, which had previously 
appeared competent for cleavage and packaging, would not be so in an HSV-2 directed 
assay. Interestingly, the only difference between the HSV-1 and HSV-2 directed assays was 
the opposite of this. pPH19, which contains a uc-DRl-ub sequence with the pac2 
unconserved region deleted, is significantly impaired in HSV-1 directed transient packaging 
assays, but appears to be unimpaired when HSV-2 is used as the helper virus (figure 3.40 B 
lane 21).
This experiment supports the evidence from the restriction enzyme analysis which 
indicates that mutant plasmids are not being rescued by the helper virus. The behaviour of 
pPH19 does, however, suggest that there may be differences between the essential 
components of the packaging signals of HSV-1 and HSV-2.
3.3.5 - Ability of amplicons to be serially propagated.
As described earlier (section 3.3.1) the mutant plasmids were also assayed for their 
ability to be serially passaged. For this to be possible the plasmids must behave as defective 
genomes. This means that they must be replicated, cleaved and packaged into preformed 
capsids, and then be released from the cells in viral particles. These particles must be able to 
successfully re-infect fresh cells, and the DNA must re-circularise and re-enter a second
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Figure 3.41 - Transient packaging assay of all mutants using wt HSV-2 as 
helper virus.
BHK 21 C l3 monolayers were transfected with either pSAl, pSl or one of the 
pPH plasmids as indicated in lanes 3-12 and 16-24 A and B. Monolayers were 
DMSO boosted 4 hours post transfection and super-infected with wt HSV-2 strain 
HG52 (multiplicity of 1.0) at 30 hours post transfection. 16 hours post infection 
total (A) and packaged (B) DNA was harvested. The DNA was EcoRI and Dpnl 
digested and the products resolved on a 0.8% agarose TBE gel. The gel was 
Southern blotted and the membrane probed with 32P labelled pAT153. Lanes 
1,13,14 and 26 A and B contain 1 ng of linear pSAl.
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round of replication. The ability of HSV-1 amplicons to be serially passaged was 
demonstrated by Stow etal. (1983) using plasmids containing single and tandemly repeated 
‘a’ sequences. The aim of this section of work was to establish whether plasmids containing 
the uc-DRl-ub sequence could be serially passaged, and whether this process was affected 
by any of the mutations which had been introduced into this region. The experiments would 
also independently assess the ability of mutated uc-DRl-ub sequences to direct packaging.
The serial passaging assay was based on that described by Stow et al. (1983) and is 
illustrated in Fig 3.42. Transfection and superinfection of BHK cells in 35 mm dishes was 
performed as in the transient packaging assay. 16 hours p.i. the cells were scraped into the 
medium and divided into two equal portions. Total cellular DNA was prepared from one 
portion and this is referred to as the ‘pre passage’ DNA. The second portion was sonicated 
to prepare a virus stock. One half of this stock was used to infect a fresh 35 mm plate of 
BHK cells, and 16 hours p.i. total cellular DNA was again prepared; this is referred to as the 
‘post-passage’ DNA. Amounts the pre-passage and post-passage DNAs each representing 
that from one-fifth of the cells on a plate (i.e. 4xl05) were digested with EcoRl and Dpnl. 
The products then resolved on an agarose gel and analysed by Southern blotting.
Three outcomes for this experiment can be envisaged: (i) the replicated amplicon is not 
packaged in the original transfected cells and therefore cannot be serially passaged, (ii) the 
replicated amplicon is packaged but cannot enter a second round of replication when 
passaged (e.g. it may fail to circularise on infection), and (iii) the replicated amplicon is 
packaged and can enter a second round of replication when the virus stock is passaged. 
Since the amount of virus stock used corresponds to only 25% of the original transfected 
monolayer, the presence in the post-passage sample of greater than 25% of the amount of 
replicated plasmid DNA in the pre-passaged sample indicates that replication of the amplicon 
must have occurred on infection of the fresh cells.
The pPH series of plasmids (except the double mutant pPH15.1), pSl and pSAl were 
tested in this way and the results are shown in Fig. 3.43, where the ‘a’ and ‘b’ samples 
correspond to pre-passage and post passage DNA respectively. It can be clearly seen that in 
this experiment all the plasmids replicated to similar levels in the transfected cells (‘a’ 
samples. In addition this experiment clearly shows that the uc-DRl-ub sequence (pSAl) 
contains all of the sequences necessary for serial passaging, since similar intensity bands 
were detected in the pre and post passage DNA samples (lane 5 and 6) indicating that 
replication of the plasmid sequences must have occurred when the virus stock was passaged. 
In contrast pSl, which lacks the uc-DRl-ub element was detected in the pre-passage but not 
the post-passage DNA sample (lanes 7 and 8). The absence of pSl DNA in the post 
passaged sample is probably because the DNA accumulating in the transfected cells is not
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Figure 3.43 - Passaging assay with all mutants.
BHK 21 C13 monolayers were transfected with indicated plasmids (lanes 3-12, 16- 
25, 29-38 and 42-50). The monolayers were DMSO boosted at 4 hours post 
transfection and super-infected with wrHSV-1 strain 17 (multiplicity of 1.0) at 30 
hours post transfection. 16 hours post infection the cells from each monolayer were 
divided into two halves. Total DNA was harvested from one half (indicated as sample 
'a') The other half was used to derive a virus stock. Half of this virus stock was then 
used to infect a fresh BHK 21 C l3 monolayer. 16 hours post re-infection total DNA 
was prepared (indicated as sample 'b'). DNAs ‘a’ and ‘b’ were digested with £ce>RI 
and Dpnl and the products resolved on a 0.8 % agarose TBE gel. The gel was 
Southern blotted and the membrane was probed with 32P labelled pAT153. Lanes 1, 
13, 14, 26, 27, 39, 40 and 52 contain 1 ng linear pSAl.
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packaged and is likely to be sheared into small pieces by the sonication process. These small 
fragments are then either not taken up or degraded by the cells in the second infection.
All the pPH plasmids which were impaired in the transient packaging assay were 
detected at very low levels in the post passage DNA samples (pPH3, pPH4, pPH9, pPHIO, 
pPH15.2 and pPH19). Of the plasmids that were relatively unimpaired in the transient 
packaging assay several behaved similarly to pSAl and gave post passage bands 
approximately equal to (or greater) in intensity to the bands in the pre-passage samples 
(pPH6, pPH7, pPH16, pPH17, pPH18 and pPH20). In contrast four plasmids that were 
relatively unimpaired in the transient packaging assay generated significantly reduced bands 
in the post passage samples (pPH ll, pPH12, pPH21 and pPH22).
In order to examine these observations quantitatively, the intensity of each band was
measured using the phosphorimager software (Molecular Dynamics). 
Table 3.10 - Transient passaging assay.____________________
Plasmid
Serial Passage Assay B eh a v io u r  
in transient 
p a c k a g in g  
assay /  /X
B e h a v io u r  
in transient 
p a s s a g in g  
assay (+- =)
Band Intensity  
Total DNA
xlO ^ plate a
Band Intensity
Total DNA xlO5 
plate b
( a / b ) * 100
pSAl 26.6 27.1 1 01 .9 / n/a
pSl 38.7 1.13 2 .9 X n/a
pPH3 16.7 2.26 13.5 X n/a
pPH4 1.90 0.684 3 . 6 X n/a
pPH6 31.8 27.7 86 . 9 / —
pPH7 41.7 87.6 21 0 . 2 / +
pPH9 28.4 9.00 31 . 7 X +
pPHIO 25.2 2.00 7 . 9 X n/a
pPHl l 31.4 5.91 18.38 / -
pPH12 36.7 5.07 13.8 / -
pPH15.2 27.2 2.63 6 .7 X n/a
pPH16 33.7 46.9 139.2 / =
pPH17 26.0 27.8 106.9 / =
pPH18 22.6 17.8 78 . 6 / —
pPH19 35.6 5.05 14.2 X n/a
pPH20 44.7 39.0 87 . 3 / —
pPH21 31.0 12.9 41 . 7 / -
pPH22 31.3 12.6 40 . 3 / -
The samples were rim on 2 separate gels and so data has been standardised against the 
intensity of the 1 ng markers. All the data is shown xlO^ and to 3 significant figures. /  
or X indicate plasmids that are packaged effectively or poorly, respectively, in the 
transient packaging assay. For the efficiently packaged plasmids the fifth column 
indicates whether these amplicons are passaged with similar (=), lesser (-) or Greater (+) 
efficient than pSAl.
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The data (table 3.10) confirms that pSAl has been serially passaged, the level of pSAl 
in the passaged sample (lane 6) exceeding the maximum value of 25% carry over from the 
pre-passage infection. Each of the 6 mutant plasmids which were impaired for packaging (as 
labelled in table 3.10) are, unsurprisingly, also accumulated to low levels on passaging. One 
plasmid which could be considered an exception to this is pPH9. pPH9, which contains the 
uc-DRl-ub sequence with the pac2 T element substitution mutation, has a post passage band 
intensity of 32% the pre-passage level. This is most likely a reflection of the fact that pPH9 
packages approximately 4% of its replicated DNA (cf. pPH3 which packages around 1%). 
This means that as much as 4 fold more DNA is available to re-establish a second round of 
replication. This relationship between apparent packaging efficiency and the absolute 
amount of plasmid seen in the post passaged sample is also apparent for the other packaging 
deficient plasmids.
These observations suggest that although these amplicons are packaged ineffectively, 
they may nevertheless be capable of being amplified when delivered to fresh cells as 
defective genomes within a virus stock. The quantitative analysis also confirms that pPH6, 
7 , 16, 17, 18 and 20 are unimpaired in their ability to be serially passaged, whilst pPHl 1, 
12, 21 & 22 are passaged less efficiently than pSAl. pPHl 1 and 12 contain the deletion and 
substitution mutations of the p ad  distal GC rich region while pPH21 and 22 contain the 
deletion and substitution mutations of the pad  proximal GC rich region. The mutations in 
the distal GC rich region have resulted in pPH ll and 12 being seriously impaired for 
passaging, the post-passage level of plasmid being less than the 25% of the pre-passaged 
level. It is not possible, however, to determine whether the DNA detected in the post 
passage sample represents solely input DNA from the virus stock or whether limited 
replication of these amplicons has occurred. The mutations in the proximal GC rich region 
of pPH21 and 22 have a less pronounced effect, both plasmids have post passage DNA 
levels of approximately 40% the pre passage level. This suggests that these mutants do 
replicate during passaging albeit with reduced efficiency.
Another interesting observation, which is compounded in the transient passaging 
assay, relates to pPH7 which contains the deletion mutation of the pac 1 T rich element. The 
data in table 3.10 shows that pPH7 has a post-passaged level of DNA which is more than 
twice the pre passaged level, this is also twice the level of passaged pSAl. This is consistent 
with the observation that pPH7 often replicates particularly well in the transient packaging 
assay.
The transient passaging assay has therefore shown that all of the sequences required 
for serially passaging a viral genome are contained within the uc-DRl-ub sequence, and it has 
highlighted the fact that the proximal and distal GC rich regions of p ad  are important in this
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process. In addition, the results from this assay support the observations made using the 
transient packaging assay, which indicated that the GC rich region, the T rich element and 
the unconserved region of pac2, as well as p ad  and pac2 as a whole, are important in the 
encapsidation of HSV-1 DNA.
3.3.6 - D iscussion.
The data presented in this section confirm that the uc-DRl-ub sequence contains all of 
the sequences necessary to act as a functional packaging signal for HSV-1 (Nasseri & 
Mocarski, 1988), and it extends the analysis by identifying specific regions that are 
important for packaging. In addition, it has been shown that the uc-DRl-ub sequence 
contains all of the sequences necessary for the HSV-1 genome to be serially passaged, 
highlighting two regions within the p ad  homology which appear to be important in this 
process. Overall, the mutagenesis has identified 5 regions of the uc-DRl-ub sequence which 
appear to have functions either in the encapsidation of the viral genome or in the ability of 
that genome to be serially passaged. Despite the high recombination rates reported during 
HS V-1 replication, no evidence of mutants being repaired by recombination with the helper 
virus was observed during this study.
3.3.6.1 - The importance o f the p a d  and pac2 homologies.
The key nature of both p a d  and pac2 is indicated by the behaviour of pPH4, and 
pPH3, which are the p ad  and pac2 deletions respectively, although a low level of packaging 
was observed for both plasmids. This is consistent with the work of previous investigators 
who also found that the p ad  and pac2 homologies coincided with regions of the ‘a’ 
sequence which were important in the cleavage and packaging process (Deiss et al., 1986; 
Nasseri & Mocarski, 1988; McVoy et al., 1998. The low level of packaging could 
potentially be caused by recombination between the plasmids and the helper virus, integrated 
copies of the plasmid being packaged into capsids along with the viral genome. This 
possibility appears unlikely however, as no evidence of homologous recombination was 
observed. Another explanation may be that there is a low level of redundancy between the 
two pac elements. This would not be totally surprising as both elements contain a small run 
of T residues flanked by GC rich sequences. Alternatively, it may be that the low level of 
packaging observed represents packaging of DNA under unusual circumstances; for example 
packaging is initiated but the end of the concatemer is reached before a functional termination 
signal is encountered, thus circumventing the need for a termination cleavage event.
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3.3.6.2 - M utations in the p a d  homology.
Five mutations within p ad  were constructed, identifying two regions which are 
required for efficient serial passage of viral genomes. While no specific elements within 
pad  were identified as important in the packaging process, the p ad  region as a whole is 
essential. It is possible that the p ad  region maintains some important contextual feature of 
the packaging signal, or that redundancy within the region means that loss of individual 
regions can be compensated for.
a) M utations in the p a d  GC rich regions.
The transient passaging assay highlighted both the proximal and distal GC rich regions 
of p ad  as important for the serial passage of viral genomes. This involvement of regions of 
the uc-DRl-ub sequence in the passaging of viral genomes is not totally surprising 
considering that these sequences are found at the terminus of the viral genome. It is, 
however, surprising that the important sequences lie exclusively at one terminus. This data 
supports the earlier suggestion that these sequences are important, based on the observation 
that the proximal and distal GC rich regions of p ad  both contain quite well conserved 
regions across a wide range of herpes viruses (see figure 3.44). Their exact role in the 
passaging process cannot be established from this study, but it presumably lies in either the 
release of genomes from the capsid, their delivery to the replication centre or their 
circularisation. Circularisation would appear the most likely of these possibilities, and this 
could be tested by examining the fate of the amplicon DNA following passage into fresh 
cells.
The evidence from these single element mutations is supported by the behaviour of the 
pad  and pac2 deletion mutants. The accumulation of the pac2 deletion mutant (pPH3) after 
passaging is consistent with the plasmid being impaired for packaging, but the small amount 
which is packaged being able to re-initiate infection. The lower level of the pad  deletion 
mutant (pPH4) after passaging suggests that it is impaired in its ability to be packaged and 
also in its ability to re-initiate infection. This, therefore, implies that essential sequences for 
passaging lie within the p ad  homology.
b) Mutation in the p a d  T rich element.
The T rich elements of both p ad  and pac2 have been shown to have conserved 
locations with respect to the termini in a wide variety of herpesviruses (Deiss et al, 1986). 
The exception to this is HCMV which appears to lack a pac2 T rich element (Broil et al, 
1999). This feature of conserved location has lead to at least one model for DNA cleavage
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and packaging which involves cleavage events at a fixed distance from these T rich elements 
(Varmuza & Smiley, 1985). Despite this, the data from the transient packaging assays 
shows that substitution of the p a d  T rich sequence has no observable effect on the ability of 
the mutant to be packaged. There are a number of possible reasons which might underlie 
this observation. The first being that the p ad  T rich element is dispensable in a functional 
cleavage and packaging signal. This conclusion is supported, in part, by the fact that the T 
rich element of p ad  is less well conserved than the pac2 T rich element. This is clear from 
the alignment shown in figure 3.44. This alignment of putative pad  and pac2 sequences 
from a range of herpes viruses was compiled from the sequences presented by Broil et al 
(1999) and Deiss et al. (1986). There is, however, an alternative explanation. The HSV-1 
p ad  T rich element consists of the sequence TGTG(T)4, but there is another (T)4 sequence 
12 bases further from the terminus in the uc region. The possibility exists that in pPH7, 
which has the uc-DRl-ub sequence with the p ad  T rich element substitution mutation, this 
second run of T residues is able to compensate for the loss of the principle T rich element. 
This scenario does not, however, account for the observation that in for example the 
transient passaging assay shown, pPH7 appears to replicate significantly more efficiently 
than pSAl. This may reflect that the p ad  T rich element acts as a negative regulator of 
packaging. The absence of such a signal would imply that more DNA would be packaged.
3.3.6.3 - M utations in the pac2 homology.
Eight mutations within pac2 were constructed and these highlighted one region which 
was directly involved in the packaging process and a further two regions which appear to 
play a more indirect role in affecting either the spacing of different elements or the overall 
structure of the packaging signal. None of the mutations, which between them spanned the 
entire pac2 sequence, had any effect on the ability of the plasmids to be serially passaged 
(i.e. to re-initiate infection).
a) Mutation of the pac2 T rich element.
As mentioned above, the T rich elements of both p ad  and pac2 have been shown to 
have conserved locations with respect to the termini in a wide variety of herpes viruses 
(Deiss et al., 1986).
The data from the transient packaging assays identifies the pac2 T element as an 
important component of the packaging signal. The plasmids containing the substitution 
(pPH9) and the deletion mutation (pPHIO) of the pac2 T rich element are significantly 
impaired in their ability to be packaged. There is, however, a noticeable difference in the
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degree to which these mutants are impaired. pPHIO, which contains the deletion mutation, 
is impaired in packaging to a level similar to that of the mutant deleting all of pac2. pPH9, 
which contains the substitution mutation, is also packaged at a low level, however, it is 
consistently packaged more efficiently than the deletion mutation. Possible explanations for 
this observation are discussed in the context of several other mutations in section 3.3.6.3b.
b) Mutations in the pac2 GC rich and unconserved regions.
The observation that deletion of the pac2 GC rich region (pPHl5.2) disrupts the 
function of the packaging signal, but that substitution (pPHl6) of the same sequence has no 
effect, suggests that the deletion mutation is affecting the spatial arrangement of the 
packaging signal rather than destroying essential sequences. In the uc-DRl-ub sequence the 
pac2 GC rich region separates the pac2 T rich element from the DR1 repeat, which contains 
the site of cleavage, and the pacl region. The observation that the deletion of the pad  
proximal GC rich region has no effect on packaging suggests that deleting the pac2 GC rich 
region is effecting the spacing between an essential pac2 element and the site of cleavage. 
The essential nature and the conserved location of the pac2 T rich element make it a prime 
candidate for this position specific element.
pPH19 contains the pac2 unconserved region deletion mutation. Again, the 
observation that deletion of this element disrupts the ability of the mutant to direct packaging 
but that the substitution mutation has no effect suggests that the mutation is affecting the 
spatial arrangement of the packaging signal. Further evidence supporting this hypothesis can 
be found by comparing the amount of DNA which is packaged by the different substitution 
and deletion mutants of the uc-DRl-ub sequence. Broadly speaking there appear to be three 
classes of mutation: i) Mutations which almost completely abrogate DNA cleavage and 
packaging, e.g. the pac2 deletion, ii) Mutations which significantly impair DNA cleavage 
and packaging, e.g. substitution of the pac2 T rich element, iii) Mutations which do not 
appear to significantly affect DNA cleavage and packaging, e.g. substitution of the pacl T 
rich element. Table 3.11 shows which mutants fall into each group.
pPH15.2 (pac2 GC rich element deletion) falls into the first class, being as impaired as 
the complete pac2 deletion. pPHIO (pac2 T rich element deletion) also fall into this class. 
The substitution of the pac2 T rich element (pPH9) however, while causing significant 
impairment clearly enables more DNA to be packaged than pPHIO, putting this mutation into 
the second class. pPH19 (pac2 unconserved region deletion) also falls into this class. 
Putting all of these observations together, it seems to suggest that there are two 
position-specific features within the pac2 region. The substitution of the pac2 T rich element 
destroys the sequence but maintains the overall spacing of the region, thus leaving the
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hypothetical second element intact. The deletion of the pac2 unconserved region disrupts the 
spacing of the hypothetical second element but leaves the pac2 T rich element unaffected. 
Deletion of the pac2 T rich element or deletion of the pac2 GC rich region destroys or 
displaces both elements, severely impairing the ability of both these mutants to direct 
cleavage and packaging. The obvious importance of the pac2 T rich element indicates that 
this is one position-specific element, but no second element was identified during this study. 
The pac2 consensus sequence, as defined by Deiss et al. (1986), occupies a location which 
would be consistent with this being the position specific-element but, as discussed below, 
mutations in this region failed to disrupt the ability of the mutants to direct packaging.
It, therefore, remains possible that the pac2 unconserved and GC rich sequences are 
somehow involved in the overall structure of the packaging signal, e.g. presenting a specific 
DNA conformation or DNA bending within the packaging signal, as opposed to simply 
affecting the spacing of two position-specific elements.
Table 3.11 - The effect o f different mutations on packaging efficiency.
Seriously Impaired Mutants
Plasmid Mutation Description
pPH3 Pac2 deletion
pPH4 pacl deletion
pPHIO pac2 T element deletion
pPH15.2 pac2 GC element deletion
Partially Impaired Mutants
Plasmid Mutation Description
pPH9 pac2 T element substitution
pPH20 pac2 unconserved region substitution
Unimpaired Mutants
Plasmid Mutation Description
pPH6 DR1 substitution
pPH7 pacl T element substitution
pPH ll pacl GC distal element deletion
pPHl 2 pacl GC distal element substitution
pPHl 6 pac2 GC element substitution
pPH17 pac2 consensus deletion
pPHl 8 pac2 consensus substitution
pPHl 9 pac2 unconserved region deletion
pPH21 pacl proximal GC element deletion
pPH22 pacl proximal GC element substitution
The observation thatpPH19 packages at a similar level to pSAl when HSV-2 is used 
as the helper virus, but is significantly impaired when HSV-1 is used, raises a puzzling 
issue. It was anticipated that the use of HSV-2 as the helper virus would reduce the 
possibility of homologous recombination occurring between the plasmids and the helper 
virus, thus highlighting any mutants which were being rescued as a result of recombination 
with HSV-1 helper virus. The observation that one mutant packages more successfully
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when HSV-2 is the helper virus appears to indicate a degree of flexibility (which was not 
anticipated), in the HSV-2 packaging mechanism. Although surprising, similar observations 
have been reported else where, for example in adenovirus DNA replication. The Adenovirus 
2 (Ad2) origin of replication contains three domains which are required for efficient initiation 
of replication. The three domains include a nine base pair region which is highly conserved 
in all human adenoviruses, and 2 regions which form binding sites for host proteins NFI and 
NFIII. NFI binding is necessary for efficient Ad2 replication in vitro and is absolutely 
essential in vivo. The Ad2 origin of replication can be activated by Ad4 DNA replication 
proteins, but it was noticed that the opposite was not the case. The reason for this is that the 
Ad4 virus does not require NFI binding to its origin, in fact its origin does not contain an 
NFI binding site. This means that Ad4 proteins can initiate replication from an Ad2 origin 
with the NFI binding site deleted, whilst the cognate, Ad2 proteins cannot (Hay, 1985a&b).
Obtaining further insight into this apparent flexibility within the HSV-2 packaging 
mechanism will probably require a more detailed understanding of the function of the pac2 
unconserved region in the packaging process.
c) Mutations in the pac2 consensus sequence.
The data from the transient packaging assays shows that neither the deletion or 
substitution mutations of the pac2 consensus sequence have any effect on packaging. As 
this was difficult to reconcile with either their predicted behaviour or the behaviour of the 
mutants described in section b above, the presence of mutated copies of the uc-DRl-ub 
sequence was confirmed directly by re-sequencing the mutant amplicons.
The evidence therefore, suggests that the pac2 consensus sequence is not the 
hypothetical second position specific-element described earlier. A closer examination of the 
sequence of this region indicates that this might not be unreasonable. The designation of the 
pac2 GC rich region as a highly conserved element is based on sequence comparisons 
between the termini of several different herpes viruses (Deiss et al., 1986). However, the 
GC rich sequence is itself found in a region of the genome which is highly GC rich. In fact 
the 14 bp deletion of the pac2 GC rich region alters the sequence, at the position of the 
consensus sequence, to a sequence in which five of the seven residues are identical to the wt 
sequence. Deletion of the consensus sequence itself replaces the sequence with residues 
which are identical in four of the seven positions. A more recent sequence comparison, 
using newly available sequences, has also found that the so called pac2 consensus sequence 
is less well conserved than had been previously thought (Broil et al., 1999)(see figure 3.44)
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3.3.6.4 - The apparently reduced replication of unpackageable amplicons
The reduced efficiency with which the plasmids impaired for packaging were able to 
replicate in some experiments was not found to be completely unprecedented. A similar 
connection between replication and packaging competence was reported for HHV-6 
amplicons (Deng & Dewhurst, 1998). Although in this virus the packaging signal lies 
adjacent to the origin of replication the pac elements share extensive homology. For HHV-6 
the hypothesis was presented that the activity of the packaging signal somehow up-regulated 
the origin of replication. In the study described here however, the effect appears to be 
intimately related to the cells, possibly to their ‘condition’ or position in the cell cycle. 
Subsequent investigations have revealed that the reduced level of replicated plasmid DNA in 
the total fraction of these experiments is probably a consequence of unpackaged DNA 
degradation during the preparation of the total cellular DNA (N.Stow, personal 
communication). This, combined with the observations made during this study (indicating 
that the effect is related to the cells), suggests that in older or less healthy cells nucleases are 
possibly produced at higher levels or are more active. These enzymes act on the unpackaged 
DNA following the cell lysis with NP40 and prior to SDS / protease treatment. Because the 
packaged DNA is protected from nuclease digestion by the viral capsid, those mutants which 
are deficient for packaging have a higher proportion of their total DNA which is susceptible 
to nuclease digestion. This leads to the apparent reduction in the levels of replication for 
packaging deficient plasmids.
However, these conclusions are unlikely to explain the observations made by Deng 
and Dewhurst (1998) described above. In that study the extra-chromosomal DNA, which is 
equivalent to the total DNA in this study, was prepared using the Hirt method (Hirt, 1967) 
which does not involve cell lysis with NP40. Despite this, it remains possible that the 
observed reduction in the replication of unpackageable amplicons is an artefact of the assay 
system used. The Hirt method of preparing extra-chromosomal DNA relies on pelleting the 
high molecular weight chromosomal DNA and leaving the lower molecular weight DNAs in 
solution. It would appear likely that at least a proportion of the high molecular weight 
replicated plasmid DNA, which will be in concatemeric form, may also be pelleted. As 
described above, those plasmids which are unpackaged will have a larger proportion of their 
total DNA in an unprotected concatemeric form and anything which acts to specifically 
reduce this unpackaged form will have the effect of apparently reducing the level of 
replication.
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Conclusion
Chapter 4 - Conclusion.
In summary, five of the eight elements within the uc-DRl-ub sequence have been 
implicated as being necessary for either DNA packaging or serial passage of the viral 
genome. The pac2 T rich element has been shown to be central to the packaging 
mechanism, both in terms of its sequence and its location. The pac2 GC rich and 
unconserved sequences have been shown to be required for an undefined spacing function in 
the packaging signal. The p ad  proximal and distal GC rich regions have been shown to be 
required for efficient serial propagation of amplicons, most probably in the mechanism of 
circularisation. The DR1 repeat which corresponds to the normal site of viral cleavage has 
also been confirmed as non essential. No specific function could be attributed to two 
regions, the pac2 consensus sequence and the p a d  T element. However, the possibility that 
this is due to redundancy within the packaging signal as opposed to a lack of biological 
function cannot be excluded. This information is summarised in figure 3.45.
S ection  4 .1  - S eq u en ces in vo lved  in  cleavage and packagin g.
This study has directly implicated the pac2 T rich element as a central player in the 
cleavage and packaging process. Mutations which affect either the sequence itself or its 
location with respect to the site of cleavage were impaired in their ability to direct cleavage 
and packaging. This observation is consistent with the hypothesis presented by Varmuza 
and Smiley (1985) which proposed that the T rich elements of p ad  and pac2 functioned to 
direct separate ss cleavage events at a fixed distance. Correspondingly, the pad  T rich 
element mutants might have been anticipated to behave in a similar way. There are in fact, 
several possible explanations for why this was not the case. As described in section 
3.3.6.2b, there is a second (T)4 sequence, 12 bp further away from the S terminus which 
may be able to compensate for the loss of the T rich element. Although if this sequence does 
prove to be involved it would indicate that for p ad  the importance of the location of the T 
rich sequence was significantly reduced. In addition to this, the observation that the pad  T 
rich element is non essential in cleavage and packaging is supported by the sequence 
alignments presented by Broil et al. (1999) which showed that following analysis of a wider 
range of herpesviruses the p ad  T rich element is less well conserved than had been 
previously thought. Despite this, it is possible that the p ad  T rich element has a function in 
cleavage and packaging which has not been identified in this study. Firstly the termini of 
packaged amplicons were not directly examined as part of this study and it remains possible 
the p ad  T rich element has a function analogues to the role of bacteriophage X cosB and 12
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sites in termination. During termination these sequences have been shown to have a role in 
increasing the fidelity of cleavage at the N2 site (Cue & Feiss, 1998). Finally it is also 
possible that the pacl T rich element, functioning as part of a termination signal, could be 
compensated for by a re-initiation cleavage event directed by pac2. However, this would be 
expected to result in at least some reduction in packaging efficiency, which was not 
observed.
The observation that pacl as a whole is essential for cleavage and packaging but that 
no individual element proved to be so, also raises an apparent contradiction. The most 
probable explanation for this is that sequences within the pacl region are essential for 
cleavage and packaging but that they exhibit a degree of redundancy, allowing individual 
elements to be deleted without effecting the function of the region as a whole. As mentioned 
above this may still have consequences for the fidelity of cleavage. Interestingly, parallels 
can be drawn between X cosQ and the pacl sequence in this regard. cosQ is required for the 
efficient termination of packaging in X, having roles in the introduction of nicks at both Nj 
and N2. However, while total deletions of cosQ impair in vivo packaging some mutations in 
cosQ have actually been shown to increase nicking at the N2 site (Cue & Feiss, 1998).
The other surprising result from the cleavage and packaging experiments was the 
un-importance of the pac2 consensus sequence. The alignment of herpesvirus termini 
presented by Deiss et al. (1986) suggested that this sequence was highly conserved and it 
was proposed to have a function in the cleavage and packaging signal. The present study 
has however, shown that this is probably not the case and more recent work tends to support 
this. Firstly, the observation that a degenerate pac2 homologue in GPCMV functions as a 
cleavage and packaging signal but does not appear to contain a sequence corresponding to 
the pac2 consensus sequence appears to suggest that, in GPCMV at least, this sequence is 
not involved in either cleavage, packaging or other events necessary for genome propagation 
(McVoy etal., 1997). Secondly the alignment of herpesvirus termini presented by Broil et 
al, (1999) has also cast doubt on the conservation of the consensus sequence. This 
however, is not the end of the story with regard to the pac2 consensus sequence. Since this 
element is clearly present in a range of herpesviruses including the GPCMV M terminus and 
this may reflect an as yet unidentified biological function.
4 ,2  - Sequen ces in volved  in the serial propagation o f  d efective  genom es.
The attempts to serially passage plasmids containing mutated uc-DRl-ub sequences 
identified two regions of pacl which are important in this process but which were not 
identified as important for cleavage and packaging. Although both the proximal and distal
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GC rich sequences of pac 1 were identified as important their exact function remains unclear. 
It is tempting to suggest that these sequences are involved in the process of circularisation 
which allows the genome / plasmid to enter a second round of replication. It is however, 
possible that mutations in these sequences impair propagation by producing aberrant termini 
during cleavage or that they are involved in other aspects of serial propagation e.g. the 
release of viral DNA from the capsid or the targeting of released DNA to the sites of 
replication within the nucleus. It is interesting to note that the UL36 protein of HSV-1 has 
been implicated both in the release of viral DNA from the capsid and binding to parts of the 
‘a’ sequence, although in that study the probes used were mainly from the pac2 region of the 
‘a’ sequence (Chou & Roizman, 1989).
The lack of identifiable pac2 sequence involvement in the passaging of defective 
genomes may have a number of explanations. It may be that specific pac2 sequences are not 
required, although this would be surprising, as this would suggest that events such as 
circularisation only require the specific recognition of one genome terminus. Alternatively 
the apparent lack of involvement may reflect a level of redundancy within the pac2 sequence. 
However, it should also be noted that the transient passaging assay used in this study will 
only identify sequences involved in serial propagation where they are not also involved in 
cleavage and packaging. This would mean that, for example, the pac2 T rich element maybe 
required for efficient serial propagation but as the mutant is not packaged it is not possible to 
identify any subsequent functions of this sequence. In order to extend this analysis it may 
be possible to artificially generate linear mini genomes containing these mutations and 
transfect the linear DNA into BHK cells in the presence of helper virus. Subsequent 
replication of these plasmids would require circularisation, thus replication would be 
indicative of the presence of the signals necessary for circularisation.
4 .3  - Future w ork .
Several aspects of this study warrant further investigation in order to extend or clarify 
the observations which have already been made.
As mentioned above, the termini of packaged mutants were not examined as part of 
this study but as discussed earlier mutations in the cleavage and packaging signal which 
appear to have little or no effect on packaging may in fact be effecting the fidelity of 
cleavage. Thus an examination of the precise sequences at the termini of packaged 
molecules may provide further insight into the functions of the packaging signal elements.
Additional mutations to delete the (T)4 region with the ub sequence and double deletion 
/ substitution mutants within pacl may help to more clearly identify those sequences which
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are involved in the cleavage and packaging process. In addition work is already underway 
to insert the mutated uc-DRl-ub sequences generated in this study, into the tk locus of 
HSV-1 strain 17. The appearance of novel termini during infection with these recombinant 
viruses will indicate the presence of a functional cleavage and packaging signal and in this 
way test the validity of the observations made in the transient packaging assays described 
here, in the context of the full length viral genome.
Finally a major use for the mutants described here will be hopefully to help in the 
identification of protein interactions with the HSV-1 cleavage and packaging signal. The fact 
that the cleavage and packaging signal used in this study is approximately 200 bp in size 
lends itself to use in mobility shift assays for example. In this way it should be possible to 
identify sequence-specific DNA binding proteins responsible for the encapsidation of the 
viral genome, and also using the mutants to correlate the binding activity with the cleavage 
and packaging of DNA. It is possible that similar approaches will also be useful in 
dissecting the mechanism of genome circularisation.
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